
<html lang="en"     class="pb-page"  data-request-id="8261413e-70ab-41f8-ae06-9b261940cf0c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2011.54.issue-13;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm200483x"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationships of C-17-Substituted Estratriene-3-O-sulfamates as Anticancer Agents" /></meta><meta name="dc.Creator" content="Fabrice  Jourdan" /></meta><meta name="dc.Creator" content="Mathew P.  Leese" /></meta><meta name="dc.Creator" content="Wolfgang  Dohle" /></meta><meta name="dc.Creator" content="Eric  Ferrandis" /></meta><meta name="dc.Creator" content="Simon P.  Newman" /></meta><meta name="dc.Creator" content="Surinder  Chander" /></meta><meta name="dc.Creator" content="Atul  Purohit" /></meta><meta name="dc.Creator" content="Barry V. L.  Potter" /></meta><meta name="dc.Description" content="The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bo..." /></meta><meta name="Description" content="The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bo..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 9, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200483x" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200483x" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200483x" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200483x" /></link>
        
    
    

<title>Structure–Activity Relationships of C-17-Substituted Estratriene-3-O-sulfamates as Anticancer Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200483x" /></meta><meta property="og:title" content="Structure–Activity Relationships of C-17-Substituted Estratriene-3-O-sulfamates as Anticancer Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0008.jpeg" /></meta><meta property="og:description" content="The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bond acceptor is essential for high activity; its optimal linkage to C-17 and the local environment in which it resides are defined. In the non-sulfamoylated series 17β-acyl substitution delivers 48b, the most potent compound identified to date. In the sulfamate series a number of permutations of linker and H-bond acceptor deliver excellent activity, with 55, 61, 65, 49a, and 49b proving especially promising. The in vivo potential of these compounds was explored in the NCI hollow fiber assay and also in a mouse Matrigel model of antiangiogenesis in which 49 and 55 show significant inhibitory activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200483x"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200483x">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200483x&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200483x&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200483x&amp;href=/doi/10.1021/jm200483x" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 4863-4879</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2004688" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200484c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationships of C-17-Substituted Estratriene-3-<i>O</i>-sulfamates as Anticancer Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrice++Jourdan">Fabrice Jourdan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mathew+P.++Leese">Mathew P. Leese</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wolfgang++Dohle">Wolfgang Dohle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Ferrandis">Eric Ferrandis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+P.++Newman">Simon P. Newman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Surinder++Chander">Surinder Chander</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atul++Purohit">Atul Purohit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barry+V.+L.++Potter">Barry V. L. Potter</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-text">Institut de Recherche Henri Beaufour, Ipsen, 91966 Les Ulis Cedex, France</span></div><div class="aff-info" id="aff3"><span class="aff-text">Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Hospital, London, W12 0NN, U.K.</span></div><div class="corresp-info">Phone: +44 1225 386639. Fax: +44 1225 386114. E-mail: <a href="/cdn-cgi/l/email-protection#2f6d01790163017f405b5b4a5d6f4d4e5b47014e4c015a44"><span class="__cf_email__" data-cfemail="41036f176f0d6f112e3535243301232035296f20226f342a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200483x&amp;href=/doi/10.1021%2Fjm200483x" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 4863–4879</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 23, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 April 2011</li><li><span class="item_label"><b>Published</b> online</span>9 June 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 July 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200483x" title="DOI URL">https://doi.org/10.1021/jm200483x</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4863%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFabrice%2BJourdan%252C%2BMathew%2BP.%2BLeese%252C%2BWolfgang%2BDohle%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D13%26contentID%3Djm200483x%26title%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BC-17-Substituted%2BEstratriene-3-O-sulfamates%2Bas%2BAnticancer%2BAgents%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4879%26publicationDate%3DJuly%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200483x"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1070</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200483x" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationships of C-17-Substituted Estratriene-3-O-sulfamates as Anticancer Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fabrice&quot;,&quot;last_name&quot;:&quot;Jourdan&quot;},{&quot;first_name&quot;:&quot;Mathew&quot;,&quot;last_name&quot;:&quot;P. Leese&quot;},{&quot;first_name&quot;:&quot;Wolfgang&quot;,&quot;last_name&quot;:&quot;Dohle&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Ferrandis&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;P. Newman&quot;},{&quot;first_name&quot;:&quot;Surinder&quot;,&quot;last_name&quot;:&quot;Chander&quot;},{&quot;first_name&quot;:&quot;Atul&quot;,&quot;last_name&quot;:&quot;Purohit&quot;},{&quot;first_name&quot;:&quot;Barry&quot;,&quot;last_name&quot;:&quot;V. L. Potter&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;4863-4879&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200483x&quot;},&quot;abstract&quot;:&quot;The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bond acceptor is essential for high activity; its optimal linkage to C-17 and the local environment in which it resides are defined. In the non-sulfamoylated series 17β-acyl substitution delivers 48b, the most potent compound identified to date. In the sulfamate series a number of permutations of linker and H-bond acceptor deliver excellent activity, with 55, 61, 65, 49a, and 49b proving especially promising. The in vivo potential of these compounds was explored in the NCI hollow fiber assay and also in a mouse Matrigel model of antiangiogenesis in which 49 and 55 show significant inhibitory activity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200483x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200483x" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200483x&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200483x" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200483x&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200483x" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200483x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200483x&amp;href=/doi/10.1021/jm200483x" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200483x" /></input><a href="/doi/pdf/10.1021/jm200483x" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200483x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200483x%26sid%3Dliteratum%253Aachs%26pmid%3D21604672%26genre%3Darticle%26aulast%3DJourdan%26date%3D2011%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BC-17-Substituted%2BEstratriene-3-O-sulfamates%2Bas%2BAnticancer%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D13%26spage%3D4863%26epage%3D4879%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291945" title="Ketones">Ketones</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jmcmar.2011.54.issue-13/production/jmcmar.2011.54.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bond acceptor is essential for high activity; its optimal linkage to C-17 and the local environment in which it resides are defined. In the non-sulfamoylated series 17β-acyl substitution delivers <b>48b</b>, the most potent compound identified to date. In the sulfamate series a number of permutations of linker and H-bond acceptor deliver excellent activity, with <b>55</b>, <b>61</b>, <b>65</b>, <b>49a</b>, and <b>49b</b> proving especially promising. The in vivo potential of these compounds was explored in the NCI hollow fiber assay and also in a mouse Matrigel model of antiangiogenesis in which <b>49</b> and <b>55</b> show significant inhibitory activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The hypothesis that inhibition of angiogenesis, by blocking blood vessel formation and thus the blood supply required to support the growth of solid tumors, might constitute a new strategy for the treatment of cancer was made four decades ago.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Recently, a number of drugs disrupting tumor vasculature by targeting vascular endothelial growth factor (VEGF), like the monoclonal antibody bevacizumab<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and the small molecule vascular endothelial growth factor receptor (VEGFR) inhibitors sorafenib<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and sunitinib,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> have gained approval for the treatment of cancer, including various combinations with other anticancer agents.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Clinical studies have shown that the success of anti-VEGF therapy is highly dependent on cancer phenotype and clinical history. Through eradicating excess systemic VEGF, bevacizumab treatment initially effects a maturation of the tumor vasculature; this allows for an enhanced delivery of cytotoxic agent to the tumor and, consequently, improved efficacy relative to single agent cytotoxic therapy.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> However, tumors are able to circumvent blockage of VEGF signaling by, for example, switching to fibroblast growth factor (FGF) to sustain their blood vessel formation:<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> anti-VEGF therapy also results in considerable side effects, and periodic dosing regimes are required to avoid dose limiting toxicity. As a result, rapid tumor regrowth is often observed in the off-dose periods in these regimes after initial tumor regression. In preclinical models there are indications that anti-VEGF therapy may generate more aggressive disease; inhibition of angiogenesis with sunitinib, for example, has been correlated with increased tumor metastasis and decreased overall survival in mice.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Nevertheless, the promising results obtained by combining antiangiogenic agents with other anticancer agents encourage studies into compounds that combine an antiangiogenic effect with a second antitumor activity.<a onclick="showRef(event, 'ref5 ref9'); return false;" href="javascript:void(0);" class="ref ref5 ref9">(5, 9)</a> Furthermore, there is considerable interest in the development of agents that cause a disruption of tumor vasculature through alternative, non-VEGF based mechanisms.</div><div class="NLM_p">In previous studies, we detailed the discovery of a number of sulfamoylated 2-substituted estratriene derivatives that, like the endogenous estrogen metabolite 2-methoxyestradiol <b>1</b> (2-MeOE2), inhibit cancer cell proliferation and angiogenesis. 2-Substituted-estradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamates <b>3</b> (2-MeOE2bisMATE) and <b>4</b> (2-EtE2bisMATE),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and the 2-substituted-estradiol-3-<i>O</i>-sulfamates <b>5</b> (2-MeOE2MATE) and <b>6</b> (2-EtE2MATE)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) are differentiated from <b>1</b> by their enhanced biological activities and superior druglike properties. The excellent oral bioavailability of <b>3</b> (>85% in rodents),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> for example, appears to derive from the ability of a sulfamate group both to block inactivating metabolism and deactivating conjugation, while also allowing the molecule to interact reversibly with carbonic anhydrase.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> This latter reversible interaction, which has been characterized by protein crystallography, may minimize first pass liver metabolism through sequestration of the sulfamate drugs in red blood cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Moreover, as with other aryl sulfamates, <b>3</b>–<b>6</b> are irreversible inhibitors of steroid sulfatase (STS), itself a target for the treatment of hormone dependent cancer.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Although a full mechanistic picture for the activity of these compounds continues to emerge, it was recently shown that their ability to disrupt the tubulin–microtubule equilibrium in cells is critical for their antitumor activity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> It is also important to note, first, that these compounds are not substrates for the P-glycoprotein pump and are thus active against taxane-resistant tumors<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and, second, that their activity is independent of the estrogen receptor even though they are estrogen derivatives.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">The A-ring modified estrogen-3-<i>O</i>-sulfamates were initially synthesized with the goal of obtaining potent nonestrogenic, STS inhibitors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It was subsequently discovered that 2-methoxyestrone-3-<i>O</i>-sulfamate <b>7</b> (2-MeOEMATE) and 2-ethylestrone-3-<i>O</i>-sulfamate <b>8</b> (2-EtEMATE) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) also exhibited an antiproliferative effect against a range of estrogen-independent human cancer cells in vitro.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> SAR studies on the A-ring estrogen-3-<i>O</i>-sulfamates demonstrated that optimal antiproliferative activity is obtained with a 2-methoxy, 2-ethyl, or 2-methylsulfanyl group.<a onclick="showRef(event, 'ref11 ref21'); return false;" href="javascript:void(0);" class="ref ref11 ref21">(11, 21)</a> Further SAR studies focused on D-ring modifications, principally at the C-17 position of the estratriene skeleton. A number of modifications were explored, including variation of the oxidation level of C-17 and substitution at this position. While 17β-hydroxy, 17-keto, and 17-oximino derivatives show similar antiproliferative activity, the 17-deoxy and 17α-benzyl analogues are considerably less active.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Sulfamoylation of the 17β-hydroxy group gave the bis-sulfamates <b>3</b> and <b>4</b> that exhibit slightly enhanced in vitro activity and greatly improved in vivo antitumor effects.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> It was recently established that deletion or substitution of the C-17-oxygen linker of the 17-<i>O</i>-sulfamate group with an electronically neutral methylene group and replacement of the sulfamate’s terminal NH<sub>2</sub> with methyl are well tolerated.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In addition, an SAR study of C-17 cyanated analogues revealed that 2-methoxy-3-<i>O</i>-sulfamoyl-17β-cyanomethylestra-1,3,5(10)-triene <b>11</b> and the corresponding 2-ethyl compound <b>12</b> offer further enhanced antiproliferative and antiangiogenic activities relative to <b>3</b> and <b>4</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> We have also shown that a high level of antiproliferative activity can be retained when a heterocycle possessing a well exposed H-bond acceptor is installed at C-17.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> All data accrued to date indicate that optimal in vitro activity results from three key pharmacophore elements, namely, the C-2 XMe group (X = O, CH<sub>2</sub> or S), the 3-<i>O</i>-sulfamate, and an H-bond acceptor around the C-17 position. Translation of in vitro activities into the in vivo environment is somewhat more complex. For example, when evaluated for activity against the growth of MDA-MB-231 xenografts in female nude athymic mice, <b>11</b> proved to be less active than the corresponding bis-sulfamate <b>3</b>, despite being 4-fold more potent in vitro. This difference in in vitro and in vivo activities observed for <b>3</b> and <b>11</b> is dependent on their respective oral bioavailability, itself a function of their uptake, transport, metabolism, conjugation, and clearance profiles.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of 2-methoxyestradiol <b>1</b>, 2-ethylestradiol <b>2</b>, 2-methoxyestradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamate <b>3</b>, 2-ethylestradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamate <b>4</b>, 2-methoxyestradiol-3-<i>O</i>-sulfamate <b>5</b>, 2-ethylestradiol-3-<i>O</i>-sulfamate <b>6</b>, 2-methoxyestrone-3-<i>O</i>-sulfamate <b>7</b>, 2-ethylestrone-3-<i>O</i>-sulfamate <b>8</b>, 2-methoxy-3-hydroxy-17β-cyanomethyl-1,3,5(10)-estratriene <b>9</b>, 2-ethyl-3-hydroxy-17β-cyanomethylestra-1,3,5(10)-triene <b>10</b>, 2-methoxy-3-<i>O</i>-sulfamoyl-17β-cyanomethylestra-1,3,5(10)-triene <b>11</b>, 2-ethyl-3-<i>O</i>-sulfamoyl-17β-cyanomethylestra-1,3,5(10)-triene <b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In light of these results, we set out to examine whether further C-17 modifications could deliver improvements in both in vitro and, more importantly, in vivo activity and thus embarked on more extensively defining the SAR of this series by synthesizing C-17 modified 2-methoxyestratriene-3-<i>O</i>-sulfamates and 2-ethylestratriene-3-<i>O</i>-sulfamates projecting an oxygen-containing H-bond acceptor (“Z”, see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) around C-17. The linker “Y” between the estratriene ring system and the H-bond acceptor group was varied in length in order to map onto the region of space occupied by the SO<sub>2</sub> group of the bisMATES <b>3</b> and <b>4</b> and that of the cyano group of <b>11</b> and <b>12</b>. We describe here our synthetic approaches to these compounds together with their in vitro biological activities as antiproliferative agents and in vivo data for two selected compounds.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed modifications at C-17 of the 2-substituted estratriene nucleus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26665" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26665" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Previous SAR studies on 2-substituted estratriene-3-<i>O</i>-sulfamates indicated that an H-bond acceptor around C-17 is required for optimal antiproliferative activity and microtubule disruption.<a onclick="showRef(event, 'ref10 ref11 ref16 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref16 ref22 ref23 ref24 ref25">(10, 11, 16, 22-25)</a> Aiming to further refine the series, we set out to tether various oxygen-containing H-bond acceptor functions (e.g., OH, OSO<sub>2</sub>NH<sub>2</sub>, OMe, and COCH<sub>3</sub>) to C-17 of the estratriene nucleus through short linkers. 2-Ethyl-17β-hydroxymethyl-3-<i>O</i>-benzylestra-1,3,5(10)-triene <b>14</b> serves as a common intermediate for the synthesis of the 17β-sulfamoyloxy <b>16</b>, 17 β-methoxymethyl <b>18</b>, and the 17 β-hydroxymethyl derivatives <b>20</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Methylenation of 2-ethyl-3-<i>O</i>-benzylestrone <b>13</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> followed by a stereoselective hydroboration using 9-BBN yielded <b>14</b>. Hydrogenolysis of <b>14</b> delivered phenol <b>15</b> which was then treated with sulfamoyl chloride to give the bis-sulfamate derivative <b>16</b>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Alkylation of <b>14</b> with methyl iodide and subsequent hydrogenolysis afforded the 17β-methoxymethylphenol <b>17</b> which was then converted to sulfamate <b>18</b>. Access to compound <b>20</b> first required a sequence of silyl protection of the aliphatic alcohol and debenzylation. This was found to be best achieved with <i>tert</i>-butyldiphenylsilyl chloride as silylating agent, as other silyl protecting groups like the TBS and TIPS group proved less stable to the following hydrogenolysis. Phenol <b>19</b> was then successively sulfamoylated and desilylated to give the desired sulfamate <b>20</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 17-Hydroxy- and Alkoxymethyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Mg, TiCl<sub>4</sub>, DCM, THF, 0 °C; (ii) 9-BBN, THF, 0 °C, then 37% H<sub>2</sub>O<sub>2</sub>, 10% NaOH, 0 °C; (iii) H<sub>2</sub>, Pd/C, THF, MeOH, room temp; (iv) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (v) NaH, MeI, THF, reflux; (vi) TBDPSCl, imidazole, DMF, room temp; (vii) TBAF, THF, room temp.</p></p></figure><div class="NLM_p">A similar synthetic approach was applied to prepare a series of ether, sulfamate, and hydroxy derivatives incorporating a two-carbon linker to C-17 (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Horner–Wadsworth–Emmons olefination of 2-ethyl-3-<i>O</i>-benzylestrone <b>13</b> with triethyl phosphonoacetate afforded a 5:1 mixture of olefins <b>21</b> and <b>22</b> that were separable by column chromatography. Concomitant debenzylation and olefin reduction over Pd/C afforded ester <b>23</b>. Sulfamoylation of <b>23</b> afforded sulfamate <b>24</b>. Benzyl reprotection of <b>23</b> followed by reduction with LiAlH<sub>4</sub> afforded 2-ethyl-17β-(2-hydroxyethyl)-3-<i>O</i>-benzylestra-1,3,5(10)-triene <b>25</b> that was converted to <b>27</b>, <b>29</b>, and <b>31</b> in a manner analogous to that described for <b>16</b>, <b>18</b>, and <b>20</b> above.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of C-17 Ethyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (EtO)<sub>2</sub>POCH<sub>2</sub>CO<sub>2</sub>Et, NaH, THF, reflux; (ii) H<sub>2</sub>, Pd/C, THF/MeOH, room temp; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (iv) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (v) LiAlH<sub>4</sub>, THF, 0 °C; (vi) MeI, NaH, THF, room temp; (vii) TBDPSCl, imidazole, DMF, room temp; (viii) TBAF, THF, 0 °C.</p></p></figure><div class="NLM_p">In order to prepare the C-17-C-20 olefinic analogues of <b>27</b> and thus explore the effects of the reduced rotational freedom of such compounds on biological activity, 2-ethyl-3-<i>O</i>-(<i>tert</i>-butyldimethylsilyl)estrone <b>32</b> was treated with triethyl phosphonoacetate to give <b>33</b> as a mixture of its <i>E</i> and <i>Z</i> isomers in excellent yield (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Desilylation of <b>33</b> afforded phenols <b>34</b> and <b>35</b> that were separated by flash column chromatography. Each phenol was reacted with sulfamoyl chloride to afford sulfamates <b>36</b> and <b>37</b>, respectively. Upon reduction with DIBAL-H, <b>34</b> and <b>35</b> afforded the corresponding alcohols <b>38</b> and <b>39</b>. Attempts to sulfamoylate both hydroxyl groups with sulfamoyl chloride in DMA<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> or 2,6-di-<i>tert</i>-butyl-4-methylpyridine in DCM proved unsuccessful in this case with 17-vinyl-2-ethyl-3-<i>O</i>-sulfamoylestra-1,3,5(10),16-tetraene <b>40</b> being obtained as the sole product. Presumably, the vinyl sulfamate formed in the reaction is unstable to elimination under the reaction conditions.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0014.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Various C-17 Olefin Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (EtO)<sub>2</sub>POCH<sub>2</sub>CO<sub>2</sub>Et, NaH, THF, reflux; (ii) TBAF, THF, 0 °C; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (iv) DIBAL-H, THF, −78 to 0 °C; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, 2,6-di-<i>tert</i>-butyl-4-methylpyridine, toluene, DCM, room temp.</p></p></figure><div class="NLM_p">2-Ethyl-17-(<i>E</i>)-(2-methoxyethylidene)-3-<i>O</i>-sulfamoylestra-1,3,5(10)-triene <b>41</b> was accessed from ester <b>21</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Reduction of <b>21</b> with LiAlH<sub>4</sub> delivered the vinyl alcohol that was methylated and debenzylated to afford phenol <b>41</b>. Sulfamoylation of <b>41</b> under standard conditions gave <b>42</b>. The sulfamoylated ester <b>36</b> was reduced with DIBAL-H to afford the 17-(<i>E</i>)-hydroxyethylidene derivative <b>43</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of C-17 Tethered Alkoxy and Hydroxy Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LiAlH<sub>4</sub>, THF, 0 °C; (ii) CH<sub>3</sub>I, NaH, THF, room temp; (iii) Na, <i>t</i>-BuOH, reflux; (iv) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (v) DIBAL-H, THF, −78 to 0 °C.</p></p></figure><div class="NLM_p">As mentioned above, the 17β-cyanomethylestra-1,3,5(10)-triene-3-<i>O</i>-sulfamates <b>8</b> and <b>9</b> are particularly potent antiproliferative agents in vitro. We therefore investigated isosteric replacement of the cyano group with a ketone and thus targeted C-17 acylestra-1,3,5(10)-triene-3-<i>O</i>-sulfamates <b>49a</b> and <b>49b</b>. A Wittig reaction between <b>13</b> and ethyltriphenylphosphonium iodide in DMSO furnished olefin <b>45a</b> as a mixture of <i>E</i> and <i>Z</i> isomers (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Hydroboration with borane THF afforded the C-17β-isomer of the alcohol <b>46a</b> along with a trace amount of the corresponding 17α-isomer which could be removed by chromatography; attempts to achieve complete selectivity with 9-BBN proved unsuccessful in this case. Dess–Martin oxidation afforded compound <b>47a</b>, which was converted to the phenol <b>48a</b> and sulfamate <b>49a</b> under standard conditions. The same set of reactions was also carried out with 2-methoxy-3-<i>O</i>-benzylestrone <b>44</b> to afford the 2-methoxy analogues <b>48b</b> and <b>49b</b> for biological evaluation.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 17β-Acyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) EtPPh<sub>3</sub>I, NaH, DMSO, 100 °C; (ii) BH<sub>3</sub>–THF, THF, 0 °C, then NaOH 30%, H<sub>2</sub>O<sub>2</sub>, 37%; (iii) Dess–Martin periodinane, DCM; (iv) H<sub>2</sub>, Pd/C, THF, MeOH; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp.</p></p></figure><div class="NLM_p">Projection of the carbonyl group further from C-17 requires a two-carbon linker, and the 17β-(2-oxopropyl) derivatives <b>55</b> and <b>61</b> were thus elaborated (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). The 17β-cyanomethyl compound <b>50</b> was prepared in analogy to the method described earlier for the synthesis of <b>56</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> A DIBAL-H reduction of <b>50</b> then delivered aldehyde <b>51</b> in good yield. <b>51</b> was reacted with methylmagnesium bromide to afford the secondary alcohol <b>52</b> that was then oxidized to ketone <b>53</b> with Dess–Martin periodinane. Hydrogenolysis of <b>53</b> and subsequent sulfamoylation delivered phenol <b>54</b> and sulfamate <b>55</b> derivatives. 2-Ethyl-3-<i>O</i>-benzyl-17β-cyanomethylestra-1,3,5(10)-triene <b>56</b> was transformed to compounds <b>57</b>–<b>61</b> under analogous conditions.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of C-17 2-Hydroxypropyl and 2-Oxopropyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIBAL-H, THF, 0 °C to room temp; (ii) MeMgBr, THF, 0 °C; (iii) Dess–Martin periodinane, DCM, 0 °C to room temp; (iv) H<sub>2</sub>, Pd/C, THF, MeOH, room temp; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp.</p></p></figure><div class="NLM_p">A shorter and higher yielding route to <b>55</b> was later developed (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). 2-Methoxy-3-<i>O</i>-triisopropylsilyloxyestrone <b>62</b> was converted to the ester <b>63</b> by sequential Horner–Wadsworth–Emmons olefination and hydrogenation as described above for the synthesis of <b>23</b>. A Tebbe methylenation<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> followed by acidic hydrolysis of the intermediate enol ether then delivered ketone <b>64</b> in excellent yield. Deprotection of <b>64</b> and subsequent sulfamoylation furnished sulfamate <b>55</b> in 61% overall yield starting from 2-methoxyestrone. Reduction of <b>55</b> with NaBH<sub>4</sub> afforded 17β-(2-hydroxypropyl) derivative <b>65</b>, while reaction of <b>55</b> with hydroxylamine delivered oxime <b>66</b>.</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Improved Approach to 17-(2-Oxopropyl)estratriene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (EtO)<sub>2</sub>POCH<sub>2</sub>CO<sub>2</sub>Et, NaH, THF, reflux; (ii) H<sub>2</sub>, Pd/C, THF, MeOH, room temp; (iii) Tebbe reagent, pyridine, THF, toluene, −78 to 0 °C; (iv) 2 M HCl, room temp; (v) TBAF, THF, room temp; (vi) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (vii) NaBH<sub>4</sub>, <i>i</i>-PrOH, THF, room temp; (viii) H<sub>2</sub>NOH·HCl, NaOAc, MeOH/H<sub>2</sub>O, room temp.</p></p></figure><div class="NLM_p">We also wished to assess the antiproliferative activity of C-17 fluorinated analogues of sulfamates <b>31</b>, <b>55</b>, and <b>61</b>, since fluorine has long proven to be a successful bioisostere of the hydroxyl in various contexts.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> We therefore treated compound <b>25</b> with DAST to afford <b>67</b> that, after successive debenzylation and sulfamoylation, gave access to phenol <b>68</b> and sulfamate <b>69</b>, respectively (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>). Similarly, aldehyde <b>57</b> could be transformed into the difluoro compounds <b>70</b>–<b>72</b>.</div><figure id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of 17-(Fluoroethyl)estratriene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DAST, THF, 0 °C; (ii) H<sub>2</sub>, Pd/C, THF, MeOH, room temp; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Biology</h3><div class="NLM_p">To assess their potential as anticancer agents, the series of novel 2-ethyl- and 2-methoxyestratriene derivatives was evaluated for antiproliferative activity against DU-145 (androgen receptor negative) prostate cancer cells and MDA-MB-231 (estrogen receptor negative) and MCF-7 (estrogen receptor positive) breast cancer cells in vitro. The results of these assays and comparative data for benchmark compounds <b>1</b>–<b>9</b> are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antiproliferative Activities of 2-Ethyl and 2-Methoxyestratriene Derivatives against DU-145, MDA-MB-231, and MCF-7 Human Cancer Cells in Vitro<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0006.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">GI<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">DU-145</th><th class="colsep0 rowsep0" align="center">MDA MB-231</th><th class="colsep0 rowsep0" align="center">MCF-7</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">1.22</td><td class="colsep0 rowsep0" align="left">0.94</td><td class="colsep0 rowsep0" align="left">2.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">10.3</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">10.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="left">0.062</td><td class="colsep0 rowsep0" align="left">0.071</td><td class="colsep0 rowsep0" align="left">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="left">0.054</td><td class="colsep0 rowsep0" align="left">0.141</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">10.1</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">25.3</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="left">0.53</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.11</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">26.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">24.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(<i>E</i>)-CHCO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(<i>Z</i>)-CHCO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">31.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">(E)-CHCO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(<i>E</i>)-CHCH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(<i>Z</i>)-CHCH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(<i>E</i>)-CHCH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">(<i>E</i>)-CHCH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48a</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49a</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.062</td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left">0.026</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48b</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.30</td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49b</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.046</td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.089</td><td class="colsep0 rowsep0" align="left">0.068</td><td class="colsep0 rowsep0" align="left"><0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">18.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH(OH)CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>C═N(OH)CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2.09</td><td class="colsep0 rowsep0" align="left">2.35</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>F</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>F</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1.81</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Data for compounds <b>1</b>–<b>12</b> are taken from the literature.<a onclick="showRef(event, 'ref14 ref23 ref27'); return false;" href="javascript:void(0);" class="ref ref14 ref23 ref27">(14, 23, 27)</a> GI<sub>50</sub> values are the mean values obtained from experiments performed in triplicate; SEM, ±7%.</p></div></div></div><div class="NLM_p">The bis-sulfamates <b>3</b> and <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) are promising multitargeted antitumor agents that exhibit excellent activity against cancer cell proliferation and angiogenesis in tandem with their high oral bioavailability.<a onclick="showRef(event, 'ref10 ref12 ref30'); return false;" href="javascript:void(0);" class="ref ref10 ref12 ref30">(10, 12, 30)</a> An SAR study on this class of 2-substituted estratriene sulfamates led to the discovery of <b>11</b> and <b>12</b> and indicated that a sterically unhindered hydrogen bond acceptor attached to C-17 is essential for activity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This finding was confirmed in a further SAR study wherein a systematic substitution or deletion of the constituent atoms the C-17 <i>O</i>-sulfamate group, deletion or substitution of the C-17-oxygen linker with an electronically neutral methylene group, and/or replacement of the terminal NH<sub>2</sub> with a methyl group is well tolerated.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">As can be seen from data presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, activities of the compounds across all three cell lines are generally comparable in magnitude and trend; thus, for clarity, data for antiproliferative activity against DU-145 cells are discussed herein when possible. In agreement with our foregoing studies, the 3-hydroxy derivatives generally exhibit only modest activity when compared with the corresponding 3-<i>O</i>-sulfamoyl derivatives. However, a number of functional groups at C-17 are found to confer greater antiproliferative activity than the 17β-hydroxyl of the estradiol derivatives (e.g., 2-MeOE2 <b>1</b>). For example, insertion of a two-carbon linker between the hydroxyl group and C-17 (in <b>26</b>, <b>38</b>, and <b>39</b>) delivers a 4- to 15-fold enhancement in antiproliferative activity relative to the parent estradiol derivative <b>2</b>. This observation reflects that made for 2-substituted estradiol derivatives <b>1</b> and <b>2</b> and their 17β-cyanomethyl analogues <b>9</b> and <b>10</b>,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> respectively, wherein a two-carbon linker also separates C-17 and the hydrogen bond acceptor. In contrast <b>16</b>, which features a one-carbon linker between the H-bond acceptor and C-17, is only equipotent to its parent estradiol derivative <b>2</b>, in DU-145 cells. Interestingly, the C-17-(2-fluoroethyl) derivative <b>68</b> displays similar activity to the C-17-(2-hydroxyethyl) derivative <b>26</b> (albeit the compounds were assessed in different cell lines), indicating that the fluorine is a reasonable bioisostere of hydroxyl in this case. Furthermore, the relative activities of <b>68</b> and <b>71</b> show the monofluoro derivative to be superior to the difluoro analogue.</div><div class="NLM_p">In the case where the hydrogen bond acceptor is a ketone, a one-carbon linker proved optimal (cf. <b>48a</b> and <b>48b</b> with <b>60</b> and <b>54</b>, respectively). The 2-methoxy-17β-acylestratriene derivative <b>48b</b> exhibits the best antiproliferative activity of any 3-hydroxy 2-substituted estratriene to our knowledge with a GI<sub>50</sub> of 300 nM against DU-145 cells, 4-fold better than the activity of 2-MeOE2 <b>1</b> and over 30-fold better than 2-MeOE1, which has GI<sub>50</sub> > 10 μM against this cell line. Likewise, a 5-fold improvement in activity is seen for the corresponding 2-ethyl compound <b>48a</b> relative to 2-ethylestradiol <b>2</b>. Ketones <b>54</b> and <b>60</b> in contrast proved to be 2-fold less active the corresponding estradiol derivatives <b>1</b> and <b>2</b>. The significant antiproliferative activities of compounds such as <b>26</b>, <b>48a</b>, and <b>39</b>, assuming similar cellular uptake properties, are likely to stem from the ability of their C-17 tethered H-bond acceptor groups (CN, OH, C═O) to project into a very specific area of space around C-17 favorable for optimum interaction in the colchicine binding site of tubulin where these compounds are believed to bind. These results suggest that such an interaction is accessible when a one- or two-carbon linker is inserted between C-17 and the H-bond acceptor.</div><div class="NLM_p">When considering the activities of the 3-<i>O</i>-sulfamate derivatives, it is useful to first consider the effect of variation of the linker “Y” while the same hydrogen bond acceptor “Z” is kept constant. In the case where Z is a hydroxyl group, both one- and two-carbon linkers “Y” deliver excellent antiproliferative activity (see <b>20</b>, <b>31</b>, and <b>65</b>). This result reflects the essential equipotency of the cyano and hydroxyl groups as H-bond acceptors<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and also their ability to access the same interactions around C-17 with these linkers. Methylation of the hydroxyl group proves deleterious to activity, and although this is not as pronounced when the linker “Y” is a methyl group (cf. <b>20</b> and <b>18</b>), a greater than 6-fold reduction in activity is apparent between <b>29</b> and <b>31</b> when “Y” is an ethyl group. The negative impact of methylation of the hydroxy group on antitumor activity indicates, as observed in earlier studies,<a onclick="showRef(event, 'ref16 ref23'); return false;" href="javascript:void(0);" class="ref ref16 ref23">(16, 23)</a> that steric bulk around the H-bond acceptor is often detrimental to the necessary interaction in the binding site. Likewise when a one-carbon linker is introduced between the sulfamate and C-17, little difference in antiproliferative activity results (cf. <b>4</b> 210 nM and <b>16</b> 290 nM) while the corresponding analogue <b>27</b> featuring a two-carbon linker displays only modest micromolar activity. In the ketone series (Z equals C═O) both one- and two-carbon linkers are well tolerated though. As with the 3-hydroxy derivatives discussed above, the one-carbon linker appears optimal, for example, with <b>49b</b> exhibiting a GI<sub>50</sub> of 62 nM. In general, a longer linker brings unfavorable steric factors into play, as demonstrated by the activities obtained for compounds such as sulfamate <b>27</b> and ester <b>36</b>.</div><div class="NLM_p">The present study also allows for a comparison between hydrogen bond acceptors Z with constant linker Y. One series of compound that is instructive to compare is the two-carbon-linked series of ketone <b>55</b>, alcohol <b>65</b>, oxime <b>66</b>, ester <b>24</b>, and methyl ether <b>29</b>. The ketone <b>55</b> and alcohol <b>65</b> with their unsubstituted H-bond acceptors display excellent activity, with <b>55</b> proving slightly more active in vitro (GI<sub>50</sub> = 89 nM). In contrast, the larger oxime, ester, and methyl ether display activity in the low micromolar range, once more illustrating the steric restrictions to interaction around C-17. Similarly, with a one-carbon linker, ketone <b>49a</b> and alcohol <b>20</b> are of equivalent activity (62 and 100 nM, respectively) while the methyl ether <b>18</b> (GI<sub>50</sub> = 330 nM) is less active. Once more, substitution of the hydrogen bond acceptor proved detrimental to activity, albeit here, with a shorter linker, this substitution is better tolerated than in the longer two-carbon-linked series.</div><div class="NLM_p">A selection of compounds was also tested in the NCI 60-cell line assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) which allows the activity across a wide range of cancer types to be assessed. Data from six cell lines are presented along with the mean activity across the whole panel (MGM value). Screening is conducted at concentrations ranging from 10 nM upward, with maximal activity (where a 50% growth inhibition was obtained in all cell lines at 10 nM) being indicated by an MGM value of 10 nM. The data obtained in the assay are consistent with those obtained in the preliminary antiproliferative screens discussed above and confirm the potential of these compounds against a broad range of cancer phenotypes. A number of compounds proves to be exceptionally active, with six compounds exhibiting an MGM below 100 nM. Of particular note are the C17-hydroxymethyl compound <b>20</b>, the ketones <b>49a</b> and <b>55</b>, and the 2-hydroxypropyl derivative <b>65</b>, whose MGM values are all below 30 nM.</div><div class="NLM_p">On the strength of its in vitro antiproliferative activity <b>20</b> was selected for in vivo evaluation at the NCI. Preliminary toxicology showed that the compound is well tolerated by female athymic nude mice at doses up to 400 mg/kg (single ip dose) when formulated in 10% DMSO in saline/Tween 80. Evaluation of <b>20</b> in the hollow fiber assay<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> involved assessment of activity against the proliferation of various cancer lines in sealed polyvinylidine fluoride fibers implanted ip or sc. A 50% net cell growth inhibition is awarded a score of 2, and over 48 fibers (12 cell lines × 2 sites × 2 dose levels) a maximum score of 96 is possible. <b>20</b> achieved an overall score of 18 with the growth of 25% cells in the ip fibers and 12.5% of the cells in the sc fibers being inhibited by 50% or more. Although this result is promising, a score of 20 or more is required for further NCI development. <b>20</b> may potentially suffer inactivating conjugation or metabolism of the C-17 group in vivo, both of which are known issues for the 2-substituted estradiol series.<a onclick="showRef(event, 'ref12 cit13b'); return false;" href="javascript:void(0);" class="ref ref12 cit13b">(12, 13b)</a> Interestingly, the net score of <b>20</b> in this system is equal to that achieved by 2-ethylestrone-3-<i>O</i>-sulfamate.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. GI<sub>50</sub> and MGM Obtained for Representative Cell Lines in the NCI-60 Screening Panel<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">GI<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">lung<br /></br>HOP-62</th><th class="colsep0 rowsep0" align="center">colon<br /></br>HCT-116</th><th class="colsep0 rowsep0" align="center">CNS<br /></br>SF-539</th><th class="colsep0 rowsep0" align="center">melanoma<br /></br>UACC-62</th><th class="colsep0 rowsep0" align="center">ovarian<br /></br>OVCAR-3</th><th class="colsep0 rowsep0" align="center">renal<br /></br>SN12-C</th><th class="colsep0 rowsep0" align="center">MGM (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.051</td><td class="colsep0 rowsep0" align="left">0.045</td><td class="colsep0 rowsep0" align="left">0.036</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.126</td><td class="colsep0 rowsep0" align="left">0.087</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.028</td><td class="colsep0 rowsep0" align="left">0.018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">0.061</td><td class="colsep0 rowsep0" align="left">0.038</td><td class="colsep0 rowsep0" align="left">0.056</td><td class="colsep0 rowsep0" align="left">0.022</td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left">0.309</td><td class="colsep0 rowsep0" align="left">0.085</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.045</td><td class="colsep0 rowsep0" align="left">0.022</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.072</td><td class="colsep0 rowsep0" align="left">0.042</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.018</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.59</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">0.45</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">0.63</td><td class="colsep0 rowsep0" align="left">0.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">4.90</td><td class="colsep0 rowsep0" align="left">2.70</td><td class="colsep0 rowsep0" align="left">5.01</td><td class="colsep0 rowsep0" align="left">2.34</td><td class="colsep0 rowsep0" align="left">4.07</td><td class="colsep0 rowsep0" align="left">4.68</td><td class="colsep0 rowsep0" align="left">4.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">2.89</td><td class="colsep0 rowsep0" align="left">11.48</td><td class="colsep0 rowsep0" align="left">2.45</td><td class="colsep0 rowsep0" align="left">1.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">0.58</td><td class="colsep0 rowsep0" align="left">0.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49a</b></td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.021</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left">0.025</td><td class="colsep0 rowsep0" align="left">0.023</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left"><0.01</td><td class="colsep0 rowsep0" align="left">0.052</td><td class="colsep0 rowsep0" align="left">0.028</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">3.72</td><td class="colsep0 rowsep0" align="left">3.39</td><td class="colsep0 rowsep0" align="left">5.25</td><td class="colsep0 rowsep0" align="left">3.89</td><td class="colsep0 rowsep0" align="left">22.9</td><td class="colsep0 rowsep0" align="left">7.59</td><td class="colsep0 rowsep0" align="left">6.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">3.89</td><td class="colsep0 rowsep0" align="left">2.82</td><td class="colsep0 rowsep0" align="left">1.95</td><td class="colsep0 rowsep0" align="left">4.90</td><td class="colsep0 rowsep0" align="left">3.47</td><td class="colsep0 rowsep0" align="left">5.37</td><td class="colsep0 rowsep0" align="left">3.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Results are GI<sub>50</sub> values in micromolar. Data for compounds <b>1</b>–<b>4</b> are taken from the literature.<a onclick="showRef(event, 'ref14 ref21 ref30'); return false;" href="javascript:void(0);" class="ref ref14 ref21 ref30">(14, 21, 30)</a> The MGM represents the mean concentration that caused 50% growth inhibition in all 60 cell lines.</p></div></div></div><div class="NLM_p">A second evaluation of this class of molecule in vivo was carried out for the ketone derivatives <b>49a</b> and <b>55</b>. The in vivo antiangiogenic activity of compounds <b>49a</b> and <b>55</b> was assessed in mice using a Matrigel plug assay in which the bFGF stimulated vessel formation into a Matrigel plug is evaluated in the presence or absence of inhibitor.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Mice were thus dosed orally with <b>49a</b> and <b>55</b> at 10 and 20 mg/kg for 4 days, starting 24 h after Matrigel injection. Visual inspection of the plugs after removal clearly indicated that a marked increased in vascularization, as indicated by increasing red intensity of the plug, occurred in plugs of untreated animals (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). For treated animals a noticeable reduction in the level of vascularization was observed and quantification of angiogenesis through FITC staining revealed a very significant inhibitory effect of both <b>49a</b> and <b>55</b> at 10 and 20 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a). This study confirms the in vivo antiangiogenic potential of these new derivatives, which reflects observations made for foregoing members of this series such as <b>3</b> and <b>11</b>.</div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compounds <b>49a</b> and <b>55</b> on bFGF induced angiogenesis in Matrigel plugs in mice. Compounds <b>49a</b> and <b>55</b> were administered orally at the doses indicated for 4 days starting 24 h after Matrigel injection. (a) Quantification of angiogenesis within the Matrigel plugs was achieved after FITC-dextran injection. Compounds <b>49a</b> and <b>55</b> significantly inhibited FGF-induced angiogenesis at both doses (<i>p</i> < 0.05, unpaired <i>t</i> test). (b) Effect of <b>49a</b> and <b>55</b> on Matrigel plug neovascularization. Normal (upper) and fluorescent (lower) images of excised Matrigel plugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38018" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38018" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study we set out to further refine the anticancer activity of 2-substituted estratriene-3-<i>O</i>-sulfamates by optimizing the C-17 substituent. Variation of the hydrogen bond acceptor “Z” and the linker group “Y” (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) that tethers “Z” to C-17 provided further insights into the steric and electronic factors that deliver optimal antiproliferative activity. We have identified a number of C-17 substituents that confer enhanced antiproliferative activity to non-sulfamoylated derivatives relative to the corresponding 2-substituted estradiols; these new derivatives include the 2-methoxy-17β-acyl estratriene <b>48b</b> which is the most active D-ring modified 2-methoxyestradiol analogue identified to date. These C-17 substituents could conceivably be combined with alternative C-2 substitution to yield yet more potent nonsulfamoylated estratriene derivatives. Results obtained for the 3-<i>O</i>-sulfamates revealed the tolerance to, and benefit of, introducing a linker group between the hydrogen bond acceptor group tethered to C-17. The hydroxymethyl <b>20</b>, acyl <b>49a</b> and <b>49b</b>, 2-hydroxypropyl <b>65</b>, and 2-propoxy <b>55</b> and <b>61</b> derivatives all exhibit excellent antiproliferative activity in vitro across a broad range of cancer cell lines with MGM values below 30 nM across the NCI 60-cell line panel. The potential of three of these compounds as in vivo antitumor and antiangiogenic agents has been established. Promising activity in the NCI hollow fiber assay for compound <b>20</b> illustrates in vivo antitumor potential, while <b>49a</b> and <b>55</b> showed good in vivo antiangiogenic activity. On the basis of these studies, a number of compounds that could supersede <b>3</b>, which is currently in preclinical development, are available.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Biology. In Vitro Studies: Cell Lines</h3><div class="NLM_p last">DU145 (brain metastasis carcinoma of the prostate) and MDA-MB-231 (metastatic pleural effusion of breast adenocarcinoma) established human cell lines were obtained from ATCC Global Bioresource Center. Cells were maintained in a 5% CO<sub>2</sub> humidified atmosphere at 37 °C in RPMI-1640 medium, supplemented with 10% fetal bovine serum, penicillin, and streptomycin.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Antiproliferative Assays</h3><div class="NLM_p last">DU145 and MDA-MB-231 cells were seeded into 96-well microtiter plates (5000 cells/well) and treated with 10<sup>–9</sup>–10<sup>–4</sup> M compounds or with vehicle control. At 96 h after treatment, live cell counts were determined by WST-1 cell proliferation assay (Roche, Penzberg, Germany), as instructed by the manufacturer. Viability results were expressed as a percentage of mean control values resulting in the calculation of the 50% growth inhibition (GI<sub>50</sub>). All experiments were performed in triplicate.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vivo Angiogenesis Assay</h3><div class="NLM_p last">The Matrigel plug assay was a modified version of previously described methods.<a onclick="showRef(event, 'ref30 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref33">(30, 33)</a> Briefly, female C57BL/6J mice (6–8 weeks old) were obtained from Charles River UK Ltd. (Margate, Kent, U.K.). Animals were maintained in positive pressure isolators under a 12 h light–dark cycle and allowed access to food and water ad libitum. The experiments were approved by the Imperial College Animal Ethical Review Committee and met the standards required by the UKCCCR guidelines.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Mice were anesthetized, placed on a heated pad (37 °C), and injected subcutaneously into the flanks with 0.5 mL of ice-cold Matrigel (Becton Dickinson, Oxford, Oxon, U.K.) supplemented with 500 ng of basic fibroblast growth factor (bFGF; R&D Systems, Oxford, Oxon, U.K.). Control mice were injected with Matrigel without bFGF. After Matrigel injection they were divided into six groups of five mice: control, bFGF only, bFGF, and <b>49a</b> (10 mg/kg, po), bFGF and <b>49a</b> (20 mg/kg, po), bFGF and <b>55</b> (10 mg/kg, po), and bFGF and <b>55</b> (20 mg/kg, po). Control and bFGF only mice were dosed orally with vehicle (10% THF, 90% PG), while the others were dosed every day for 4 days with <b>49a</b> or <b>55</b> at the indicated dose. Before the end of each study vascularization of Matrigel was quantified by injecting mice with FITC-dextran (125 000 molecular weight, Sigma), 0.1 mL of a 0.25 mg/mL solution intravenously (iv), which allowed blood vessels within plugs to be visualized. Animals were euthanized 20 min after injection, when Matrigel plugs were removed and photographs showing the extent of vascularization taken using a dissecting microscope (Nikon SMZ1500). Photographs of blood vessels within Matrigel plugs were also obtained using a microscope with a fluorescent light source (Zeiss-Axiovert 200). Quantification of FITC-dextran in the Matrigel plugs was achieved by incubating plugs in 1 mL pf Dispase reagent (Becton Dickinson) for 16 h at 37 °C. The resulting mixture was centrifuged in a microfuge at 13 000 rpm for 30 s. The fluorescence of the resulting supernatants was measured using a fluorimeter (Fluostar plus Optima, BCG, Bucks, U.K.), with excitation at 480 nm and measurement at 520 nm, and quantitated against a standard curve of FITC dextran (0.4–25 mg/mL).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p">All chemicals were either purchased from Aldrich Chemical Co. (Gillingham, U.K.) or Alfa Aesar (Heysham, U.K.). Organic solvents of A.R. grade were supplied by Fisher Scientific (Loughborough, U.K.) and used as supplied. Anhydrous DMA and anhydrous THF were purchased from Aldrich and stored under a positive pressure of N<sub>2</sub> after use. Sulfamoyl chloride was prepared by an adaptation of the method of Appel and Berger<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and was stored in the refrigerator under positive pressure of N<sub>2</sub> as a solution in toluene as described by Woo et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> An appropriate volume of this solution was freshly concentrated in vacuo immediately before use. Reactions were carried out at room temperature unless stated otherwise. Flash column chromatography was performed on silica gel (Matrex C60).</div><div class="NLM_p last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded with either a JMN-GX 270 at 270 and 67.5 MHz, respectively, or a Varian Mercury VX 400 NMR spectrometer at 400 and 100 MHz, respectively, and chemical shifts are reported in parts per million (ppm, δ) relative to tetramethylsilane (TMS) as internal standard. Deuteriochloroform was used as solvent unless otherwise stated. Mass spectra were recorded at the Mass Spectrometry Service Center, University of Bath, U.K. FAB-MS were carried out using <i>m</i>-nitrobenzyl alcohol (NBA) as the matrix. Elemental analyses were performed by the Microanalysis Service, University of Bath. Melting points were determined using a Stuart SMP3 melting point apparatus and are uncorrected. All compounds were ≥98% pure by reverse phase HPLC run with acetonitrile/water and methanol/water (Sunfire C18 reverse phase column, 4.6 mm × 150 mm, 3.5 μm pore size).</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-Ethyl-3-<i>O</i>-benzyl-17β-hydroxymethylestra-1,3,5(10)-triene <b>14</b></h3><div class="NLM_p last">Compound <b>13</b> (2.35 g, 6 mmol) was added portionwise over 15 min into a mixture of Mg (576 mg, 24 mmol) and TiCl<sub>4</sub> (0.63 mL, 6 mmol) in DCM (10 mL) at 0 °C under nitrogen. The reaction mixture was stirred at 0 °C for 2 h and then at room temperature overnight. After cooling to 0 °C, the mixture was neutralized with potassium carbonate (saturated) and extracted with EtOAc (2 × 60 mL). The combined organics were successively washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 50:1) afforded the alkene as a light yellow oil (1.3 g, 56%). δ<sub>H</sub> 0.88 (3H, s), 1.26 (3H, t, <i>J</i> 7.4), 1.27–1.70 (7H, m), 1.80–2.05 (3H, m), 2.22–2.68 (5H, m), 2.74 (2H, q, <i>J</i> 7.4), 2.87–2.95 (2H, m), 4.74 (2H, m), 5.10 (2H, s), 6.70 (1H, s), 7.19 (1H, s), 7.28–7.50 (5H, m). LC/MS (APCI+): <i>m</i>/<i>z</i> 387.1 (M<sup>+</sup> + H). A solution of this oil (1.24 g, 3.2 mmol) in THF (10 mL) was added to solution of 9-BBN (1.56 g, 6.4 mmol) in THF (20 mL) at 0 °C, and the mixture was stirred at 0 °C for 5 h. Sodium hydroxide (10%, 20 mL) was cautiously added followed by hydrogen peroxide (37%, 10 mL). The solution was stirred at 0 °C for 2 h and then extracted with EtOAc (2 × 50 mL). The combined organics were washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 10:1 to 5:1) afforded compound <b>14</b> as a white solid (1.05 g, 81%), mp 99–100 °C. δ<sub>H</sub> 0.68 (3H, s), 1.20 (3H, t, <i>J</i> 7.3 Hz), 1.27–1.70 (8H, m), 1.62–1.90 (4H, m), 1.95–2.04 (1H, m), 2.17–2.36 (2H, m), 2.66 (2H, q <i>J</i> 7.3), 2.75–2.90 (2H, m), 3.58 (1H, dd, <i>J</i> 10.4, 7.4), 3.76 (1H, dd, <i>J</i> 10.4, 6.7), 5.03 (2H, s), 6.63 (1H, s), 7.10 (1H, s), 7.26–7.46 (5H, m). LC/MS (APCI−): <i>m</i>/<i>z</i> 403.4 (M<sup>–</sup> – H).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-Ethyl-3-hydroxy-17β-hydroxymethylestra-1,3,5(10)-triene <b>15</b></h3><div class="NLM_p last">A solution of compound <b>14</b> (202 mg, 0.5 mmol) in THF (10 mL) and methanol (10 mL) was treated with Pd/C (10%, 30 mg), degassed, then stirred under an atmosphere of hydrogen at room temperature for 24 h. The mixture was filtered through Celite, washed with EtOAc, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 8:1 to 5:1) afforded compound <b>15</b> as a white powder (140 mg, 89%), mp 169–170 °C. δ<sub>H</sub> 0.68 (3H, s), 1.20–1.61 (11H, m), 1.65–1.91 (3H, m), 1.94–1.99 (1H, m), 2.14–2.32 (2H, m), 2.58 (2H, q, <i>J</i> 7.4), 2.70–2.88 (2H, m), 3.58 (1H, dd, <i>J</i> 9.9, 7.9), 3.76 (1H, dd, <i>J</i> 9.9, 7.4), 4.65 (1H, s), 6.48 (1H, s), 7.04 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 315.2324; C<sub>21</sub>H<sub>31</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 315.2319. Anal. (C<sub>21</sub>H<sub>30</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-sulfamoyloxymethylestra-1,3,5(10)-triene <b>16</b></h3><div class="NLM_p last">Compound <b>15</b> (80 mg, 0.25 mmol) was added to solution of sulfamoyl chloride (1.0 mmol) in DMA (1.0 mL) at 0 °C. The reaction mixture was stirred at room temperature for 24 h. Water (10 mL) was added, and the mixture was extracted with EtOAc (2 × 30 mL). The combined organics were successively washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 3:2) afforded compound <b>16</b> as a white powder (90 mg, 76%), mp 167–168 °C. δ<sub>H</sub> (acetone-<i>d</i><sub>6</sub>): 0.77 (3H, s), 1.16 (3H, t, <i>J</i> 7.4), 1.28–1.55 (7H, m), 1.79–1.97 (3H, m), 2.21–2.41 (2H, m), 2.68 (2H, q, <i>J</i> 7.4), 2.76–2.85 (2H, m), 4.08 (1H, dd, <i>J</i> 9.4, 6.4), 4.21 (1H, dd, <i>J</i> 9.4, 7.4), 6.63 (2H, s, br), 7.07 (1H, s), 7.12 (2H, s, br), 7.23 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 473.1767; C<sub>21</sub>H<sub>33</sub>N<sub>2</sub>O<sub>6</sub>S<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 473.1775. Anal. (C<sub>21</sub>H<sub>32</sub>N<sub>2</sub>O<sub>6</sub>S<sub>2</sub>) C, H, N.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-Ethyl-3-hydroxy-17β-methoxymethylestra-1,3,5(10)-triene <b>17</b></h3><div class="NLM_p last">A solution of compound <b>14</b> (265 mg, 0.65 mmol) in THF (20 mL) was stirred under nitrogen, and sodium hydride (60% suspension in oil, 52 mg, 1.3 mmol) was added portionwise at room temperature. After 15 min iodomethane (0.08 mL, 1.3 mmol) was added and the mixture was heated to reflux for 2 h, cooled to room temperature. Water (5 mL) was added, and the mixture was extracted with EtOAc (2 × 50 mL). The combined organics were washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 20:1) afforded the methyl ether as a white powder (220 mg, 81%), mp 60–61 °C. δ<sub>H</sub> 0.66 (3H, s), 1.21 (3H, t, <i>J</i> 7.3), 1.22–1.51 (7H, m), 1.71–2.02 (5H, m), 2.17–2.33 (2H, m), 2.66 (2H, q <i>J</i> 7.3), 2.75–2.92 (2H, m), 3.26–3.31 (1H, m), 3.34 (3H, s), 3.47 (1H, dd, <i>J</i> 9.3, 6.3), 5.03 (2H, s), 6.63 (1H, s), 7.10 (1H, s), 7.28–7.46 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 419.2937; C<sub>29</sub>H<sub>39</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 419.2945. The above methyl ether (190 mg, 0.45 mmol) was treated with Pd/C (10%, 30 mg) in THF (5 mL) and methanol (20 mL) following the method described to access compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 10:1) afforded compound <b>17</b> as a white powder (125 mg, 84%), mp 132–133 °C. δ<sub>H</sub> 0.65 (3H, s), 1.19–1.55 (10H, m), 1.70–1.91 (4H, m), 1.95–2.03 (1H, m), 2.14–2.29 (2H, m), 2.56 (2H, q <i>J</i> 7.4), 2.69–2.88 (2H, m), 3.27 (1H, dd, <i>J</i> 9.2, 7.4), 3.34 (3H, s), 3.47 (1H, dd, <i>J</i> 9.2, 6.4), 4.61 (1H, s), 6.48 (1H, s), 7.04 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 329.2465; C<sub>22</sub>H<sub>33</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 329.2475. Anal. (C<sub>22</sub>H<sub>32</sub>O<sub>2</sub>) C, H.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-methoxymethylestra-1,3,5(10)-triene <b>18</b></h3><div class="NLM_p last">Compound <b>17</b> (82 mg, 0.25 mmol) was treated with sulfamoyl chloride (0.5 mmol) in DMA (1.0 mL) following the method described to access compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 5:1) afforded compound <b>18</b> as a white powder (80 mg, 79%), mp 132–133 °C. δ<sub>H</sub> 0.65 (3H, s), 1.17–1.60 (11H, m), 1.73–2.03 (5H, m), 2.18–2.30 (2H, m), 2.68 (2H, q <i>J</i> 7.4), 2.80–2.87 (2H, m), 3.24–3.32 (1H, m), 3.34 (3H, s), 3.46 (1H, dd, <i>J</i> 9.4, 6.9), 4.99 (2H, s), 7.06 (1H, s), 7.18 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 408.2205; C<sub>22</sub>H<sub>34</sub>NO<sub>4</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 408.2203. Anal. (C<sub>22</sub>H<sub>33</sub>NO<sub>4</sub>S) C, H, N.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Ethyl-3-hydroxy-17β-<i>tert</i>-butyldiphenylsilyloxymethylestra-1,3,5(10)-triene <b>19</b></h3><div class="NLM_p last">A solution of compound <b>14</b> (404 mg, 1 mmol), <i>tert</i>-butyldiphenylsilyl chloride (302 mg, 1.1 mmol), and imidazole (82 mg, 1.2 mmol) in DMF (10 mL) was stirred at room temperature for 4 h. Water (10 mL) was added, and the mixture was extracted with EtOAc (2 × 30 mL). The combined organics were washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane to hexane/EtOAc 25:1) gave the silyl protected alcohol as a colorless oil (600 mg, 93%). δ<sub>H</sub> 0.67 (3H, s), 1.06 (9H, s), 1.18–1.58 (11H, m), 1.65–1.92 (4H, m), 2.12–2.36 (3H, m), 2.67 (2H, q <i>J</i> 7.4), 2.72–2.92 (2H, m), 3.58 (1H, dd, <i>J</i> 10.2, 5.7), 3.73 (1H, dd, <i>J</i> 10.2, 7.7), 5.04 (2H, s), 6.64 (1H, s), 7.13 (1H, s), 7.28–7.47 (11H, m), 7.65–7.73 (4H, m). LC/MS (ES−): <i>m</i>/<i>z</i> 641.5 (M<sup>–</sup> – H). The above silyl protected alcohol (570 mg, 0.89 mmol) was treated with Pd/C (10%, 50 mg) in THF (20 mL) and methanol (20 mL) following the method described to access compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 25:1 to 20:1) afforded compound <b>19</b> as a white powder (430 mg, 88%), mp 63–65 °C. δ<sub>H</sub> 0.65 (3H, s), 1.04 (9H, s), 1.17–1.51 (10H, m), 1.71–1.88 (4H, m), 2.08–2.32 (3H, m), 2.58 (2H, q, <i>J</i> 7.4), 2.71–2.87 (2H, m), 3.57 (1H, dd, <i>J</i> 10.1, 5.9), 3.71 (1H, dd, <i>J</i> 10.1, 7.6), 4.44 (1H, s), 6.48 (1H, s), 7.06 (1H, s), 7.35–7.43 (6H, m), 7.66–7.71 (4H, m). HRMS (ES−): <i>m</i>/<i>z</i> found 553.3326; C<sub>37</sub>H<sub>47</sub>O<sub>2</sub>Si<sup>–</sup> (M<sup>–</sup> – H) requires 551.3340.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-hydroxymethylestra-1,3,5(10)-triene <b>20</b></h3><div class="NLM_p last">Sulfamoyl chloride (0.5 M in toluene, 2.2 mL, 1.1 mmol) was added to a solution of 2,6-di-<i>tert-</i>butyl-4-methylpyridine (275 mg, 1.34 mmol) and compound <b>19</b> (370 mg, 0.67 mmol) in DCM (10 mL). The reaction mixture was stirred at room temperature for 5 h. Water (10 mL) was added, and the mixture was extracted with DCM (2 × 30 mL). The combined organics were successively washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 10:1 to 5:1) afforded the sulfamoylated compound as a white powder (340 mg, 80%), mp 79–81 °C. δ<sub>H</sub> 0.66 (3H, s), 1.04 (9H, s), 1.18–1.53 (10H, m), 1.68–1.91 (4H, m), 2.13–2.32 (3H, m), 2.68 (2H, q <i>J</i> 7.4), 2.79–2.87 (2H, m), 3.57 (1H, dd, <i>J</i> 10.1, 5.9), 3.70 (1H, dd, <i>J</i> 10.1, 7.7), 4.94 (2H, s), 7.06 (1H, s), 7.21 (1H, s), 7.34–7.46 (6H, m), 7.66–7.70 (4H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 632.3223; C<sub>37</sub>H<sub>50</sub>NO<sub>4</sub>SSi<sup>+</sup> (M<sup>+</sup> + H) requires 632.3224. The sulfamoylated compound (200 mg, 0.32 mmol) was stirred in THF (10 mL), cooled to 0 °C, and treated with TBAF in THF (1M, 0.65 mL, 0.65 mmol). The reaction mixture was stirred at room temperature for 7 h. Water (10 mL) was added, and the mixture was extracted with EtOAc (2 × 30 mL). The combined organics were successively washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 5:1 to 1:1) afforded compound <b>20</b> as a white powder (85 mg, 68%), mp 176–177 °C. δ<sub>H</sub> (acetone-<i>d</i><sub>6</sub>) 0.58 (3H, s), 1.09 (3H, t, <i>J</i> 7.4), 1.15–1.47 (7H, m), 1.57–1.69 (2H, m), 1.75–1.82 (2H, m), 1.87–1.96 (2H, m), 2.12–2.23 (2H, m), 2.59 (2H, q <i>J</i> 7.4), 2.70–2.74 (2H, m), 3.44–3.51 (1H, m), 3.60–3.69 (1H, m), 5.93 (2H, s), 6.98 (1H, s), 7.07 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 394.2052; C<sub>21</sub>H<sub>32</sub>NO<sub>4</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 394.2047. Anal. (C<sub>21</sub>H<sub>31</sub>NO<sub>4</sub>S) C, H, N.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Ethyl-3-benzyloxy-17-(2-ethoxy-2-oxoethylidene)estra-1,3,5(10)-trienes <b>21</b> and <b>22</b></h3><div class="NLM_p last">Sodium hydride (60% dispersion in mineral oil, 0.8 g, 20 mmol) was washed with hexane (3 × 1 mL), then stirred in THF (50 mL) at 0 °C under nitrogen. Triethylphosphonoacetate (4.48 g, 20 mmol) was added dropwise at 0 °C, and the reaction mixture was stirred until gas evolution ceased. Compound <b>13</b> (3.9 g, 10 mmol) in THF (10 mL) was added dropwise, and the reaction mixture was heated to reflux for 18 h, then cooled to 0 °C, poured into water (30 mL), and extracted with EtOAc (2 × 50 mL). The combined organics were washed with water and brine, then dried (MgSO<sub>4)</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane to hexane/EtOAc 20:1) successively afforded compounds <b>22</b> (590 mg, 13%) and <b>21</b> (3.5 g, 75%) as white powders. Compound <b>21</b>: mp 61–63 °C. δ<sub>H</sub> 0.87 (3H, s), 1.23 (3H, t, <i>J</i> 7.4), 1.31 (3H, t, <i>J</i> 7.1), 1.30–1.61 (6H, m), 1.84–2.01 (3H, m), 2.19–2.30 (1H, m), 2.41–2.48 (1H, m), 2.67 (2H, q, <i>J</i> 7.4), 2.77–2.96 (2H, m), 4.16 (2H, q, <i>J</i> 7.1), 5.04 (2H, s), 5.61 (1H, t, <i>J</i> 2.3), 6.64 (1H, s), 7.11 (1H, s), 7.28–7.46 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 459.2896; C<sub>31</sub>H<sub>39</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 459.2894. Compound <b>22</b>: mp 119–120 °C. δ<sub>H</sub> 1.05 (3H, s), 1.22 (3H, t, <i>J</i> 7.4), 1.30 (3H, t, <i>J</i> 7.2), 1.32–1.64 (6H, m), 1.77–1.85 (1H, m), 1.88–1.96 (1H, m), 2.14–2.26 (1H, m), 2.32–2.50 (2H, m), 2.56–2.71 (3H, m), 2.76–2.89 (3H, m), 4.10–4.19 (2H, m), 5.03 (2H, s), 5.69 (1H, t, <i>J</i> 1.9), 6.64 (1H, s), 7.11 (1H, s), 7.27–7.46 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 459.2907; C<sub>31</sub>H<sub>39</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 459.2894.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Ethyl-3-hydroxy-17β-(2-ethoxy-2-oxoethyl)estra-1,3,5(10)-triene <b>23</b></h3><div class="NLM_p last">Compounds <b>21</b> and <b>22</b> (3.4 g, 7.4 mmol) were treated with Pd/C (10%, 250 mg) in THF (10 mL) and methanol (50 mL) as described for the synthesis of compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 20:1 to 10:1) afforded compound <b>23</b> as a white powder (2.6 g, 95%), mp 82–84 °C. δ<sub>H</sub> 0.62 (3H, s), 1.20 (3H, t, <i>J</i> 7.2), 1.25 (3H, t, <i>J</i> 7.3), 1.28–1.50 (7H, m), 1.74–1.98 (5H, m), 2.09–2.43 (4H, m), 2.58 (2H, q, <i>J</i> 7.3), 2.77–2.86 (2H, m), 4.12 (2H, q, <i>J</i> 7.2), 4.77 (1H, s), 6.49 (1H, s), 7.04 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 371.2572; C<sub>24</sub>H<sub>35</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 371.2581. Anal. (C<sub>24</sub>H<sub>34</sub>O<sub>3</sub>) C, H.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-(2-ethoxy-2-oxoethyl)estra-1,3,5(10)-triene <b>24</b></h3><div class="NLM_p last">Compound <b>23</b> (100 mg, 0.27 mmol) was treated with sulfamoyl chloride (0.54 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 9:1 to 4:1) afforded compound <b>24</b> as a white powder (83 mg, 68%), mp 120–122 °C. δ<sub>H</sub> 0.63 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.27 (3H, t, <i>J</i> 7.0), 1.24–1.50 (7H, m), 1.74–1.98 (5H, m), 2.11–2.42 (4H, m), 2.68 (2H, q, <i>J</i> 7.4), 2.82–2.84 (2H, m), 4.12 (2H, q, <i>J</i> 7.0), 5.08 (2H, s), 7.05 (1H, s), 7.16 (1H, s). HRMS (FAB+): <i>m</i>/<i>z</i> found 450.2313; C<sub>24</sub>H<sub>36</sub>NO<sub>5</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 450.2309. Anal. (C<sub>24</sub>H<sub>35</sub>NO<sub>5</sub>S) C, H.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Ethyl-3-<i>O</i>-benzyloxy-17β-(2-hydroxyethyl)estra-1,3,5(10)-triene <b>25</b></h3><div class="NLM_p last">Compound <b>23</b> (2.6 g, 7 mmol) was stirred with potassium carbonate (2.75 g, 20 mmol) and benzyl bromide (0.86 mL, 7.2 mmol) in DMF (30 mL) at room temperature for 24 h. Water (50 mL) was added, and the mixture was extracted with EtOAc (2 × 60 mL). The combined organics were washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 50:1) afforded the phenol as a white powder (3.1 g, 91%), mp 94–95 °C. δ<sub>H</sub> 0.64 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.27 (3H, t, <i>J</i> 7.7), 1.26–1.60 (7H, m), 1.76–2.05 (5H, m), 2.11–2.46 (4H, m), 2.68 (2H, q, <i>J</i> 7.7), 2.83 (2H, m), 4.14 (2H, q, <i>J</i> 7.4), 5.04 (2H, s), 6.63 (1H, s), 7.11 (1H, s), 7.29–7.47 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 461.3057; C<sub>31</sub>H<sub>41</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 461.3050. A solution of the phenol (2.8 g, 6 mmol) in THF (30 mL) was treated with lithium aluminum hydride (0.45 g, 12 mmol) at 0 °C for 3 h. Ammonium chloride (saturated) was added, and the mixture was extracted with EtOAc. The organic layer was washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 15:1 to 8:1) afforded compound <b>25</b> as a white powder (2.2 g, 88%), mp 98–99 °C. δ<sub>H</sub> 0.63 (3H, s), 1.20 (3H, t, <i>J</i> 7.4), 1.22–1.58 (9H, m), 1.70–1.92 (5H, m), 2.16–2.34 (2H, m), 2.66 (2H, q, <i>J</i> 7.4), 2.82–2.88 (2H, m), 3.64–3.72 (2H, m), 5.03 (2H, s), 6.62 (1H, s), 7.10 (1H, s), 7.28–7.45 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 419.2939; C<sub>29</sub>H<sub>39</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 419.2945.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Ethyl-3-hydroxy-17β-(2-hydroxyethyl)estra-1,3,5(10)-triene <b>26</b></h3><div class="NLM_p last">Compound <b>25</b> (420 mg, 1.0 mmol) was treated with Pd/C (10%, 40 mg) in THF (5 mL) and methanol (10 mL) as described for the synthesis of compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 10:1 to 3:1) and crystallization from hexane/EtOAc afforded compound <b>26</b> as a white solid (300 mg, 91%), mp 166–167 °C. δ<sub>H</sub> 0.62 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.23–1.55 (3H, m), 1.70–1.93 (5H, m), 2.13–2.34 (2H, m), 2.58 (2H, q, <i>J</i> 7.4), 2.74–2.84 (2H, m), 3.63–3.70 (2H, m), 4.57 (1H, s), 6.49 (1H, s), 7.05 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 329.2470; C<sub>22</sub>H<sub>33</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 329.2475. Anal. (C<sub>22</sub>H<sub>32</sub>O<sub>2</sub>) C, H.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Ethyl-17β-(2-sulfamoyloxyethyl)estra-3-<i>O</i>-sulfamoyl-1,3,5(10)-triene <b>27</b></h3><div class="NLM_p last">Compound <b>26</b> (105 mg, 0.32 mmol) was treated with sulfamoyl chloride (0.54 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 10:1 to 4:1) and crystallization from hexane/EtOAc afforded compound <b>27</b> as a white powder (85 mg, 54%), mp 192–194 °C. δ<sub>H</sub> (acetone-<i>d</i><sub>6</sub>): 0.69 (3H, s), 1.18 (3H, t, <i>J</i> 7.4), 1.29–1.62 (10H, m), 1.76–2.42 (6H, m), 2.70 (2H, q, <i>J</i> 7.4), 2.80–2.84 (2H, m), 4.16–4.18 (2H, m), 6.63 (2H, s), 7.09 (1H, s), 7.13 (2H, s), 7.24 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 487.1928; C<sub>22</sub>H<sub>35</sub>O<sub>6</sub>N<sub>2</sub>S<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 487.1931. Anal. (C<sub>22</sub>H<sub>34</sub>O<sub>6</sub>N<sub>2</sub>S<sub>2</sub>) C, H, N.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-Ethyl-3-hydroxy-17β-(2-methoxyethyl)estra-1,3,5(10)-triene <b>28</b></h3><div class="NLM_p last">Compound <b>25</b> (0.42 g, 1 mmol) was treated with NaH (60% dispersion in mineral oil, 0.06 g, 1.5 mmol) and iodomethane (0.12 mL, 2.0 mmol) in THF (30 mL) following the method described for the synthesis of compound <b>17</b>. Purification by flash column chromatography (hexane/EtOAc 20:1) afforded the methyl ether as a white powder (415 mg, 96%), mp 70–71 °C. δ<sub>H</sub> 0.66 (3H, s), 1.25 (3H, t, <i>J</i> 7.4), 1.26–1.60 (9H, m), 1.76–1.96 (5H, m), 2.20–2.42 (2H, m), 2.70 (2H, q, <i>J</i> 7.4), 2.82–2.89 (2H, m), 3.38 (3H, s), 3.40–3.46 (2H, m), 5.07 (2H, s), 6.66 (1H, s), 7.15 (1H, s), 7.31–7.50 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 433.3101; C<sub>30</sub>H<sub>41</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 433.3090. The methyl ether (0.4 g, 0.93 mmol) was treated with Pd/C (10%, 30 mg) in THF (5 mL) and methanol (20 mL) as described for the synthesis of compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 15:1 to 10:1) afforded compound <b>28</b> as a white powder (305 mg, 97%), mp 58–59 °C. δ<sub>H</sub> 0.62 (3H, s), 1.19–1.56 (12H, m), 1.72–1.91 (5H, m), 2.13–2.34 (2H, m), 2.60 (2H, q, <i>J</i> 7.4), 2.73–2.80 (2H, m), 3.37 (3H, s), 3.42–3.48 (2H, m), 5.26 (1H, s), 6.48 (1H, s), 7.06 (1H, s). HRMS (FAB+): <i>m</i>/<i>z</i> found 342.2555; C<sub>23</sub>H<sub>34</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup>) requires 342.2559. Anal. (C<sub>23</sub>H<sub>34</sub>O<sub>2</sub>) C, H.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-(2-methoxyethyl)estra-1,3,5(10)-triene <b>29</b></h3><div class="NLM_p last">Compound <b>28</b> (250 mg, 0.73 mmol) was treated with sulfamoyl chloride (1.5 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 10:1 to 4:1) and crystallization from hexane/EtOAc afforded compound <b>29</b> as a white powder (260 mg, 84%), mp 168–169 °C. δ<sub>H</sub> 0.61 (3H, s), 1.20 (3H, t, <i>J</i> 7.4), 1.22–1.54 (9H, m), 1.70–1.95 (5H, m), 2.15–2.33 (2H, m), 2.68 (2H, q, <i>J</i> 7.4), 2.79–2.86 (2H, m), 3.33 (3H, s), 3.35–3.39 (2H, m), 4.95 (2H, s), 7.06 (1H, s), 7.18 (1H, s). HRMS (ES+) <i>m</i>/<i>z</i> found 422.2360; C<sub>23</sub>H<sub>36</sub>NO<sub>4</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 422.2360. Anal. (C<sub>23</sub>H<sub>35</sub>NO<sub>4</sub>S) C, H, N.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Ethyl-3-hydroxy-17β-(2<i>-tert-</i>butyldiphenylsilyloxyethyl)estra-1,3,5(10)-triene <b>30</b></h3><div class="NLM_p last">Compound <b>25</b> (419 mg, 1 mmol), imidazole (136 mg, 2 mmol), and <i>tert-</i>butyldiphenylsilyl chloride (300 mg, 1.1 mmol) were stirred in DMF (5 mL) as described for the synthesis of compound <b>19</b>. Purification by flash column chromatography (hexane/EtOAc 25:1) afforded the silyl protected alcohol as a white powder (590 mg, 90%), mp 48–50 °C. δ<sub>H</sub> 0.63 (3H, s), 1.12 (9H, s) 1.15–1.60 (11H, m), 1.71–2.01 (5H, m), 2.20–2.44 (2H, m), 2.69 (, <i>J</i> 7.4), 2.84–2.91 (2H, m), 3.65–3.81 (2H, m), 5.09 (2H, s), 6.68 (1H, s), 7.20 (1H, s), 7.32–7.51 (11H, m), 7.72–7.77 (4H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 657.4119; C<sub>45</sub>H<sub>57</sub>O<sub>2</sub>Si<sup>+</sup> (M<sup>+</sup> + H) requires 657.4122. The silyl protected alcohol (550 mg, 0.84 mmol) was treated with Pd/C (10%, 50 mg) in THF (5 mL) and methanol (15 mL) following the method described to access compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 25:1 to 15:1) afforded compound <b>30</b> as a white powder (410 mg, 87%), mp 134–135 °C. δ<sub>H</sub> 0.59 (3H, s), 1.08 (9H, s), 1.18–1.56 (12H, m), 1.68–1.89 (5H, m), 2.10–2.33 (2H, m), 2.61 (2H, q, <i>J</i> 7.4), 2.73–2.82 (2H, m), 3.61–3.78 (2H, m), 4.71 (1H, s), 6.49 (1H, s), 7.07 (1H, s), 7.36–7.47 (6H, m), 7.68–7.74 (4H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 567.3666; C<sub>38</sub>H<sub>51</sub>O<sub>2</sub>Si<sup>+</sup> (M<sup>+</sup> + H) requires 567.3653.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-(hydroxyethyl)estra-1,3,5(10)-triene <b>31</b></h3><div class="NLM_p last">Compound <b>30</b> (142 mg, 0.25 mmol) was treated with sulfamoyl chloride (0.5 mmol) in DMA (5 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 20:1 to 8:1) afforded the sulfamate as a white powder (115 mg, 70%), mp 185–186 °C. δ<sub>H</sub> 0.57 (3H, s), 1.05 (9H, s), 1.18–1.55 (13H, m), 1.68–1.89 (4H, m), 2.15–2.31 (2H, m), 2.68 (2H, q, <i>J</i> 7.4), 2.80–2.87 (2H, m), 3.57–3.70 (2H, m), 4.91 (2H, s, br), 7.06 (1H, s), 7.19 (1H, s), 7.34–7.45 (6H, m), 7.64–7.69 (4H, m). HRMS (FAB+): <i>m</i>/<i>z</i> found 646.3384; C<sub>38</sub>H<sub>51</sub>NO<sub>4</sub>SSi<sup>+</sup> (M<sup>+</sup> + H) requires 646.3386. The sulfamate (110 mg, 0.17 mmol) was reacted with TBAF (1 M in THF, 0.34 mL, 0.34 mmol) in THF (10 mL) at room temperature for 4 h as described for the synthesis of <b>20</b>. Purification by flash column chromatography (hexane/EtOAc 10:1 to 2:1) and crystallization from hexane/EtOAc afforded compound <b>31</b> as a white powder (50 mg, 72%), mp 157–158 °C. δ<sub>H</sub>: 0.62 (3H, s), 1.17–1.55 (12H, m), 1.70–1.94 (5H, m), 2.16–2.33 (2H, m), 2.68 (2H, q, <i>J</i> 7.4), 2.80–2.87 (2H, m), 3.60–3.76 (2H, m), 4.87 (2H, s, br), 7.06 (1H, s), 7.19 (1H, s). HRMS (FAB+): <i>m</i>/<i>z</i> found 407.2141; C<sub>22</sub>H<sub>33</sub>NO<sub>4</sub>S<sup>+</sup> (M<sup>+</sup>) requires 407.2130. Anal. (C<sub>22</sub>H<sub>33</sub>NO<sub>4</sub>S) C, H, N.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-Ethyl-17-(2-ethoxy-2-oxoethylidene)-3-<i>O</i>-(<i>tert</i>-butyldimethylsilyl)estra-1,3,5(10)-triene <b>33</b></h3><div class="NLM_p last">Compound <b>32</b> (4.1 g, 10 mmol) was reacted with triethylphosphonoacetate following the method used for the synthesis of compounds <b>21</b> and <b>22</b>. Purification by flash column chromatography (hexane to hexane/EtOAc 25:1) afforded compound <b>33</b> as a light yellow oil (4.3 g, 89%; mixture of <i>E</i> and <i>Z</i> isomers). δ<sub>H</sub> 0.22 (6H, s), 0.85 (3H, s, major) and 1.03 (3H, s, minor), 0.99 (9H, s), 1.16 (3H, t, <i>J</i> 7.4), 1.28 (3H, t, <i>J</i> 7.1), 1.31–1.59 (5H, m), 1.82–1.98 (3H,m), 2.13–2.25 (1H, m), 2.37–2.44 (1H, m), 2.55 (2H, q, <i>J</i> 7.4), 2.76–2.92 (4H, m), 4.15 (2H, q, <i>J</i> 7.1), 5.58 (1H, t, <i>J</i> 2.2, major), 5.67 (1H, t, <i>J</i> 1.7, minor), 6.48 (1H, s), 7.05 (1 H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 483.3279; C<sub>30</sub>H<sub>47</sub>O<sub>3</sub>Si<sup>+</sup> (M<sup>+</sup> + H) requires 483.3289.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Ethyl-3-hydroxy-17-(2-ethoxy-2-oxoethylidene)estra-1,3,5(10)-trienes <b>34</b> and <b>35</b></h3><div class="NLM_p last">Compound <b>33</b> (4.0 g, 8.3 mmol) was treated with TBAF (1 M in THF, 9.2 mL, 9.2 mmol) in THF (50 mL) as described for the synthesis of compound <b>20</b>. Purification by flash column chromatography (hexane to hexane/EtOAc 10:1) afforded successively the <i>Z</i>-isomer <b>35</b> (380 mg, 12%) and the <i>E</i>-isomer <b>34</b> (2.2 g, 72%) as white powders. Compound <b>34</b>: mp 85–87 °C. δ<sub>H</sub> 0.86 (3H, s), 1.23 (3H, t, <i>J</i> 7.4), 1.30 (3H, t, <i>J</i> 7.1), 1.33–1.58 (6H, m), 1.85–2.00 (3H, m), 2.18–2.25 (1H, m), 2.39–2.45 (1H, m), 2.60 (2H, q, <i>J</i> 7.4), 2.78–2.84 (2H, m), 2.86–2.91 (2H, m), 4.16 (2H, q, <i>J</i> 7.1), 4.67 (1H, s), 5.59 (1H, t, <i>J</i> 2.3), 6.51 (1H, s), 7.06 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 369.2416; C<sub>24</sub>H<sub>33</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 369.2424. Anal. (C<sub>24</sub>H<sub>32</sub>O<sub>3</sub>) C, H, N. Compound <b>35</b>: mp 157–159 °C. δ<sub>H</sub> 1.04 (3H, s), 1.22 (3H, t, <i>J</i> 7.4), 1.29 (3H, t, <i>J</i> 7.2), 1.36–1.62 (6H, m), 1.78–1.84 (1H, m), 1.89–1.95 (1H, m), 2.16–2.23 (1H, m), 2.31–2.37 (1H, m), 2.41–2.49 (1H, m), 2.57–2.65 (3H, m), 2.77–2.84 (3H, m), 4.11–4.20 (2H, m), 4.60 (1H, s, br), 5.68 (1H, t, <i>J</i> 1.9), 6.50 (1H, s), 7.05 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 369.2419; C<sub>24</sub>H<sub>33</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 369.2424. Anal. (C<sub>24</sub>H<sub>32</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>E</i>)-2-Ethyl-3-<i>O</i>-sulfamoyl-17-(2-ethoxy-2-oxoethylidene)estra-1,3,5(10)-triene <b>36</b></h3><div class="NLM_p last">Compound <b>34</b> (185 mg, 0.5 mmol) was treated with sulfamoyl chloride (1.5 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 10:1 to 3:1) afforded compound <b>36</b> as a white powder (195 mg, 87%), mp 116–118 °C. δ<sub>H</sub> 0.86 (3H, s), 1.22 (3H, t, <i>J</i> 7.4), 1.29 (3H, t, <i>J</i> 7.1), 1.38–1.64 (6H, m), 1.76–2.02 (3H, m), 2.23–2.29 (1H, m), 2.38–2.44 (1H, m), 2.67 (2H, q, <i>J</i> 7.4), 2.85–2.91 (4H, m), 4.16 (2H, q, <i>J</i> 7.1), 4.98 (2H, s), 5.59 (1H, t, <i>J</i> 2.3), 7.09 (1H, s), 7.20 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 448.2149; C<sub>24</sub>H<sub>34</sub>NO<sub>5</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 448.2152. Anal. (C<sub>24</sub>H<sub>33</sub>NO<sub>5</sub>S) C, H, N</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>Z</i>)- 2-Ethyl-3-<i>O</i>-sulfamoyl-17-(2-ethoxy-2-oxoethylidene)estra-1,3,5(10)-triene <b>37</b></h3><div class="NLM_p last">Compound <b>35</b> (170 mg, 0.46 mmol) was treated with sulfamoyl chloride (1.5 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 10:1 to 3:1) afforded compound <b>37</b> as a white powder (190 mg, 92%), mp 152–153 °C. δ<sub>H</sub> 1.04 (3H, s), 1.22 (3H, t, <i>J</i> 7.4), 1.29 (3H, t, <i>J</i> 7.2), 1.34–1.64 (6H, m), 1.77–1.85 (1H, m), 1.91–1.97 (1H, m), 2.18–2.27 (1H, m), 2.31–2.38 (1H, m), 2.40–2.49 (1H, m), 2.56–2.74 (3H, m), 2.79–2.88 (3H, m), 4.10–4.18 (2H, m), 4.92 (2H, s), 5.69 (1H, t, <i>J</i> 2.1), 7.08 (1H, s), 7.19 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 448.2143; C<sub>24</sub>H<sub>34</sub>NO<sub>5</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 448.2152. Anal. (C<sub>24</sub>H<sub>33</sub>NO<sub>5</sub>S) C, H, N</div></div><div id="sec4_4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>E</i>)-2-Ethyl-3-hydroxy-17-(2-hydroxyethylidene)estra-1,3,5(10)-triene <b>38</b></h3><div class="NLM_p last">A solution of <b>34</b> (370 mg, 1.0 mmol) in THF (5 mL) stirred under nitrogen was cooled to −78 °C, and DIBAL-H (1 M in THF, 2.2 mL, 2.2 mmol) was added dropwise. The mixture was stirred at −78 °C for 1 h and then slowly warmed to room temperature and stirred for 30 min. Ammonium chloride (saturated, 5 mL) was added at 0 °C, and the mixture was extracted with EtOAc (2 × 30 mL). The combined organics were washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane to hexane/EtOAc 4:1) afforded compound <b>38</b> as a white powder (260 mg, 79%), mp 167–169 °C. δ<sub>H</sub> 0.79 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.27–1.61 (6H, m), 1.74–1.97 (3H, m), 2.20–2.48 (5H, m), 2.59 (2H, q, <i>J</i> 7.4), 2.77–2.83 (2H, m), 4.03–4.12 (2H, m), 4.49 (1H, s), 5.26–5.37 (1H, m), 6.48 (1H, s), 7.06 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 349.2129; C<sub>22</sub>H<sub>30</sub>O<sub>2</sub>Na<sup>+</sup> (M<sup>+</sup>+Na) requires 349.2138. Anal. (C<sub>22</sub>H<sub>30</sub>O<sub>2</sub>) C, H.</div></div><div id="sec4_4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>Z</i>)-2-Ethyl-3-hydroxy-17- (2-hydroxyethylidene)estra-1,3,5(10)-triene <b>39</b></h3><div class="NLM_p last">Compound <b>35</b> (180 mg, 0.49 mmol) was treated with DIBAL-H (1 M in THF, 1.0 mL, 1.0 mmol) in THF (5 mL) as described for the synthesis of <b>38</b>. Purification by flash column chromatography (hexane to hexane/EtOAc 4:1) afforded compound <b>39</b> as a white powder (90 mg, 56%), mp 149–151 °C. δ<sub>H</sub> 0.93 (3H, s), 1.23 (3H, t, <i>J</i> 7.4), 1.28–1.61 (6H, m), 1.72–1.82 (2H, m), 1.87–1.92 (1H, m), 2.19–2.40 (4H, m), 2.47–2.54 (1H, m), 2.60 (2H, q, <i>J</i> 7.4), 2.74–2.83 (2H, m), 4.21 (1H, dd, <i>J</i> 12.1, 7.4), 4.35 (1H, dd, <i>J</i> 12.1, 7.4), 4.57 (1H, s, br), 5.32–5.37 (1H, m), 6.50 (1H, s), 7.04 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 349.2151; C<sub>22</sub>H<sub>30</sub>O<sub>2</sub>Na<sup>+</sup> (M<sup>+</sup>+Na) requires 349.2138. Anal. (C<sub>22</sub>H<sub>30</sub>O<sub>2</sub>) C, H</div></div><div id="sec4_4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17-vinyl-estra-1,3,5(10),16-tetraene <b>40</b></h3><div class="NLM_p">Compound <b>38</b> (80 mg, 0.24 mmol) was treated with sulfamoyl chloride (0.5 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 10:1 to 3:1) afforded compound <b>40</b> as a colorless oil (52 mg, 56%). δ<sub>H</sub> 0.91 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.27–1.55 (2H, m), 1.61–1.73 (4H, m), 1.85–2.07 (2H, m), 2.18–2.39 (4H, m), 2.69 (2H, q, <i>J</i> 7.4), 2.83–2.92 (2H, m), 4.88–4.97 (1H, m), 4.99 (2H, s), 5.35 (1H, d, <i>J</i> 18.0), 5.73 (1H, s, br), 6.32 (1H, dd, <i>J</i> 18.0, 11.4), 7.10 (1H, s), 7.18 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 388.1937; C<sub>22</sub>H<sub>30</sub>NO<sub>3</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 388.1941.</div><div class="NLM_p last">Treatment of <b>39</b> (80 mg, 0.24 mmol) with sulfamoyl chloride (0.5 mmol) in DMA (1.0 mL) also yielded <b>40</b> (70 mg, 74%).</div></div><div id="sec4_4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>E</i>)-2-Ethyl-3-hydroxy-17-(2-methoxyethylidene)estra-1,3,5(10)-triene <b>41</b></h3><div class="NLM_p last">Compound <b>21</b> (0.9 g, 1.97 mmol) was treated with lithium aluminum hydride (0.45 g, 12 mmol) in THF (30 mL) at 0 °C as described for the synthesis of compound <b>25</b>. Purification by flash column chromatography (hexane/EtOAc 15:1 to 6:1) afforded the allylic alcohol as a white powder (0.75 g, 89%), mp 61–62 °C. δ<sub>H</sub> 0.84 (3H, s), 1.20–1.66 (9H, m), 1.82–2.02 (3H, m), 2.21–2.51 (3H, m), 2.71 (2H, q, <i>J</i> 7.4), 2.82–2.89 (2H, m), 4.10–4.21 (2H, m), 5.07 (2H, s), 5.28–5.34 (1H, m), 6.66 (1H, s), 7.15 (1H, s), 7.30–7.48 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 417.2793; C<sub>29</sub>H<sub>37</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 417.2788. Method was as for <b>17</b> using the allylic alcohol, sodium hydride (60% dispersion in mineral oil, 80 mg, 2 mmol), and iodomethane (0.19 mL, 3.0 mmol) in THF (10 mL) at room temperature for 18 h. Purification by flash column chromatography (hexane/EtOAc 20:1) afforded the methyl ether as a colorless oil (0.59 g, 91%). δ<sub>H</sub>: 0.84 (3H, s), 1.24 (3H, t, <i>J</i> 7.4), 1.26–1.66 (6H, m), 1.82–2.02 (3H, m), 2.20–2.51 (3H, m), 2.70 (2H, q, <i>J</i> 7.4), 2.82–2.89 (2H, m), 3.36 (3H, s), 3.90–3.97 (2H, m), 5.06 (2H, s), 5.24–5.30 (1H, m), 6.66 (1H, s), 7.15 (1H, s), 7.31–7.48 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 431.2937; C<sub>30</sub>H<sub>39</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 431.2945. A solution of the benzyl ether (180 mg, 0.42 mmol) in <i>t</i>-BuOH (10 g) was refluxed and treated sodium (∼50 mg). Further chunks of sodium were added every hour until deprotection was complete by TLC (8 h). The mixture was cooled, and the reaction was then quenched with isopropanol. The mixture was then diluted with water. The organics were extracted with ethyl acetate, and the organic layer was washed with water, brine and then evaporated. Purification by flash column chromatography (hexane/EtOAc 15:1 to 8:1) afforded <b>41</b> as a white powder (95 mg, 67%), mp 133–134 °C. δ<sub>H</sub> 0.79 (3H, s), 1.22 (3H, t, <i>J</i> 7.4), 1.28–1.60 (6H, m), 1.75–1.96 (3H, m), 2.18 (1H, m), 2.39 (3H, m), 2.59 (2H, q, <i>J</i> 7.4), 2.79 (2H, m), 3.35 (3H, s), 3.90–3.98 (2H, m), 5.11 (1H, s), 5.21–5.28 (1H, m), 6.48 (1H, s), 7.05 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 341.2472; C<sub>23</sub>H<sub>33</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 341.2475. Anal. (C<sub>23</sub>H<sub>32</sub>O<sub>2</sub>) C, H</div></div><div id="sec4_4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>E</i>)-2-Ethyl-3-<i>O</i>-sulfamoyl-17-(2-methoxyethylidene)estra-1,3,5(10)-triene <b>42</b></h3><div class="NLM_p last">Compound <b>41</b> (170 mg, 0.5 mmol) was treated with sulfamoyl chloride (1.0 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 10:1 to 5:1) afforded compound <b>42</b> as a white powder (142 mg, 68%), mp 126–127 °C. δ<sub>H</sub> 0.79 (3H, s), 1.20 (3H, t, <i>J</i> 7.4), 1.22–1.67 (6H, m), 1.78–1.98 (3H, m), 2.17–2.47 (4H, m), 2.68 (2H, q, <i>J</i> 7.4), 2.82–2.88 (2H, m), 3.32 (3H, s), 3.87–3.93 (2H, m), 5.14 (2H, s), 5.18–5.24 (1H, m), 7.06 (1H, s), 7.19 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 420.2188; C<sub>23</sub>H<sub>34</sub>O<sub>4</sub>NS<sup>+</sup> (M<sup>+</sup> + H) requires 420.2203. Anal. (C<sub>23</sub>H<sub>33</sub>O<sub>4</sub>NS) C, H, N</div></div><div id="sec4_4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>E</i>)-2-Ethyl-3-<i>O</i>-sulfamoyl-17-(2-hydroxyethylidene)estra-1,3,5(10)-triene <b>43</b></h3><div class="NLM_p last">Compound <b>36</b> (110 mg, 0.25 mmol) was treated with DIBAL-H in (1 M in THF, 0.5 mL, 0.5 mmol) in THF (5 mL) at −78 °C as described for the synthesis of compound <b>38</b>. Purification by flash column chromatography (hexane to hexane/EtOAc 1:1) afforded compound <b>43</b> as a white powder (65 mg, 65%) with mp 145–147 °C. δ<sub>H</sub> 0.81 (3H, s), 1.22 (3H, t, <i>J</i> 7.1), 1.28–1.62 (7H, m), 1.78–2.01 (3H, m), 2.20–2.27 (1H, m), 2.32–2.47 (3H, m), 2.70 (2H, q, <i>J</i> 7.1), 2.84–2.88 (2H, m), 4.08–4.21 (2H, m), 5.04 (1H, s, br), 5.29 (1H, t, <i>J</i> 6.8), 7.08 (1H, s), 7.20 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 388.1932; C<sub>22</sub>H<sub>30</sub>NO<sub>3</sub>S<sup>+</sup> (M<sup>+</sup>–OH) requires 388.1941. Anal. (C<sub>22</sub>H<sub>31</sub>O<sub>4</sub>NS) C, H, N</div></div><div id="sec4_4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-Ethyl-3-<i>O</i>-benzyl-17-(1-ethenyl)estra-1,3,5(10)-triene <b>45a</b></h3><div class="NLM_p last">A solution of ethyltriphenylphosphonium iodide (3.75 g, 6.45 mmol) in DMSO (25 mL) was treated with sodium hydride (420 mg, 10.5 mmol, 60% dispersion in mineral oil) and then brought to 100 °C for 0.25 h. 2-Ethyl-3-<i>O</i>-benzylestrone (1.85 g, 4.76 mmol) in DMSO (10 mL) was then added to the orange reaction mixture, and heating was continued for a further 16 h. The cooled reaction mixture was then poured onto ice–water (100 mL) and extracted with ether (3 × 100 mL). The organic layers were then washed with water (3 × 100 mL), brine (10 mL), dried, and evaporated. The crude product was purified by column chromatography (hexane/ethyl acetate gradient 100–97%) to give the desired alkene <b>45a</b>, as a mixture of geometric isomers, as a clear colorless oil (1.35 g, 71%) which showed significant resonances at δ<sub>H</sub> 0.91 and 0.89 (3H, 2<i>s</i>, 18-CH<sub>3</sub>), 1.22 (3H, t, <i>J</i> 7.4, CH<sub>2</sub><i>Me</i>), 1.70 (app dt, <i>J</i> 7.2 and 1.7,:CH<i>Me</i> major isomer), 2.68 (2H, q, <i>J</i> 7.4, C<i>H</i><sub>2</sub>Me), 2.74–2.90 (2H, m, 6-CH<sub>2</sub>), 4.98–5.25 (1H, m, CH both isomers), 5.40 (2H, s, OCH<sub>2</sub>), 6.64 (1H, s, ArH), 7.12 (1H, s, ArH), and 7.27–7.48 (5H, m). <i>m</i>/<i>z</i> (AP+) 401.6 (M<sup>+</sup> + H, 100%) and 309.6 (65%). HRMS (ES+) <i>m</i>/<i>z</i> found 401.2839; C<sub>29</sub>H<sub>36</sub>O (M<sup>+</sup> + H) requires 401.2834.</div></div><div id="sec4_4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Ethyl-3-<i>O</i>-benzyl-17β-(1-hydroxyethyl) estra-1,3,5(10)-triene <b>46a</b></h3><div class="NLM_p last">To a room temperature solution of <b>45a</b> (700 mg, 1.74 mmol, as a mixture of geometric isomers) was added borane THF (16 mL, 1M). The mixture was stirred for 14 h at room temperature and then treated with sodium hydroxide (20 mL, 10% aqueous) (causing vigorous gas evolution) and then hydrogen peroxide (60 mL, 27.5% aqueous). After 2 h of further stirring the THF was removed on a rotary evaporator and the resultant mixture was extracted into ether (2 × 100 mL). The combined organic layers were then washed with water (2 × 100 mL) and brine (75 mL), dried, and evaporated to give a colorless oil. The crude product was purified by column chromatography to give two fractions. The second fraction (<i>R</i><sub><i>f</i></sub> = 0.22 in 15% ethyl acetate/hexane), a clear colorless oil (350 mg, 48%), proved to be the desired alcohol <b>46a</b> as a single diastereoisomer with 17β configuration at C-17 (likely (<i>S</i>)-configuration at C-20). δ<sub>H</sub> 0.65 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.18–2.34 (21H, m, including 1.26 (3H, d, <i>J</i> 6.2) and 1.20 (3H, t, <i>J</i> 7.4)), 2.66 (2H, q, <i>J</i> 7.4), 2.76–2.92 (2H, m), 3.69–3.79 (1H, m), 5.04 (2H, s), 6.63 (1H, s), 7.09 (1H, s), and 7.29–7.44 (5H, m). <i>m</i>/<i>z</i> (AP+) 419.6 (M<sup>+</sup> + H, 100%) and 401.6 (75%). HRMS (ES+) <i>m</i>/<i>z</i> found 419.2945; C<sub>29</sub>H<sub>38</sub>O<sub>2</sub> (M<sup>+</sup> + H) requires 419.2950.</div></div><div id="sec4_4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-Ethyl-3-<i>O</i>-benzyl-17β-(acyl)estra-1,3,5(10)-triene <b>47a</b></h3><div class="NLM_p last">To a stirred, 0 °C solution of <b>46a</b> (330 mg, 0.77 mmol) in dichloromethane (20 mL) was added Dess–Martin periodinane (392 mg, 1.2 equiv, 0.92 mmol) in one portion. The mixture was stirred overnight and then diluted with ether (100 mL) and sodium hydroxide (2 mL, 1 M aqueous) and then stirred for a further 0.5 h prior to washing with water (100 mL) and brine (100 mL), drying, and evaporating. The desired ketone <b>47a</b> was isolated by adding hexane to the resultant oil which caused white needles to form (280 mg, 87%), mp 134–135 °C (<i>R<sub>f</sub></i> = 0.45 in 4:1 hexane/ethyl acetate). δ<sub>H</sub> 0.65 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.25–2.40 (13H, m), 2.15 (3H, s), 2.66 (2H, q, <i>J</i> 7.4), 2.59–2.71 (1H, m), 2.76–2.92 (2H, m), 5.04 (2H, s), 6.63 (1H, s), 7.10 (1H, s), and 7.28–7.45 (5H, m). <i>m</i>/<i>z</i> (AP+) 417.6 (M<sup>+</sup> + H, 100%).</div></div><div id="sec4_4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-Ethyl-3-<i>O</i>-hydroxy-17β-acylestra-1,3,5(10)-triene <b>48a</b></h3><div class="NLM_p last">A solution of <b>47a</b> (260 mg, 0.62 mmol) in THF (3 mL) and methanol (20 mL) was treated with Pd/C (10%, 50 mg) as described for the synthesis of compound <b>15</b>. The mixture was then filtered through a pad of Celite and evaporated to give <b>48a</b> as a white solid (180 mg, 89%) which was then crystallized from ethyl acetate/hexane to give white needles, mp 197–200 °C. δ<sub>H</sub> 0.64 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.24–1.90 (9H, m), 2.15 (3H, s), 2.12–2.40 (4H, m), 2.58 (2H, q, <i>J</i> 7.4), 2.60 (1H, app t, <i>J</i> 9.4), 2.74–2.86 (2H, m), 4.72 (1H, s), 6.49 (1H, s), and 7.03 (1H, s). <i>m</i>/<i>z</i> (AP−) 325.6 (M<sup>+</sup>, 100%) and 267.5 (75%).</div></div><div id="sec4_4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-acylestra-1,3,5(10)-triene <b>49a</b></h3><div class="NLM_p last">Compound <b>48a</b> (80 mg, 0.25 mmol) was treated with sulfamoyl chloride (0.6 mmol) in DMA (2 mL) as described for the synthesis of compound <b>16</b>. The desired product 2-ethyl-3-<i>O</i>-sulfamoyl-17β-acylestrone was purified by column chromatography (10% acetone in chloroform) to give a white solid (95 mg, 95%). This material was crystallized from ethyl acetate/hexane to give <b>49a</b> as fine white needles (73 mg of first crop), mp 192–194 °C. δ<sub>H</sub> 0.65 (3H, s, 18-CH<sub>3</sub>), 1.21 (3H, t, <i>J</i> 7.4), 1.24–1.93 (9H, m), 2.15 (3H, s), 2.15–2.40 (4H, m), 2.60 (1H, dd, <i>J</i> 9.4, 9.0), 2.69 (2H, q, <i>J</i> 7.4), 2.81–2.87 (2H, m), 4.93 (2H, s), 7.07 (1H, s), and 7.17 (1H, s). <i>m</i>/<i>z</i> (AP−) 404.5 (M<sup>+</sup>, 100%). HRMS (ES+) <i>m</i>/<i>z</i> found 423.2316; C<sub>22</sub>H<sub>31</sub>SO<sub>4</sub>N<sup>+</sup> + NH<sub>4</sub> (or C<sub>22</sub>H<sub>35</sub>SO<sub>4</sub>N<sub>2</sub><sup>+</sup>) (M<sup>+</sup> + NH<sub>4</sub>) requires 423.2312.</div></div><div id="sec4_4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-Methoxy-3-<i>O</i>-benzyl-17-(1-ethenyl)estra-1,3,5(10)-triene <b>45b</b></h3><div class="NLM_p last">A solution of ethyltriphenylphosphonium iodide (1.25 g, 3 mmol) in DMSO (20 mL) was treated with sodium hydride (120 mg, 3 mmol, 60% dispersion in mineral oil) and then brought to 100 °C for 0.25 h. 2-Methoxy-3-<i>O</i>-benzylestrone (390 mg, 1 mmol) was then added to the red reaction mixture, and heating was continued for a further 16 h. The cooled reaction mixture was then poured onto ice–water (50 mL) and extracted with ether (3 × 30 mL). The organic layers were then washed with water (3 × 30 mL), brine (10 mL), dried, and evaporated. The crude product was purified by column chromatography (hexane/ethyl acetate gradient 100–94%) to give the desired alkene <b>45b</b> as a mixture of geometric isomers (∼9:1) as a clear colorless oil (200 mg, 57%). δ<sub>H</sub> 0.93 and 0.80 (3H, 2s), 1.25–2.54 (14 H, m including 1.70 (app dt, <i>J</i> 7.2, 1.7)), 2.68–2.84 (2H, m), 3.88 (3H, s), 5.08–5.23 (1H, m), 5.12 (2H, s), 6.64 (1H, s), 6.87 (1H, s), 7.26–7.48 (5H, m). <i>m</i>/<i>z</i> (ES+) 425.2 (M<sup>+</sup> + Na, 100%).</div></div><div id="sec4_4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-Methoxy-3-<i>O</i>-benzyl-17β-(1-hydroxyethyl)estra-1,3,5(10)-triene <b>46b</b></h3><div class="NLM_p last">To an ice cold solution of <b>45b</b> (160 mg, 0.39 mmol) in THF (5 mL) was added borane–THF (5 mL, 5 mmol). The mixture was stirred for 14 h at 0 °C, then treated with sodium hydroxide (5 mL, 10% aqueous) and hydrogen peroxide (5 mL, 30% aq). After the mixture was further stirred for 1 h, the THF was removed on a rotary evaporator and the resultant mixture was extracted into ether (2 × 30 mL). The combined organic layers were then washed with water (2 × 20 mL) and brine (25 mL), dried, and evaporated to give a colorless oil. The crude product was purified by column chromatography (4:1 hexane/ethyl acetate) to give the desired alcohol <b>46b</b> as a white solid (98 mg, 59%). δ<sub>H</sub> 0.66 (3H, s), 1.15–2.30 (17H, m including 1.24 (3H, s)), 2.68–2.80 (2H, m), 3.70–3.83 (1H, m), 3.85 (3H, s), 5.09 (2H, s), 6.61 (1H, s), 6.82 (1H, s), 7.26–7.45 (5H, m). <i>m</i>/<i>z</i> (ES+) 443.6 (M<sup>+</sup> + Na, 100%).</div></div><div id="sec4_4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-Methoxy-3-<i>O</i>-benzyl-17β-(acyl)estra-1,3,5(10)-triene <b>47b</b></h3><div class="NLM_p last">To a stirred, 0 °C solution of <b>46b</b> (90 mg, 0.21 mmol) in dichloromethane (5 mL) was added Dess–Martin periodinane (109 mg, 1.2 equiv, 0.26 mmol) in one portion. The mixture was stirred for 16 h and then diluted with ether (75 mL) and sodium hydroxide (1 mL, 1 M aqueous) and then stirred for a further 0.5 h prior to washing with water (100 mL) and brine (100 mL), drying, and evaporating. The desired ketone <b>47b</b> was obtained as a white solid (70 mg, 80%). δ<sub>H</sub> 0.64 (3H, s, 18-CH<sub>3</sub>), 1.20–1.95 (10H, m), 2.08–2.34 (6H, m including 2.14 (3H, s)), 2.60 (1H, dd, <i>J</i> 9.1, 8.6), 2.70–2.80 (2H, m), 3.85 (3H, s), 5.09 (2H, s), 6.61 (1H, s), 6.82 (1H, s), 7.26–7.45 (5H, s). <i>m</i>/<i>z</i> (ES+) 441.6 (M<sup>+</sup> + Na, 100%).</div></div><div id="sec4_4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2-Methoxy-3-<i>O</i>-hydroxy-17β-acylestra-1,3,5(10)-triene <b>48b</b></h3><div class="NLM_p last">Compound <b>47b</b> (55 mg, 0.13 mmol) in THF (1 mL) and methanol (5 mL) was treated with Pd/C (10%, 15 mg) as described for the synthesis of compound <b>15</b>. The resultant solid was washed with a small volume of ethyl acetate to remove colored impurities, and the resultant white solid was collected by filtration and dried to give <b>48b</b> as a white solid (35 mg, 82%), mp 217–219 °C. δ<sub>H</sub> 0.65 (3H, s), 1.20–1.91 (10H, m), 2.10–2.34 (6H, m including 2.14 (3H, s)), 2.60 (1H, dd, <i>J</i> 8.9, 8.1), 2.72–2.82 (2H, m), 3.89 (3H, s), 5.41 (1H, s, OH), 6.63 (1H, s), 6.77 (1H, s). <i>m</i>/<i>z</i> (ES−) 327.6 (M<sup>+</sup> – H), 100%). HRMS (ES+) <i>m</i>/<i>z</i> found 329.2122; C<sub>21</sub>H<sub>29</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 329.2117.</div></div><div id="sec4_4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-Methoxy-3-<i>O</i>-sulfamoyl-17β-acylestra-1,3,5(10)-triene <b>49b</b></h3><div class="NLM_p last">Compound <b>48b</b> (22 mg, 0.093 mmol) in DMA (1.5 mL) was added treated with sulfamoyl chloride (0.65 mmol) as described for the synthesis of compound <b>16</b>. The desired sulfamate <b>49b</b> was crystallized from ethyl acetate/hexane to give fine white needles (15 mg, 40% first crop), mp 178–180 °C. δ<sub>H</sub> 0.66 (3H, s, 18-CH<sub>3</sub>), 1.30–2.35 (H, m including 2.14 (3H, s)), 2.60 (1H, dd, <i>J</i> 9.0, 9.0), 2.82–2.90 (2H, m), 3.87 (3H, s), 4.97 (2H, s), 6.91 (1H, s), 7.02 (1H, s). <i>m</i>/<i>z</i> (ES−) 406.6 (M<sup>+</sup>, 100%). HRMS (ES+) <i>m</i>/<i>z</i> found 425.2105; C<sub>21</sub>H<sub>29</sub>SO<sub>5</sub>N<sup>+</sup> + NH<sub>4</sub> (or C<sub>21</sub>H<sub>33</sub>SO<sub>5</sub>N<sub>2</sub><sup>+</sup>) (M<sup>+</sup> + NH<sub>4</sub>) requires 425.2105.</div></div><div id="sec4_4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-Methoxy-3-benzyloxy-17β-cyanomethylestra-1,3,5(10)-triene <b>50</b></h3><div class="NLM_p last">Diethyl cyanomethylphosphonate (3.55 g, 20 mmol) in THF (60 mL) was treated with NaH (60% dispersion in mineral oil, 0.4 g, 20 mmol). 2-Methoxy-3-<i>O</i>-benzylestrone (3.94 g, 10 mmol) in THF (20 mL) was added dropwise at room temperature, and the solution was stirred for 18 h. The reaction mixture was cooled to 0 °C, and water (30 mL) was added. The mixture was extracted with EtOAc. The organic layer was washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 25:1 to 6:1) afforded the olefin (mixture of <i>Z</i> and <i>E</i> isomers). The olefin was treated with Pd/C (10%, 200 mg) in THF (15 mL) and methanol (50 mL) as described for the synthesis of compound <b>15</b>. The resultant suspension was filtered through Celite, washed with EtOAc, and concentrated in vacuo. The residue was stirred with potassium carbonate (2.8 g, 20 mmol) and benzyl bromide (1.18 mL, 10 mmol) in DMF (20 mL) for 24 h at room temperature. Water (50 mL) was added, and the mixture was extracted with EtOAc (2 × 80 mL). The combined organics were washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 20:1 to 5:1) afforded compound <b>50</b> as a white solid (3.45 g, 83% over three steps), mp 175–176 °C. δ<sub>H</sub> 0.67 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.21–1.52 (7H, m), 1.75–1.88 (3H, m), 1.96–2.11 (2H, m), 2.17–2.41 (4H, m), 2.71–2.77 (2H, m), 3.85 (3H, s), 5.10 (2H, s), 6.61 (1H, s), 6.82 (1H, s), 7.25–7.45 (5H, m). LC/MS (ES+): <i>m</i>/<i>z</i> 416.2 (M<sup>+</sup> + H).</div></div><div id="sec4_4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-Methoxy-3-benzyloxyestra-1,3,5(10)-triene-17β-acetaldehyde <b>51</b></h3><div class="NLM_p last">Compound <b>50</b> (1.5 g, 3.6 mmol) was treated with DIBAL (1.5 M in THF, 7.2 mL, 10.8 mmol) in THF (30 mL) at 0 °C as described for the synthesis of compound <b>38</b>. After addition of HCl (2 M, 20 mL) the mixture was stirred for 0.5 h and then extracted with EtOAc (3 × 30 mL). The combined organics were washed with water and brine, dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo to afford compound <b>51</b> as a white powder (1.15 g, 77%), mp 142–144 °C. δ<sub>H</sub> 0.64 (3H, s), 1.21–1.52 (7H, m), 1.75–2.05 (5H, m), 2.15–2.35 (3H, m), 2.49–2.57 (1H, m), 2.66–2.78 (2H, m), 3.85 (3H, s), 5.10 (2H, s), 6.61 (1H, s), 6.83 (1H, s), 7.26–7.45 (5H, m), 9.78 (1H, t, <i>J</i> 2.2).</div></div><div id="sec4_4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-Methoxy-3-benzyloxy-17β-(2-hydroxypropyl)estra-1,3,5(10)-triene <b>52</b></h3><div class="NLM_p last">A solution of <b>51</b> (420 mg, 1.0 mmol) in THF (10 mL) was stirred under nitrogen, cooled to 0 °C, and treated with methylmagnesium bromide (3 M in diethyl ether, 0.50 mL, 1.5 mmol). The reaction mixture was stirred at 0 °C for 4 h. Ammonium chloride (saturated, 5 mL) was added, and the mixture was extracted with EtOAc (2 × 30 mL). The combined organics were washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 20:1 to 3:1) afforded compound <b>52</b> as a white powder (300 mg, 69%), mp 77–80 °C. δ<sub>H</sub> 0.61 and 0.62 (3H, 2s), 1.18–1.60 (13H, m), 1.68–2.00 (4H, m), 2.12–2.28 (2H, m), 2.65–2.83 (2H, m), 3.78–3.87 (3H, m), 5.10 (2H, s), 6.61 (1H, s), 6.84 (1H, s), 7.26–7.45 (5H, m). HRMS (FAB+): <i>m</i>/<i>z</i> found 435.2880; C<sub>29</sub>H<sub>39</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 435.2894.</div></div><div id="sec4_4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-Ethyl-3-benzyloxy-17β-(2-hydroxypropyl)estra-1,3,5(10)-triene <b>58</b></h3><div class="NLM_p last">Compound <b>57</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (390 mg, 0.94 mmol) was treated with methylmagnesium bromide (3 M in diethyl ether, 0.5 mL, 1.5 mmol) in THF (10 mL) at 0 °C as described for the synthesis of <b>52</b>. Purification by flash column chromatography (hexane/EtOAc 20:1 to 10:1) afforded compound <b>58</b> as a white powder (310 mg, 77%), mp 66–69 °C. δ<sub>H</sub> 0.61 and 0.63 (3H, s), 1.18–1.59 (17H, m), 1.73–1.96 (3H, m), 2.16–2.35 (2H, m), 2.66 (2H, q, <i>J</i> 7.4), 2.83 (2H, m), 3.84 (1H, m), 5.03 (2H, s), 6.63 (1H, s), 7.11 (1H, s), 7.27–7.46 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 433.3093; C<sub>30</sub>H<sub>41</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 433.3101.</div></div><div id="sec4_4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-Methoxy-3-benzyloxy-17β-(2-oxopropyl)estra-1,3,5(10)-triene <b>53</b></h3><div class="NLM_p last">A solution of <b>52</b> (250 mg, 0.58 mmol) in DCM (10 mL) was stirred at 0 °C, and Dess–Martin periodinane (293 mg, 0.69 mmol) was added portionwise. The reaction mixture was stirred at 0 °C for 4 h. Then diethyl ether (50 mL) and sodium hydroxide (1 M, 5 mL) were added, and the solution was stirred at 0 °C for 1 h. The organic layer was separated, washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 10:1 to 5:1) afforded compound <b>53</b> as a white powder (165 mg, 66%), mp 120–121 °C. δ<sub>H</sub> 0.62 (3H, s), 1.20–1.52 (7H, m), 1.73–2.02 (5H, m), 2.16 (3H, s), 2.20–2.31 (3H, m), 2.52 (1H, dd, <i>J</i> 15.8, 3.6), 2.76–2.82 (2H, m), 3.85 (3H, s), 5.09 (2H, s), 6.61 (1H, s), 6.83 (1H, s), 7.28–7.45 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 433.2731; C<sub>29</sub>H<sub>37</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 433.2737.</div></div><div id="sec4_4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2-Ethyl-3-benzyloxy-17β-(2-oxopropyl)estra-1,3,5(10)-triene <b>59</b></h3><div class="NLM_p last">Compound <b>58</b> (290 mg, 0.67 mmol) was treated with Dess–Martin periodinane (355 mg, 0.83 mmol) in DCM (20 mL) at 0 °C as described for the synthesis of compound <b>53</b>. Purification by flash column chromatography (hexane/EtOAc 10:1 to 5:1) afforded compound <b>59</b> as a white powder (220 mg, 76%), mp 46–47 °C. δ<sub>H</sub> 0.65 (3H, s), 1.23 (3H, t, <i>J</i> 7.3), 1.26–1.58 (7H, m), 1.65–2.05 (5H, m), 2.18 (3H, s), 2.20–2.41 (3H, m), 2.52–2.59 (1H, m), 2.69 (2H, q, <i>J</i> 7.3), 2.83–2.88 (2H, m), 5.06 (2H, s), 6.63 (1H, s), 7.13 (1H, s), 7.30–7.48 (5H, m). HRMS (ES+): <i>m</i>/<i>z</i> found 431.2937; C<sub>30</sub>H<sub>39</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup> + H) requires 431.2945.</div></div><div id="sec4_4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-Methoxy-3-hydroxy-17β-(2-oxopropyl)estra-1,3,5(10)-triene <b>54</b></h3><div class="NLM_p last">Compound <b>53</b> (155 mg, 0.36 mmol) was treated with Pd/C (10%, 20 mg) in THF (5 mL) and methanol (15 mL) as described for the synthesis of compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 6:1) afforded compound <b>54</b> as a white powder (105 mg, 86%), mp 177–178 °C. δ<sub>H</sub> 0.62 (3H, s), 1.20–1.58 (7H, m), 1.72–2.02 (5H, m), 2.16 (3H, s), 2.19–2.32 (3H, m), 2.52 (1H,dd, <i>J</i> 15.7, 3.9), 2.72–2.79 (2H, m), 3.84 (3H, s), 5.42 (1H, s), 6.63 (1H, s), 6.77 (1H, s). HRMS (FAB+): <i>m</i>/<i>z</i> found 343.2264; C<sub>22</sub>H<sub>31</sub>O<sub>3</sub><sup>+</sup> (M<sup>+</sup> + H) requires 343.2268. Anal. (C<sub>23</sub>H<sub>30</sub>O<sub>3</sub>) C, H.</div></div><div id="sec4_4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2-Ethyl-3-hydroxy-17β-(2-oxopropyl)estra-1,3,5(10)-triene <b>60</b></h3><div class="NLM_p last">Compound <b>59</b> (200 mg, 0.46 mmol) was treated with Pd/C (10%, 30 mg) in THF (5 mL) and methanol (15 mL) as described for the synthesis of compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 5:1) afforded compound <b>60</b> as a white powder (145 mg, 92%), mp 125–126 °C. δ<sub>H</sub> 0.63 (3H, s), 1.23 (2H, t, <i>J</i> 7.3), 1.27–1.53 (7H, m), 1.74–1.81 (2H, m), 1.84–1.93 (2H, m), 1.95–2.03 (1H, m), 2.18 (3H, s), 2.16–2.24 (1H, m), 2.26–2.33 (1H, m), 2.52–2.58 (1H, m), 2.60 (2H, q, <i>J</i> 7.3), 2.74–2.82 (2H, m), 4.99 (1H, s), 6.51 (1H, s), 7.05 (1H, s). HRMS (FAB+): <i>m</i>/<i>z</i> found 340.2394; C<sub>23</sub>H<sub>32</sub>O<sub>2</sub><sup>+</sup> (M<sup>+</sup>) requires 340.2402. Anal. (C<sub>23</sub>H<sub>32</sub>O<sub>2</sub>) C, H.</div></div><div id="sec4_4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 2-Methoxy-3-<i>O</i>-sulfamoyl-17β-(2-oxopropyl)estra-1,3,5(10)-triene <b>55</b></h3><div class="NLM_p last">Compound <b>54</b> (70 mg, 0.2 mmol) was treated with sulfamoyl chloride (0.6 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 5:1 to 3:1) afforded compound <b>55</b> as a white powder (70 mg, 66%), mp 186–187 °C. δ<sub>H</sub> (acetone-<i>d</i><sub>6</sub>): 0.66 (3H, s), 1.22–1.56 (7H, m), 1.70–1.98 (5H, m), 2.10 (3H, s), 2.22–2.40 (3H, m), 2.57 (1H, dd, <i>J</i> 15.9, 3.7), 2.72–2.79 (2H, m), 3.82 (3H, s), 6.90 (2H, s, br), 6.90 (1H, s), 7.01 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 422.2002; C<sub>22</sub>H<sub>32</sub>NO<sub>5</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 422.1996. Anal. (C<sub>22</sub>H<sub>31</sub>NO<sub>5</sub>S) C, H, N.</div></div><div id="sec4_4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-(2-oxopropyl)estra-1,3,5(10)-triene <b>61</b></h3><div class="NLM_p last">Compound <b>60</b> (100 mg, 0.29 mmol) was treated with sulfamoyl chloride (0.6 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 5:1 to 3:1) afforded compound <b>61</b> as a white powder (100 mg, 81%), mp 204–205 °C. δ<sub>H</sub> (acetone-<i>d</i><sub>6</sub>): 0.40 (3H, s), 0.94 (3H, t, <i>J</i> 7.3), 0.95–1.33 (7H, m), 1.51–1.77 (5H, m), 1.91 (3H, s), 1.99–2.12 (3H, m), 2.28–2.34 (1H, m), 2.45 (2H, q, <i>J</i> 7.3), 2.56–2.63 (2H, m), 6.27 (2H, s), 6.84 (1H, s), 6.92 (1H, s). HRMS (FAB+): <i>m</i>/<i>z</i> found 419.2123; C<sub>23</sub>H<sub>33</sub>NO<sub>4</sub>S<sup>+</sup> (M<sup>+</sup>) requires 419.2130. Anal. (C<sub>23</sub>H<sub>33</sub>NO<sub>4</sub>S) C, H, N.</div></div><div id="sec4_4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 2-Methoxy-3-(triisopropylsilyloxy)estrone <b>62</b></h3><div class="NLM_p last">2-Methoxyestrone (1.801 g, 6.0 mmol) was treated with chlorotriisopropylsilane (1.389 g, 7.2 mmol) and imidazole (1.225 g, 18.0 mmol) in DMF (18 mL) as described for the synthesis of compound <b>19</b>. Compound <b>62</b> was isolated as a pale yellow oil (3.31 g, >99%). δ<sub>H</sub> (0.91 (3H, s), 1.03–1.10 (18H, m), 1.14–1.31 (3H, m), 1.32–1.69 (6H, m), 1.90–2.30 (5H, m), 2.31–2.39 (1H, m), 2.49 (1H, dd, <i>J</i> 18.2, 8.3), 2.68–2.87 (2H, m), 3.75 (3H, s), 6.56 (1H, s), 6.74 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 457.3125; C<sub>28</sub>H<sub>45</sub>O<sub>3</sub>Si<sup>+</sup> (M<sup>+</sup> – H) requires 457.3133.</div></div><div id="sec4_4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 2-Methoxy-3-(triisopropylsilyloxy)-17β-(2-ethoxy-2-oxoethyl)estra-1,3,5(10)-triene <b>63</b></h3><div class="NLM_p last">Triethyl phosphonoacetate (3.624 g, 16.2 mmol) in THF (10 mL) was treated with sodium hydride (60%, 661 mg, 16.5 mmol). Compound <b>62</b> (3.20 g; 5.8 mmol) in THF (20 mL) was added dropwise, and the mixture was refluxed for 60 h. The reaction mixture was cooled to 0 °C, poured into water (30 mL), and extracted with DCM (4 × 50 mL). The combined organics were washed with ammonium chloride (saturated, 50 mL) and brine, then dried (MgSO<sub>4)</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane to hexane/EtOAc 20:1) gave the olefin as a pale yellow oil (4.68 g, >99%). δ<sub>H</sub> 0.85 (3H, s), 1.02–1.09 (18H, m), 1.12–1.63 (12H, m), 1.74–2.04 (3H, m), 2.13–2.39 (2H, m), 2.64–3.03 (4H, m), 3.74 (3H, s), 4.06–4.23 (2H, m), 5.57 (1H × 0.85, t, <i>J</i> 2.5, <i>E</i>-isomer), 5.66 (1H × 0.15, t, <i>J</i> 2.1, <i>Z</i>-isomer), 6.55 (1H, s), 6.74 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 527.3540; C<sub>32</sub>H<sub>51</sub>O<sub>4</sub>Si<sup>+</sup> (M<sup>+</sup> – H) requires 527.3551. The above olefin (4.50 g, 5.6 mmol) was treated with Pd/C (10%, 458 mg) in THF (18 mL) and MeOH (6 mL) as described for the synthesis of compound <b>15</b>. Compound <b>63</b> was obtained as a pale brown oil (4.31 g, 95%). δ<sub>H</sub> 0.63 (3H, s), 1.02–1.10 (18H, m), 1.14–1.51 (12H, m), 1.59–2.02 (6H, m), 2.05–2.28 (3H, m), 2.39 (1H, dd, <i>J</i> 14.6, 4.7), 2.61–2.78 (2H, m), 3.74 (3H, s), 4.11 (2H, q, <i>J</i> 7.2), 6.54 (1H, s), 6.74 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 529.3699; C<sub>32</sub>H<sub>53</sub>O<sub>4</sub>Si<sup>+</sup> (M<sup>+</sup> – H) requires 529.3708.</div></div><div id="sec4_4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-Methoxy-3-(triisopropylsilyloxy-17β-(2-oxopropyl)estra-1,3,5(10)-triene <b>64</b></h3><div class="NLM_p last">Tebbe reagent (0.5 M in toluene, 12.6 mL, 6.3 mmol) was added dropwise over 15 min into a solution of compound <b>63</b> (4.20 g, 5.2 mmol) in toluene (17.4 mL), THF (10 mL) and pyridine (0.84 mL) at −78 °C. The reaction mixture was stirred at −78 °C for 1 h, then warmed to 0 °C within 2 h. The reaction mixture was poured into HCl (2 M, 400 mL), stirred vigorously at room temperature for 16 h, and extracted with diethyl ether (3 × 100 mL). The combined organics were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (SiO<sub>2</sub>, 80 g, hexane/diethyl ether 9:1) afforded compound <b>64</b> as a light brownish oil (2.504 g, 92% overall from 2-methoxyestrone). δ<sub>H</sub> 0.61 (3H, s), 1.02–1.10 (18H, m), 1.12–1.55 (11H, m), 1.71–2.04 (4H, m), 2.15 (3H, s), 2.17–2.35 (3H, m), 2.52 (1H, dd, <i>J</i> 15.7, 3.8), 2.62–2.82 (2H, m), 3.74 (3H, s), 6.54 (1H, s), 6.73 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 499.3607; C<sub>31</sub>H<sub>51</sub>O<sub>3</sub>Si<sup>+</sup> (M<sup>+</sup> – H) requires 499.3602.</div></div><div id="sec4_4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2-Methoxy-3-hydroxy-17β-(2-oxopropyl)estra-1,3,5(10)-triene <b>54</b></h3><div class="NLM_p last">Compound <b>64</b> (1.993 g, 4.0 mmol) was treated with TBAF (1 M in THF, 4.4 mL, 4.4 mmol) in THF (7.6 mL) as described for the synthesis of compound <b>20</b>. Purification by flash column chromatography (SiO<sub>2</sub>, 50 g, hexane/EtOAc 9:1 to 4:1) afforded compound <b>54</b> as white solid (1.12 g, 82%). Data are as above.</div></div><div id="sec4_4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 2-Methoxy-3-<i>O</i>-sulfamoyl-17β-(2-oxopropyl)estra-1,3,5(10)-triene <b>55</b></h3><div class="NLM_p last">By use of the method described for the synthesis of <b>16</b>, compound <b>54</b> (1.028 g, 3.0 mmol) was reacted with sulfamoyl chloride (9.0 mmol) in DMA (9.0 mL) at room temperature for 2 h. Purification by flash column chromatography (SiO<sub>2</sub>, 60 g, chloroform/acetone 9:1) and crystallization from diethyl ether afforded compound <b>55</b> as white solid (1.026 g, 81%). Data are as above.</div></div><div id="sec4_4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 17β-(2-Hydroxypropyl)-2-methoxy-3-<i>O</i>-sulfamoylestra-1,3,5(10)-triene <b>65</b></h3><div class="NLM_p last">Sodium borohydride (15.5 mg, 0.4 mmol) was added to 2-propanol (4.0 mL) under stirring. A solution of compound <b>55</b> (84 mg, 0.2 mmol) in THF (2.0 mL) was added dropwise, and the reaction mixture was stirred at room temperature for 2 h. The mixture was then poured into water (40 mL) and ammonium chloride (saturated, 10 mL) and extracted with EtOAc (3 × 30 mL). The combined organics were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (SiO<sub>2</sub>, 10 g, chloroform/acetone 9:1) afforded compound <b>65</b> as a fluffy white solid (63 mg, 75%), mp 170–172 °C. δ<sub>H</sub> 0.51 (3H, s), 1.02–1.56 (15H, m), 1.59–1.70 (1H, m), 1.72–1.89 (3H, m), 2.59–2.73 (2H, m), 3.74 (3H, s), 6.26 (2H, s, br), 6.81 (1H, s), 6.93 (1H, s). LC/MS (ES−): <i>m</i>/<i>z</i> 422.43 (M<sup>–</sup> – H) and 422.50 (M<sup>–</sup> – H). HRMS (ES−): <i>m</i>/<i>z</i> found 422.2013; C<sub>22</sub>H<sub>32</sub>NO<sub>5</sub>S<sup>–</sup> (M<sup>–</sup> – H) requires 422.2006.</div></div><div id="sec4_4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 17β-(2-Hydroxyiminopropyl)-2-methoxy-3-<i>O</i>-sulfamoylestra-1,3,5(10)-triene <b>66</b></h3><div class="NLM_p last">Compound <b>55</b> (84 mg, 0.2 mmol), sodium acetate (165 mg, 2.0 mmol), and hydroxylamine hydrochloride (141 mg, 2.0 mmol) were mixed together and dissolved in methanol (3.6 mL) and water (0.4 mL). The reaction mixture was stirred at room temperature for 2 h and then concentrated in vacuo. Water (20 mL) and ammonium chloride (saturated, 20 mL) were added, and the mixture was extracted with EtOAc (2 × 30 mL). The combined organics were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (SiO<sub>2</sub>, 10 g, DCM/acetone 4:1) afforded compound <b>66</b> as a white wax (mixture of <i>Z</i> and <i>E</i> isomers) (44 mg, 51%). δ<sub>H</sub> (CDCl<sub>3</sub>/DMSO-<i>d</i><sub>6</sub>) 0.57 (3H × 0.75, s, <i>E</i>-isomer), 0.60 (3H × 0.25, s, <i>Z</i>-isomer), 1.09–1.51 (7H, m), 1.54–1.85 (6H, m), 1.77 (3H × 0.25, s, <i>Z</i>-isomer), 1.79 (3H × 0.75, s, <i>E</i>-isomer), 2.04–2.26 (3H, m), 2.63–2.74 (2H, m), 3.74 (3H, s), 6.22 (2H, s, br), 6.81 (1H, s), 6.94 (1H, s), 8.30 (1H, s, br). LC/MS (ES−): <i>m</i>/<i>z</i> 435.51 (M<sup>–</sup> – H). HRMS (ES−): <i>m</i>/<i>z</i> found 435.1952; C<sub>22</sub>H<sub>31</sub>N<sub>2</sub>O<sub>5</sub>S<sup>–</sup> (M<sup>–</sup> – H) requires 435.1959.</div></div><div id="sec4_4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 2-Ethyl-3-benzyloxy-17β-(2-fluoroethyl)estra-1,3,5(10)-triene <b>67</b></h3><div class="NLM_p last">A solution of compound <b>25</b> (0.84 g, 2 mmol) in THF (20 mL) was cooled to 0 °C under nitrogen and treated with diethylaminosulfur trifluoride (DAST) (0.40 mL, 3.0 mmol). The reaction mixture was stirred at 0 °C for 4 h. Sodium bicarbonate (saturated, 10 mL) was added, and the mixture was extracted with EtOAc (2 × 30 mL). The combined organics were washed with water and brine, then dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. Purification by flash column chromatography (hexane/EtOAc 50:1) afforded compound <b>67</b> as a white powder (0.42 g, 50%), mp 113–114 °C. δ<sub>H</sub> 0.66 (3H, s), 1.30 (3H, t, <i>J</i> 7.4), 1.32–1.66 (9H, m), 1.81–1.87 (1H, m), 1.92–2.04 (4H, m), 2.25–2.33 (1H, m), 2.39–2.45 (1H, m), 2.76 (2H, q, <i>J</i> 7.4), 2.84–2.95 (2H, m), 4.45–4.53 (1H, m), 4.58–4.66 (1H, m), 5.12 (2H, s), 6.72 (1H, s), 7.20 (1H, s), 7.37–7.54 (5H, s). LC/MS (APCI+): <i>m</i>/<i>z</i> 421.3 (M<sup>+</sup> + H).</div></div><div id="sec4_4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2-Ethyl-3-hydroxy-17β-(2-fluoroethyl)estra-1,3,5(10)-triene <b>68</b></h3><div class="NLM_p last">Compound <b>67</b> (420 mg, 1.0 mmol) was treated with Pd/C (10%, 30 mg) in THF (10 mL) and methanol (30 mL) as described for the synthesis of compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 20:1 to 15:1) afforded compound <b>68</b> as a white powder (250 mg 76%), mp 138–139 °C. δ<sub>H</sub> 0.63 (3H, s), 1.22 (3H, t, <i>J</i> 7.4), 1.25–1.61 (10H, m), 1.73–1.98 (4H, m), 2.14–2.35 (2H, m), 2.59 (2H, q, <i>J</i> 7.4), 2.77–2.88 (2H, m), 4.34–4.44 (1H, m), 4.50–4.60 (2H, m), 6.49 (1H, s), 7.05 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 331.2432; C<sub>22</sub>H<sub>32</sub>FO<sup>+</sup> (M<sup>+</sup> + H) requires 331.2437. Anal. (C<sub>22</sub>H<sub>31</sub>FO) C, H.</div></div><div id="sec4_4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-(2-fluoroethyl)estra-1,3,5(10)-triene <b>69</b></h3><div class="NLM_p last">Compound <b>68</b> (132 mg, 0.4 mmol) was treated with sulfamoyl chloride (0.5 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 20:1 to 15:1) afforded compound <b>69</b> as a white powder (110 mg, 66%), mp 152–153 °C. δ<sub>H</sub> 0.63 (3H, s), 1.21 (3H, t, <i>J</i> 7.4), 1.23–1.59 (10H, m), 1.73–1.97 (4H, m), 2.16–2.35 (2H, m), 2.68 (2H, q, <i>J</i> 7.4), 2.79–2.88 (2H, m), 4.34–4.42 (1H, m), 4.51–4.59 (1H, m), 4.90 (2H, s), 7.11 (1H, s), 7.24 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 410.2163; C<sub>22</sub>H<sub>33</sub>FNO<sub>3</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 410.2165. Anal. (C<sub>22</sub>H<sub>32</sub>FNO<sub>3</sub>S) C, H, N.</div></div><div id="sec4_4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-Ethyl-3-benzyloxy-17β-(2,2-difluoroethyl)estra-1,3,5(10)-triene <b>70</b></h3><div class="NLM_p last">Compound <b>57</b> (0.86 g, 2.0 mmol) was treated with diethylaminosulfur trifluoride (DAST) (0.80 mL, 6.0 mmol) in THF (20 mL) as described for the synthesis of compound <b>67</b>. Purification by flash column chromatography (hexane/EtOAc 100:1) afforded compound <b>70</b> as a white powder (0.42 g, 48%), mp 114–115 °C. δ<sub>H</sub> 0.64 (3H, s), 1.22 (3H, t, <i>J</i> 7.3), 1.26–2.09 (14H, m), 2.20–2.29 (1H, m), 2.31–2.40 (1H, m), 2.68 (2H, q, <i>J</i> 7.3), 2.78–2.89 (2H, m), 5.05 (2H, s), 5.84 (1H, ddt, <i>J</i> 57.3, 5.0, 3.7), 6.64 (1H, s), 7.12 (1H, s), 7.29–7.46 (5H, m). LC/MS (APCI+): <i>m</i>/<i>z</i> 439.1 (M<sup>+</sup> + H).</div></div><div id="sec4_4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 2-Ethyl-3-hydroxy-17β-(2,2-difluoroethyl)estra-1,3,5(10)-triene <b>71</b></h3><div class="NLM_p last">Compound <b>70</b> (350 mg, 0.8 mmol) was treated with Pd/C (10%, 40 mg) in THF (10 mL) and methanol (30 mL) as described for the synthesis of compound <b>15</b>. Purification by flash column chromatography (hexane/EtOAc 50:1 to 40:1) afforded compound <b>71</b> as white powder (240 mg, 86%), mp 84–86 °C. δ<sub>H</sub> 0.62 (3H, s), 1.21 (3H, t, <i>J</i> 7.3), 1.23–2.07 (14H, m), 2.16–2.24 (1H, m), 2.27–2.36 (1H, m), 2.59 (2H, q, <i>J</i> 7.3), 2.78 (2H, m), 4.58 (1H, s), 5.84 (1H, ddt, <i>J</i> 57.2, 9.2, 5.2), 6.49 (1H, s), 7.05 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 349.2340; C<sub>22</sub>H<sub>31</sub>F<sub>2</sub>O<sup>+</sup> (M<sup>+</sup> + H) requires 349.2337. Anal. (C<sub>22</sub>H<sub>30</sub>F<sub>2</sub>O) C, H, N.</div></div><div id="sec4_4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 2-Ethyl-3-<i>O</i>-sulfamoyl-17β-(2,2-difluoroethyl)estra-1,3,5(10)-triene <b>72</b></h3><div class="NLM_p last">Compound <b>71</b> (175 mg, 0.5 mmol) was treated with sulfamoyl chloride (0.5 mmol) in DMA (1.0 mL) as described for the synthesis of compound <b>16</b>. Purification by flash column chromatography (hexane/EtOAc 15:1 to 10:1) afforded compound <b>72</b> as a white powder (155 mg, 72%), mp 164–165 °C. δ<sub>H</sub> 0.62 (3H, s), 1.20 (3H, t, <i>J</i> 7.3), 1.23–2.08 (17H, m), 2.18–2.35 (2H, m), 2.68 (2H, q, <i>J</i> 7.3), 2.82 (2H, m), 4.93 (2H, s, br), 5.82 (1H, tt, <i>J</i> 57.0, 4.7), 7.06 (1H, s), 7.18 (1H, s). HRMS (ES+): <i>m</i>/<i>z</i> found 428.2068; C<sub>22</sub>H<sub>32</sub>F<sub>2</sub>NO<sub>3</sub>S<sup>+</sup> (M<sup>+</sup> + H) requires 428.2065. Anal. (C<sub>22</sub>H<sub>31</sub>F<sub>2</sub>NO<sub>3</sub>S) C, H, N.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82"><a href="/doi/suppl/10.1021/jm200483x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results and <sup>13</sup>C NMR data. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200483x/suppl_file/jm200483x_si_001.pdf">jm200483x_si_001.pdf (86.1 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200483x" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barry V. L. Potter</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1b59354d3557354b746f6f7e695b797a6f73357a78356e70"><span class="__cf_email__" data-cfemail="b6f498e098fa98e6d9c2c2d3c4f6d4d7c2de98d7d598c3dd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrice Jourdan</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathew P. Leese</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wolfgang Dohle</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Ferrandis</span> - <span class="hlFld-Affiliation affiliation">Institut de Recherche Henri Beaufour, Ipsen, 91966 Les Ulis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon P. Newman</span> - <span class="hlFld-Affiliation affiliation">Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Hospital, London, W12 0NN, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Surinder Chander</span> - <span class="hlFld-Affiliation affiliation">Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Hospital, London, W12 0NN, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atul Purohit</span> - <span class="hlFld-Affiliation affiliation">Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Hospital, London, W12 0NN, U.K.</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Sterix Ltd., a member of the Ipsen Group. We thank Alison Smith for technical support and the NCI DTP program for providing in vitro screening resources.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> Abbreviations Used</h2></table></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i85" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i85"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl2"><tr><td class="NLM_term">DAST</td><td class="NLM_def"><p class="first last">diethylaminosulfur trifluoride</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">E2bisMATE</td><td class="NLM_def"><p class="first last">estradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiatt, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshaw, E.</span><span> </span><span class="NLM_article-title">Tumor angiogenesis—therapeutic implications</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">1182</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1056%2FNEJM197111182852108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=4938153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1971&pages=1182-1186&issue=21&author=J.+Folkmanauthor=M.+Bachauthor=J.+W.+Roweauthor=F.+Davidoffauthor=P.+Lambertauthor=C.+Hirschauthor=A.+Goldbergauthor=H.+H.+Hiattauthor=J.+Glassauthor=E.+Henshaw&title=Tumor+angiogenesis%E2%80%94therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor angiogenesis: therapeutic implications</span></div><div class="casAuthors">Folkman J</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1182-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA0C6odtE1LPxQvRxYU81tfW6udTcc2eYg6K-EnIY4Obntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D&md5=efdddcba0c04be542edd51fef2ef27b9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM197111182852108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197111182852108%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DM.%26aulast%3DRowe%26aufirst%3DJ.%2BW.%26aulast%3DDavidoff%26aufirst%3DF.%26aulast%3DLambert%26aufirst%3DP.%26aulast%3DHirsch%26aufirst%3DC.%26aulast%3DGoldberg%26aufirst%3DA.%26aulast%3DHiatt%26aufirst%3DH.%2BH.%26aulast%3DGlass%26aufirst%3DJ.%26aulast%3DHenshaw%26aufirst%3DE.%26atitle%3DTumor%2520angiogenesis%25E2%2580%2594therapeutic%2520implications%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26issue%3D21%26spage%3D1182%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fnrd1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=15136787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=391-400&issue=5&author=N.+Ferraraauthor=K.+J.+Hillanauthor=H.+P.+Gerberauthor=W.+Novotny&title=Discovery+and+development+of+bevacizumab%2C+an+anti-VEGF+antibody+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span></div><div class="casAuthors">Ferrara, Napoleone; Hillan, Kenneth J.; Gerber, Hans-Peter; Novotny, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The existence of factors that stimulate blood vessel growth, thereby recruiting a neovascular supply to nourish a growing tumor, was postulated many decades ago, although the identification and isolation of these factors proved elusive.  Now, vascular endothelial growth factor (VEGF), which was identified in the 1980s, is recognized as an essential regulator of normal and abnormal blood vessel growth.  In 1993, it was shown that a monoclonal antibody that targeted VEGF results in a dramatic suppression of tumor growth in vivo, which led to the development of bevacizumab (Avastin; Genentech), a humanized variant of this anti-VEGF antibody, as an anticancer agent.  The recent approval of bevacizumab by the US FDA as a first-line therapy for metastatic colorectal cancer validates the ideas that VEGF is a key mediator of tumor angiogenesis and that blocking angiogenesis is an effective strategy to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaLbfhdBKOLVg90H21EOLACvtfcHk0lgViYJ82vFHrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D&md5=4b1f647db4dfe2a24449cdf59b874e7c</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1381%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DGerber%26aufirst%3DH.%2BP.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DDiscovery%2520and%2520development%2520of%2520bevacizumab%252C%2520an%2520anti-VEGF%2520antibody%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26issue%3D5%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_contrib-group">Panares, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. A.</span><span> </span><span class="NLM_article-title">Bevacizumab in the management of solid tumors</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1586%2F14737140.7.4.433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=17428164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Wqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=433-445&issue=4&author=R.+L.+Panaresauthor=A.+A.+Garcia&title=Bevacizumab+in+the+management+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab in the management of solid tumors</span></div><div class="casAuthors">Panares, Roy L.; Garcia, Agustin A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">433-445</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is defined as the formation of new blood vessels from a pre-existing vascular bed.  By supplying nutrients and oxygen and removing waste products in malignant tumors, it is an essential process that regulates cancer growth and dissemination.  This process is regulated by both pro- and antiangiogenic compds.  Vascular endothelial growth factor is one of the most important and best-studied proangiogenic factors.  Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has been shown to inhibit angiogenesis and is proving to be of clin. benefit in a variety of tumor types.  The strongest evidence comes from studies in advanced colorectal and non-small-cell lung cancer, with growing evidence in breast and epithelial ovarian tumors.  The duration and timing of bevacizumab's use is currently the focus of several ongoing clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3gqfS8ed2N7Vg90H21EOLACvtfcHk0livJAUVfWuNCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Wqs74%253D&md5=27084acb248645b4ff4c7b4fd4b70aab</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1586%2F14737140.7.4.433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.7.4.433%26sid%3Dliteratum%253Aachs%26aulast%3DPanares%26aufirst%3DR.%2BL.%26aulast%3DGarcia%26aufirst%3DA.%2BA.%26atitle%3DBevacizumab%2520in%2520the%2520management%2520of%2520solid%2520tumors%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D433%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wilhelm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simantov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S.</span><span> </span><span class="NLM_article-title">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=835-844&issue=10&author=S.+Wilhelmauthor=C.+Carterauthor=M.+Lynchauthor=T.+Lowingerauthor=J.+Dumasauthor=R.+A.+Smithauthor=B.+Schwartzauthor=R.+Simantovauthor=S.+Kelley&title=Discovery+and+development+of+sorafenib%3A+a+multikinase+inhibitor+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DLowinger%26aufirst%3DT.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520development%2520of%2520sorafenib%253A%2520a%2520multikinase%2520inhibitor%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26issue%3D10%26spage%3D835%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Faivre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sargent, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E.</span><span> </span><span class="NLM_article-title">Molecular basis for sunitinib efficacy and future clinical development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=734-745&issue=9&author=S.+Faivreauthor=G.+Demetriauthor=W.+Sargentauthor=E.+Raymond&title=Molecular+basis+for+sunitinib+efficacy+and+future+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaivre%26aufirst%3DS.%26aulast%3DDemetri%26aufirst%3DG.%26aulast%3DSargent%26aufirst%3DW.%26aulast%3DRaymond%26aufirst%3DE.%26atitle%3DMolecular%2520basis%2520for%2520sunitinib%2520efficacy%2520and%2520future%2520clinical%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D9%26spage%3D734%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kohne, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, H. J.</span><span> </span><span class="NLM_article-title">Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=478-488&issue=5&author=C.+H.+Kohneauthor=H.+J.+Lenz&title=Chemotherapy+with+targeted+agents+for+the+treatment+of+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKohne%26aufirst%3DC.%2BH.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26atitle%3DChemotherapy%2520with%2520targeted%2520agents%2520for%2520the%2520treatment%2520of%2520metastatic%2520colorectal%2520cancer%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26issue%3D5%26spage%3D478%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Taming vessels to treat cancer</span> <span class="citation_source-journal">Sci. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fscientificamerican0108-56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=18225696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FntVCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2008&pages=56-63&issue=1&author=R.+K.+Jain&title=Taming+vessels+to+treat+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Taming vessels to treat cancer</span></div><div class="casAuthors">Jain Rakesh K</div><div class="citationInfo"><span class="NLM_cas:title">Scientific American</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>
        ISSN:<span class="NLM_cas:issn">0036-8733</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8CG-CamYuQUEgZCMqtRBifW6udTcc2eazel2PbBoacrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FntVCnsQ%253D%253D&md5=42f355839dbe995f63f8ca415712d417</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fscientificamerican0108-56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fscientificamerican0108-56%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DTaming%2520vessels%2520to%2520treat%2520cancer%26jtitle%3DSci.%2520Am.%26date%3D2008%26volume%3D298%26issue%3D1%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Casanovas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanahan, D.</span><span> </span><span class="NLM_article-title">Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=299-309&issue=4&author=O.+Casanovasauthor=D.+J.+Hicklinauthor=G.+Bergersauthor=D.+Hanahan&title=Drug+resistance+by+evasion+of+antiangiogenic+targeting+of+VEGF+signaling+in+late-stage+pancreatic+islet+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCasanovas%26aufirst%3DO.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DBergers%26aufirst%3DG.%26aulast%3DHanahan%26aufirst%3DD.%26atitle%3DDrug%2520resistance%2520by%2520evasion%2520of%2520antiangiogenic%2520targeting%2520of%2520VEGF%2520signaling%2520in%2520late-stage%2520pancreatic%2520islet%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26issue%3D4%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_contrib-group">Ebos, J. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz-Munoz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjarnason, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerbel, R. S.</span><span> </span><span class="NLM_article-title">Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=232-239&issue=3&author=J.+M.+L.+Ebosauthor=C.+R.+Leeauthor=W.+Cruz-Munozauthor=G.+A.+Bjarnasonauthor=J.+G.+Christensenauthor=R.+S.+Kerbel&title=Accelerated+metastasis+after+short-term+treatment+with+a+potent+inhibitor+of+tumor+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEbos%26aufirst%3DJ.%2BM.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BR.%26aulast%3DCruz-Munoz%26aufirst%3DW.%26aulast%3DBjarnason%26aufirst%3DG.%2BA.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DKerbel%26aufirst%3DR.%2BS.%26atitle%3DAccelerated%2520metastasis%2520after%2520short-term%2520treatment%2520with%2520a%2520potent%2520inhibitor%2520of%2520tumor%2520angiogenesis%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D15%26issue%3D3%26spage%3D232%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_contrib-group">Paez-Ribes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinals, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanovas, O.</span><span> </span><span class="NLM_article-title">Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=220-231&issue=3&author=M.+Paez-Ribesauthor=E.+Allenauthor=J.+Hudockauthor=T.+Takedaauthor=H.+Okuyamaauthor=F.+Vinalsauthor=M.+Inoueauthor=G.+Bergersauthor=D.+Hanahanauthor=O.+Casanovas&title=Antiangiogenic+therapy+elicits+malignant+progression+of+tumors+to+increased+local+invasion+and+distant+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaez-Ribes%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DE.%26aulast%3DHudock%26aufirst%3DJ.%26aulast%3DTakeda%26aufirst%3DT.%26aulast%3DOkuyama%26aufirst%3DH.%26aulast%3DVinals%26aufirst%3DF.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DBergers%26aufirst%3DG.%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DCasanovas%26aufirst%3DO.%26atitle%3DAntiangiogenic%2520therapy%2520elicits%2520malignant%2520progression%2520of%2520tumors%2520to%2520increased%2520local%2520invasion%2520and%2520distant%2520metastasis%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D15%26issue%3D3%26spage%3D220%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_contrib-group">Vredenburgh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desjardins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcello, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathornsumetee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gururangan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span> </span><span class="NLM_article-title">Bevacizumab plus irinotecan in recurrent glioblastoma multiforme</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">30</span><span class="NLM_x">) </span> <span class="NLM_fpage">4722</span><span class="NLM_x">–</span> <span class="NLM_lpage">4729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1200%2FJCO.2007.12.2440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=17947719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCgsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=4722-4729&issue=30&author=J.+J.+Vredenburghauthor=A.+Desjardinsauthor=J.+E.+Herndonauthor=J.+Marcelloauthor=D.+A.+Reardonauthor=J.+A.+Quinnauthor=J.+N.+Richauthor=S.+Sathornsumeteeauthor=S.+Gururanganauthor=J.+Sampsonauthor=M.+Wagnerauthor=L.+Baileyauthor=D.+D.+Bignerauthor=A.+H.+Friedmanauthor=H.+S.+Friedman&title=Bevacizumab+plus+irinotecan+in+recurrent+glioblastoma+multiforme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab plus irinotecan in recurrent glioblastoma multiforme</span></div><div class="casAuthors">Vredenburgh, James J.; Desjardins, Annick; Herndon, James E., II; Marcello, Jennifer; Reardon, David A.; Quinn, Jennifer A.; Rich, Jeremy N.; Sathornsumetee, Sith; Gururangan, Sridharan; Sampson, John; Wagner, Melissa; Bailey, Leighann; Bigner, Darell D.; Friedman, Allan H.; Friedman, Henry S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4722-4729</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The prognosis for patients with recurrent glioblastoma multiforme is poor, with a median survival of 3 to 6 mo.  We performed a phase II trial of bevacizumab, a monoclonal antibody to vascular endothelial growth factor, in combination with irinotecan.  This phase II trial included two cohorts of patients.  The initial cohort, comprising 23 patients, received bevacizumab at 10 mg/kg plus irinotecan every 2 wk.  The dose of irinotecan was based on the patient's anticonvulsant: Patients taking enzyme-inducing antiepileptic drugs (EIAEDs) received 340 mg/m2, and patients not taking EIAEDs received 125 mg/m2.  After this regimen was deemed safe and effective, the irinotecan schedule was changed to an accepted brain tumor regimen of four doses in 6 wk, in anticipation of a phase III randomized trial of irinotecan vs. irinotecan and bevacizumab.  The second cohort, comprising 12 patients, received bevacizumab 15 mg/kg every 21 days and irinotecan on days 1, 8, 22, and 29.  Each cycle was 6 wk long and concluded with patient evaluations, including magnetic resonance imaging.  The 6-mo progression-free survival among all 35 patients was 46% (95% CI, 32% to 66%).  The 6-mo overall survival was 77% (95% CI, 64% to 92%).  Twenty of the 35 patients (57%; 95% CI, 39% to 74%) had at least a partial response.  One patient developed a CNS hemorrhage, which occurred in his 10th cycle.  Four patients developed thromboembolic complications (deep venous thrombosis and/or pulmonary emboli).  Bevacizumab and irinotecan is an effective treatment for recurrent glioblastoma multiforme and has moderate toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2VM5NokRnhrVg90H21EOLACvtfcHk0lh7ASaBXWsYJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCgsLjF&md5=5081884f8df26aaf0e6b7e70d2654a9e</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.12.2440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.12.2440%26sid%3Dliteratum%253Aachs%26aulast%3DVredenburgh%26aufirst%3DJ.%2BJ.%26aulast%3DDesjardins%26aufirst%3DA.%26aulast%3DHerndon%26aufirst%3DJ.%2BE.%26aulast%3DMarcello%26aufirst%3DJ.%26aulast%3DReardon%26aufirst%3DD.%2BA.%26aulast%3DQuinn%26aufirst%3DJ.%2BA.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26aulast%3DSathornsumetee%26aufirst%3DS.%26aulast%3DGururangan%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DL.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DA.%2BH.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26atitle%3DBevacizumab%2520plus%2520irinotecan%2520in%2520recurrent%2520glioblastoma%2520multiforme%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26issue%3D30%26spage%3D4722%26epage%3D4729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_contrib-group">Burger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sill, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorosky, J. I.</span><span> </span><span class="NLM_article-title">Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a gynecologic oncology group study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">33</span><span class="NLM_x">) </span> <span class="NLM_fpage">5165</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1200%2FJCO.2007.11.5345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=18024863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKnsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=5165-5171&issue=33&author=R.+A.+Burgerauthor=M.+W.+Sillauthor=B.+J.+Monkauthor=B.+E.+Greerauthor=J.+I.+Sorosky&title=Phase+II+trial+of+bevacizumab+in+persistent+or+recurrent+epithelial+ovarian+cancer+or+primary+peritoneal+cancer%3A+a+gynecologic+oncology+group+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a gynecologic oncology group study</span></div><div class="casAuthors">Burger, Robert A.; Sill, Michael W.; Monk, Bradley J.; Greer, Benjamin E.; Sorosky, Joel I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5165-5171</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Vascular endothelial growth factor (VEGF) seems to be a promoter of tumor progression for epithelial ovarian cancer (EOC) and primary peritoneal cancer (PPC).  We conducted a phase II trial to assess the efficacy and tolerability of single-agent bevacizumab, an anti-VEGF monoclonal antibody.  Patients and Methods: Eligible patients had persistent or recurrent EOC/PPC after one to two prior cytotoxic regimens, measurable disease, and Gynecol. Oncol. Group performance status of at least 2.  Treatment consisted of bevacizumab 15 mg/kg i.v. every 21 days until disease progression or prohibitive toxicity.  Primary end points were progression-free survival (PFS) at 6 mo and clin. response.  Results: The study consisted of 62 eligible and assessable patients, median age 57 years, 41 (66.1%) having received two prior regimens and 26 (41.9%) considered platinum resistant.  Grade 3 adverse events at least possibly related to bevacizumab were hematol. (1), GI (3), hypertension (6), thromboembolism (1), allergy (2), hepatic (1), pain (3), coagulation (1), constitutional (1), and dyspnea (1).  Grade 4 adverse events included pulmonary embolus (1), vomiting and constipation (1), and proteinuria (1).  Thirteen patients (21.0%) experienced clin. responses (two complete, 11 partial; median response duration, 10 mo), and 25 (40.3%) survived progression free for at least 6 mo.  Median PFS and overall survival were 4.7 and 17 mo, resp.  There was no significant assocn. of prior platinum sensitivity, age, no. of prior chemotherapeutic regimens, or performance status with the hazard of progression or death.  Conclusion: Bevacizumab seems to be well tolerated and active in the second- and third-line treatment of patients with EOC/PPC and merits phase III investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoalKT4Ex-9J7Vg90H21EOLACvtfcHk0lh7ASaBXWsYJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKnsb%252FE&md5=eb2411fcae76037c7e214cf45c4a15ce</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.11.5345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.11.5345%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DR.%2BA.%26aulast%3DSill%26aufirst%3DM.%2BW.%26aulast%3DMonk%26aufirst%3DB.%2BJ.%26aulast%3DGreer%26aufirst%3DB.%2BE.%26aulast%3DSorosky%26aufirst%3DJ.%2BI.%26atitle%3DPhase%2520II%2520trial%2520of%2520bevacizumab%2520in%2520persistent%2520or%2520recurrent%2520epithelial%2520ovarian%2520cancer%2520or%2520primary%2520peritoneal%2520cancer%253A%2520a%2520gynecologic%2520oncology%2520group%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26issue%3D33%26spage%3D5165%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span><span class="NLM_issue">49</span><span class="NLM_x">) </span> <span class="NLM_fpage">7683</span><span class="NLM_x">–</span> <span class="NLM_lpage">7696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=7683-7696&issue=49&author=M.+P.+Leeseauthor=B.+Leblondauthor=A.+Smithauthor=S.+P.+Newmanauthor=A.+Di+Fioreauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Substituted+estradiol+bis-sulfamates%2C+multitargeted+antitumor+agents%3A+synthesis%2C+in+vitro+SAR%2C+protein+crystallography%2C+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Substituted%2520estradiol%2520bis-sulfamates%252C%2520multitargeted%2520antitumor%2520agents%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520protein%2520crystallography%252C%2520and%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26issue%3D49%26spage%3D7683%26epage%3D7696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">A-Ring-substituted estrogen-3-<i>O</i>-sulfamates: potent multitargeted anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5243</span><span class="NLM_x">–</span> <span class="NLM_lpage">5256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5243-5256&issue=16&author=M.+P.+Leeseauthor=H.+A.+M.+Hejazauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=A-Ring-substituted+estrogen-3-O-sulfamates%3A+potent+multitargeted+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm050066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050066a%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DA-Ring-substituted%2520estrogen-3-O-sulfamates%253A%2520potent%2520multitargeted%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D16%26spage%3D5243%26epage%3D5256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, R. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fsj.bjc.6601591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=14970876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=932-937&issue=4&author=C.+R.+Iresonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=S.+Pereraauthor=S.+P.+Newmanauthor=D.+Parishauthor=M.+P.+Leeseauthor=A.+C.+Smithauthor=B.+V.+L.+Potterauthor=R.+J.+Reed&title=Pharmacokinetics+and+efficacy+of+2-methoxyoestradiol+and+2-methoxyoestradiol-bis-sulphamate+in+vivo+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span></div><div class="casAuthors">Ireson, C. R.; Chander, S. K.; Purohit, A.; Perera, S.; Newman, S. P.; Parish, D.; Leese, M. P.; Smith, A. C.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">932-937</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Methoxyoestradiol (2-MeOE2) is an endogenous estrogen metabolite that inhibits the proliferation of cancer cells in vitro, and it is also antiangiogenic.  In vivo 2-MeOE2, when administered at relatively high doses, inhibits the growth of tumors derived from breast cancer cells, sarcomas and melanomas.  Sulphamoylated derivs. of 2-MeOE2 are more potent inhibitors of in vitro breast cancer cell growth than 2-MeOE2.  In the present study, the authors have compared the pharmacokinetic profiles and metab. of 2-MeOE2 and its sulfamoylated deriv., 2-methoxyestradiol-bis-sulfamate (2-MeOE2bisMATE), in adult female rats.  Their ability to inhibit tumor growth was compared in nude mice bearing xenografts derived from MDA-MB-435 (estrogen receptor neg.) melanoma cancer cells.  After a single oral 10 mg kg-1 dose of 2-MeOE2bisMATE, significant concns. of this compd. were still detectable at 24 h.  In contrast, no 2-MeOE2 or metabolites were detected in plasma at any time after a 10 mg kg-1 oral dose.  Thus, the bioavailability of 2-MeOE2 is very low, whereas for 2-MeOE2bisMATE it was 85%.  No significant metabolites of 2-MeOE2bisMATE were detected in plasma after oral or i.v. dosing, showing that this drug is resistant to metab.  In the tumor efficacy model, oral administration of 2-MeOE2bisMATE, at 20 mg kg-1 day-1 daily for 28 days, almost completely inhibited tumor growth.  Inhibition of tumor growth was maintained for a further 28 days after the cessation of dosing.  At this dose level, 2-MeOE2 did not inhibit tumor growth.  The resistance to metab. shown by 2-MeOE2bisMATE and its ability to inhibit tumor growth in vivo suggest that this compd. should have considerable potential for development as a novel anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogMoiaDGhPlLVg90H21EOLACvtfcHk0lgE5xJ52uGXZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D&md5=e92f1f7f94f9d2fdb3afad25cc41903d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601591%26sid%3Dliteratum%253Aachs%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DR.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520efficacy%2520of%25202-methoxyoestradiol%2520and%25202-methoxyoestradiol-bis-sulphamate%2520in%2520vivo%2520in%2520rodents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26issue%3D4%26spage%3D932%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=909-914&issue=4&author=Y.+T.+Hoauthor=A.+Purohitauthor=N.+Vickerauthor=S.+P.+Newmanauthor=J.+J.+Robinsonauthor=M.+P.+Leeseauthor=D.+Ganeshapillaiauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+carbonic+anhydrase+II+by+steroidal+and+non-steroidal+sulphamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVicker%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DJ.%2BJ.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520carbonic%2520anhydrase%2520II%2520by%2520steroidal%2520and%2520non-steroidal%2520sulphamates%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D305%26issue%3D4%26spage%3D909%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutill, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">The role of 17 beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=324-330&issue=1&author=S.+P.+Newmanauthor=C.+R.+Iresonauthor=H.+J.+Tutillauthor=J.+M.+Dayauthor=M.+F.+C.+Parsonsauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=The+role+of+17+beta-hydroxysteroid+dehydrogenases+in+modulating+the+activity+of+2-methoxyestradiol+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DTutill%26aufirst%3DH.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DParsons%26aufirst%3DM.%2BF.%2BC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%252017%2520beta-hydroxysteroid%2520dehydrogenases%2520in%2520modulating%2520the%2520activity%2520of%25202-methoxyestradiol%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D1%26spage%3D324%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddersen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B.</span><span> </span><span class="NLM_article-title">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">3–4</span><span class="NLM_x">) </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1016%2F0960-0760%2895%2900214-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=8541236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=395-403&issue=3%E2%80%934&author=W.+Elgerauthor=S.+Schwarzauthor=A.+M.+Heddenauthor=G.+Reddersenauthor=B.+Schneider&title=Sulfamates+of+various+estrogens+are+prodrugs+with+increased+systemic+and+reduced+hepatic+estrogenicity+at+oral+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span></div><div class="casAuthors">Elger, Walter; Schwarz, Sigfrid; Hedden, Annemarie; Reddersen, Gudrun; Schneider, Birgitt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">395-403</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oral therapy with natural or synthetic estrogens, like ethinylestradiol, suffers from low, suboptimally defined bioavailability and excess hepatic estrogen actions.  N,N-alkylated and non-alkylated sulfamates of ethinylestradiol, estradiol and estrone overcome these deficiencies.  Ovariectomized Wistar rats (-7/group) were orally treated for 7 days, and killed on day 8, plasma was gained on days 0, 4, and 8.  Systemic estrogenicity was quantified by assessment of uterine wt., vaginal cornification, and measurement of gonadotropins by homologous RIA.  Estrogenicity in the liver was analyzed.  Angiotensinogen was estd. by RIA of angiotensin-I after incubation of EDTA-plasma with porcine renin.  Total and high-d. cholesterol were measured by enzymic methods.  Preliminary biotransformation studies were performed after oral administration of 10 μg, 5 μ Ci [2,4,6,7-3H]estradiol sulfonate.  Ethinylestradiol led to distinct elevation of angiotensin-I and dramatic depression of cholesterol fractions, reflecting hepatic estrogen effects, already at doses with marginal systemic effects.  Estradiol and estrone had systemic and hepatic estrogenic activity at much higher doses only.  Estrogen sulfamates had systemic estrogen activity 10-90-fold above that of their parent estrogen.  Non-alkylated sulfamates of given estrogens were more active than N-alkylated ones.  Elevation of systemic estrogen activity was always combined with a dramatic redn. of hepatic estrogenicity.  Estradiol sulfamate had a 90-fold elevated systemic estrogen activity vs. estradiol, but lacked hepatic activity including the 30-fold dose inducing vaginal response.  Three hours after administration no unchanged estradiol sulfamate was detectable in plasma.  Rather peaks, probably representing estradiol and estrone, were found.  Estrogen sulfamates are considered prodrugs of their parent estrogen, which do not interact with any liver function during the first-pass.  They represent a new strategy of oral hormone administration.  Their main potential seems to be the systemic generation of natural estrogen when used in oral contraceptives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq93WhQsNTWFbVg90H21EOLACvtfcHk0ljrEhpH1J4dcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D&md5=60ff9ba569eb4001a4a023073e8737e0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900214-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900214-6%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DHedden%26aufirst%3DA.%2BM.%26aulast%3DReddersen%26aufirst%3DG.%26aulast%3DSchneider%26aufirst%3DB.%26atitle%3DSulfamates%2520of%2520various%2520estrogens%2520are%2520prodrugs%2520with%2520increased%2520systemic%2520and%2520reduced%2520hepatic%2520estrogenicity%2520at%2520oral%2520application%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D55%26issue%3D3%25E2%2580%25934%26spage%3D395%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: molecular biology, regulation and inhibition</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1210%2Fer.2004-0003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=15561802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=171-202&issue=2&author=M.+J.+Reedauthor=A.+Purohitauthor=S.+P.+Newmanauthor=B.+V.+L.+Potter&title=Steroid+sulfatase%3A+molecular+biology%2C+regulation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulfatase: Molecular biology, regulation, and inhibition</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Woo, L. W. L.; Newman, S. P.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-202</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Steroid sulfatase (STS) is responsible for the hydrolysis of aryl and alkyl steroid sulfates and therefore has a pivotal role in regulating the formation of biol. active steroids.  STS is widely distributed throughout the body, and its action is implicated in physiol. processes and pathol. conditions.  The crystal structure of STS has been resolved, but relatively little is known about what regulates its expression or activity.  Research into the control and inhibition of this enzyme has been stimulated by its important role in supporting the growth of hormone-dependent tumors of the breast and prostate.  STS is responsible for the hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate to estrone and dehydroepiandrosterone, resp., both of which can be converted to steroids with estrogenic properties (i.e., estradiol and androstenediol) that can stimulate tumor growth.  STS expression is increased in breast tumors and has prognostic significance.  The role of STS in supporting tumor growth prompted the development of potent STS inhibitors.  Several steroidal and nonsteroidal STS inhibitors are now available, with the irreversible type of inhibitor having a phenol sulfamate ester as its active pharmacophore.  One such inhibitor, 667 COUMATE, has now entered a phase I trial in postmenopausal women with breast cancer.  The skin is also an important site of STS activity, and deficiency of this enzyme is assocd. with X-linked ichthyosis.  STS may also be involved in regulating part of the immune response and some aspects of cognitive function.  The development of potent STS inhibitors will allow investigation of the role of this enzyme in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvDkv9jdOyZ7Vg90H21EOLACvtfcHk0ljrEhpH1J4dcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D&md5=5ea6cff3a5f23b3f31d08506c724df06</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0003%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulfatase%253A%2520molecular%2520biology%252C%2520regulation%2520and%2520inhibition%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26issue%3D2%26spage%3D171%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jourdan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2942</span><span class="NLM_x">–</span> <span class="NLM_lpage">2951</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9018806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2942-2951&issue=7&author=F.+Jourdanauthor=M.+P.+Leeseauthor=W.+Dohleauthor=E.+Hamelauthor=E.+Ferrandisauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Synthesis%2C+antitubulin%2C+and+antiproliferative+SAR+of+analogues+of+2-methoxyestradiol-3%2C17-O%2CO-bis-sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm9018806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9018806%26sid%3Dliteratum%253Aachs%26aulast%3DJourdan%26aufirst%3DF.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%252C%2520antitubulin%252C%2520and%2520antiproliferative%2520SAR%2520of%2520analogues%2520of%25202-methoxyestradiol-3%252C17-O%252CO-bis-sulfamate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2942%26epage%3D2951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raobaikady, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">The therapeutic potential of a series of orally bioavailable antiangiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fsj.bjc.6604100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=18026194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSrsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=1673-1682&issue=12&author=S.+P.+Newmanauthor=P.+A.+Fosterauthor=Y.+T.+Hoauthor=J.+M.+Dayauthor=B.+Raobaikadyauthor=P.+G.+Kasprzykauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=The+therapeutic+potential+of+a+series+of+orally+bioavailable+antiangiogenic+microtubule+disruptors+as+therapy+for+hormone-independent+prostate+and+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers</span></div><div class="casAuthors">Newman, S. P.; Foster, P. A.; Ho, Y. T.; Day, J. M.; Raobaikady, B.; Kasprzyk, P. G.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1673-1682</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Therapies for hormone-independent prostate and breast cancer are limited, with the effectiveness of the taxanes compromised by toxicity, lack of oral bioavailability and drug resistance.  This study aims to identify and characterize new microtubule disruptors, which may have improved efficacy relative to the taxanes in hormone-independent cancer.  2-Methoxy-3-O-sulfamoyl-17β-cyanomethyl-estra-1,3,5(10)-triene (STX641), 2-methoxy-3-hydroxy-17β-cyanomethyl-estra-1,3,5(10)-triene (STX640) and 2-methoxyoestradiol-3,17-O,O-bis-sulfamate (STX140) were all potent inhibitors of cell proliferation in a panel of prostate and breast cancer cell lines.  STX641 and STX640 significantly inhibited tumor growth in the MDA-MB-231 xenograft model.  STX641 inhibited both in vitro and in vivo angiogenesis.  Despite good in vivo activity, STX641 was not as potent in vivo as STX140.  Therefore, STX140 was evaluated in the prostate hormone-independent PC-3 xenograft model.  STX140 had superior efficacy to docetaxel, 2-MeOE2 and bevacizumab.  In contrast to vinorelbine, no significant toxicity was obsd.  Furthermore, STX140 could be given daily over a 60-day period leading to tumor regression and complete responses, which were maintained after the cessation of dosing.  This study demonstrates that STX641 and STX140 have considerable potential for the treatment of hormone-independent breast and prostate cancer.  In contrast to the taxanes, STX140 can be dosed orally, with no toxicity being obsd. even after prolonged daily dosing. published online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj4UzNL9Xur7Vg90H21EOLACvtfcHk0ljZv7DHJzWEFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSrsLzI&md5=68915a360f3fab3a75120ba88422a5b9</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604100%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DRaobaikady%26aufirst%3DB.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520a%2520series%2520of%2520orally%2520bioavailable%2520antiangiogenic%2520microtubule%2520disruptors%2520as%2520therapy%2520for%2520hormone-independent%2520prostate%2520and%2520breast%2520cancers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D97%26issue%3D12%26spage%3D1673%26epage%3D1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judde, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassalle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevost, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1158%2F1078-0432.CCR-07-1717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=18223236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=597-606&issue=2&author=S.+P.+Newmanauthor=P.+A.+Fosterauthor=C.+Stengelauthor=J.+M.+Dayauthor=Y.+T.+Hoauthor=J.+G.+Juddeauthor=M.+Lassalleauthor=G.+Prevostauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=STX140+is+efficacious+in+vitro+and+in+vivo+in+taxane-resistant+breast+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">STX140 Is Efficacious In vitro and In vivo in Taxane-Resistant Breast Carcinoma Cells</span></div><div class="casAuthors">Newman, Simon P.; Foster, Paul A.; Stengel, Chloe; Day, Joanna M.; Ho, Yaik T.; Judde, Jean-Gabriel; Lassalle, Myriam; Prevost, Gregoire; Leese, Mathew P.; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The aim of these studies was to characterize the action of STX140 in a P-glycoprotein-overexpressing tumor cell line both in vitro and in vivo.  In addn., its efficacy was detd. against xenografts derived from patients who failed docetaxel therapy.  Exptl. Design: The effects of STX140, Taxol, and 2-methoxyestradiol (2-MeOE2) on cell proliferation, cell cycle, and apoptosis were assessed in vitro in drug-resistant cells (MCF-7DOX) and the parental cell line (MCF-7WT).  Mice bearing an MCF-7DOX tumor on one flank and an MCF-7WT tumor on the other flank were used to assess the in vivo efficacy.  Furthermore, the responses to STX140 of three xenografts, derived from drug-resistant patients, were assessed.  RESULTS: In this study, STX140 caused cell cycle arrest, cyclin B1 induction, and subsequent apoptosis of both MCF-7DOX and MCF-7WT cells.  Taxol and 2-MeOE2 were only active in the MCF-7WT parental cell line.  Although both STX140 and Taxol inhibited the growth of xenografts derived from MCF-7WT cells, only STX140 inhibited the growth of tumors derived from MCF-7DOX cells. 2-MeOE2 was ineffective at the dose tested against both tumor types.  Two out of the three newly derived docetaxel-resistant xenografts, including a metastatic triple-neg. tumor, responded to STX140 but not to docetaxel treatment.  CONCLUSIONS: STX140 shows excellent efficacy in both MCF-7WT and MCF-7DOX breast cancer xenograft models, in contrast to Taxol and 2-MeOE2.  The clin. potential of STX140 was further highlighted by the efficacy seen in xenografts recently derived from patients who had failed on taxane therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3lf55ZqF0FLVg90H21EOLACvtfcHk0ljZv7DHJzWEFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKhtrk%253D&md5=8bfc633408bab42c4ccf5eab3d0e68c5</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1717%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DJudde%26aufirst%3DJ.%2BG.%26aulast%3DLassalle%26aufirst%3DM.%26aulast%3DPrevost%26aufirst%3DG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DSTX140%2520is%2520efficacious%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520taxane-resistant%2520breast%2520carcinoma%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26issue%3D2%26spage%3D597%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">Differential effects of estrone and estrone-3-<i>O</i>-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5441</span><span class="NLM_x">–</span> <span class="NLM_lpage">5450</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5441-5450&issue=19&author=L.+MacCarthy-Morroghauthor=P.+A.+Townsendauthor=A.+Purohitauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=Differential+effects+of+estrone+and+estrone-3-O-sulfamate+derivatives+on+mitotic+arrest%2C+apoptosis%2C+and+microtubule+assembly+in+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DTownsend%26aufirst%3DP.%2BA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3DDifferential%2520effects%2520of%2520estrone%2520and%2520estrone-3-O-sulfamate%2520derivatives%2520on%2520mitotic%2520arrest%252C%2520apoptosis%252C%2520and%2520microtubule%2520assembly%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26issue%3D19%26spage%3D5441%26epage%3D5450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummelinck, A. E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The development of A-ring modified analogues of oestrone-3-<i>O</i>-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">5–6</span><span class="NLM_x">) </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1016%2FS0960-0760%2897%2900196-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=9618028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFSqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1998&pages=269-275&issue=5%E2%80%936&author=A.+Purohitauthor=K.+A.+Vernonauthor=A.+E.+W.+Hummelinckauthor=L.+W.+L.+Wooauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+development+of+A-ring+modified+analogues+of+oestrone-3-O-sulphamate+as+potent+steroid+sulphatase+inhibitors+with+reduced+oestrogenicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The development of A-ring modified analogs of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors with reduced estrogenicity</span></div><div class="casAuthors">Purohit, A.; Vernon, K. A.; Hummelinck, A. E. Wagenaar; Woo, L. W. L.; Hejaz, H. A. M.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Steroid sulfatases regulate the formation of estrogenic steroids which can support the growth of endocrine-dependent breast tumors.  The development of potent steroid sulfatase inhibitors could therefore have considerable therapeutic potential.  Several such inhibitors have now been developed of which the most potent to date is estrone-3-O-sulfamate (EMATE).  Unexpectedly, this inhibitor proved to be a potent estrogen.  In an attempt to reduce the estrogenicity, while retaining the potent sulfatase inhibitory properties assocd. with this type of mol., a no. of A-ring modified derivs. were designed and synthesized.  A-ring modified compds. included the 2-methoxy, 2/4-nitro, 2/4-Pr and 2/4-allyl EMATE analogs.  The ability of these derivs. to inhibit estrone sulfatase activity was examd. using placental microsomes.  The allyl-substituted EMATE derivs. were more potent inhibitors than the Pr analogs but were all considerably less potent than EMATE.  In contrast, the 2-methoxy and 2/4-nitro analogs were potent sulfatase inhibitors with 4-nitro EMATE being 5 times more active than EMATE.  The 4-nitro, 2-methoxy, 4-Pr and 4-allyl derivs. were also tested in vivo for their estrogenicity and ability to inhibit sulfatase activity.  While both 4-nitro and 2-methoxy EMATE were potent inhibitors in vivo, 2-methoxy EMATE had no stimulatory effect on uterine growth in ovariectomized rats.  The identification of a potent steroid sulfatase inhibitor lacking any estrogenicity, such as 2-methoxy EMATE, should be of considerable value in evaluating the potential of steroid sulfatase inhibition for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXafBnPzDzL7Vg90H21EOLACvtfcHk0lglf_GIaB8KGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFSqsLs%253D&md5=1607054465d5934ad19e93f7e92acd14</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2900196-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252900196-9%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVernon%26aufirst%3DK.%2BA.%26aulast%3DHummelinck%26aufirst%3DA.%2BE.%2BW.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%2520A-ring%2520modified%2520analogues%2520of%2520oestrone-3-O-sulphamate%2520as%2520potent%2520steroid%2520sulphatase%2520inhibitors%2520with%2520reduced%2520oestrogenicity%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D64%26issue%3D5%25E2%2580%25936%26spage%3D269%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effect of 2-methoxyoestrone-3-<i>O</i>-sulphamate on the growth of breast cancer cells and induced mammary tumours</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">584</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=10699934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=584-589&issue=4&author=A.+Purohitauthor=H.+A.+M.+Hejazauthor=L.+Waldenauthor=L.+MacCarthy-Morroghauthor=G.+Packhamauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effect+of+2-methoxyoestrone-3-O-sulphamate+on+the+growth+of+breast+cancer+cells+and+induced+mammary+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours</span></div><div class="casAuthors">Purohit A; Hejaz H A; Walden L; MacCarthy-Morrogh L; Packham G; Potter B V; Reed M J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">584-9</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">2-Methoxyoestrogens are emerging as a new class of drug that can inhibit tumour growth and angiogenesis.  As sulphamoylation of oestrogens enhances their potency and bioavailability we have synthesized 2-methoxyoestrone-3-O-sulphamate (2-MeOEMATE) and compared its ability to inhibit the proliferation of breast cancer cells with that of 2-methoxyoestrone (2-MeOE1). 2-MeOEMATE (1 microM) inhibited the growth of oestrogen receptor positive MCF-7 breast cancer cells by 52% whereas 2-MeOE1 had little effect at this concentration. 2-MeOEMATE also inhibited the growth of oestrogen receptor negative MDA-MB-231 breast cancer cells.  Exposure of cells to 2-MeOEMATE caused them to round up and become detached suggesting that this compound may induce cells to undergo apoptosis.  Cell cycle analysis revealed that 2-MeOEMATE caused cells to arrest in the G(2)/M phase with the increase in G(2)/M arrested cells being detectable by 12 hr.  Exposure of MCF-7 cells to 2 L-MeOEMATE for 24 hr followed by culture in drug-free medium for 24 hr did not reverse the arrest of cells in the G(2)/M phase.  TUNEL analysis confirmed that 2-MeOEMATE induced apoptosis in a significant proportion of treated MCF-7 cells.  In an in vivo study, employing nitrosomethylurea-induced mammary tumours in intact rats, 2-MeOE1 (20mg/kg/d, p.o. for 11 days) had little effect on tumour growth.  In contrast, the same dose of 2-MeOEMATE resulted in the almost complete regression of 2/3 tumours over an 11-day period.  We conclude that 2-MeOEMATE should have considerable therapeutic potential for the treatment of breast tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqkhlCxw4mrynGiHuhFGv8fW6udTcc2eZ6-WXdaJi8j7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D&md5=75a9c5a896a1a00886a9c17cf2cbe241</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000215%252985%253A4%253C584%253A%253AAID-IJC22%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DWalden%26aufirst%3DL.%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effect%2520of%25202-methoxyoestrone-3-O-sulphamate%2520on%2520the%2520growth%2520of%2520breast%2520cancer%2520cells%2520and%2520induced%2520mammary%2520tumours%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26issue%3D4%26spage%3D584%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3135</span><span class="NLM_x">–</span> <span class="NLM_lpage">3138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3135-3138&issue=12&author=M.+P.+Leeseauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Alkylsulfanyl+estrogen+derivatives%3A+synthesis+of+a+novel+class+of+multi-targeted+anti-tumour+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Alkylsulfanyl%2520estrogen%2520derivatives%253A%2520synthesis%2520of%2520a%2520novel%2520class%2520of%2520multi-targeted%2520anti-tumour%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D12%26spage%3D3135%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-<i>O</i>-sulfamates</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1016%2Fj.jsbmb.2005.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=15862971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=239-251&issue=1%E2%80%933&author=M.+P.+Leeseauthor=B.+Leblondauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Anti-cancer+activities+of+novel+D-ring+modified+2-substituted+estrogen-3-O-sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates</span></div><div class="casAuthors">Leese, Mathew P.; Leblond, Bertrand; Newman, Simon P.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">239-251</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulfamoylated derivs. of the endogenous estrogen metabolite 2-methoxyestradiol [2-MeOE2 (I)], such as 2-methoxy-3-O-sulfamoylestrone [2-MeOEMATE (II)], display greatly enhanced activity against the proliferation of human cancer cells and inhibit steroid sulfatase (STS), another current oncol. target.  We explore here the effects of steroidal D-ring modification on the activity of such 2-substituted estrogen-3-O-sulfamates in respect of inhibition of tumor cell proliferation and steroid sulfatase.  The novel 17-deoxy analogs of 2-MeOEMATE and the related 2-Et and 2-methylsulfanyl compds. showed greatly reduced inhibition of MCF-7 proliferation.  Introduction of a 17α-benzyl substituent to such 2-substituted estrogen sulfamates also proved deleterious to anti-proliferative activity but could, in one case, enhance STS inhibition with respect to the parent substituted estrone sulfamate.  In contrast, selected 17-oxime derivs. of 2-MeOEMATE displayed an enhanced anti-proliferative activity.  These results illustrate that enhanced in vitro anti-cancer activity can be achieved in the 2-substituted estrogen sulfamate series and highlight, in particular, the importance of potential hydrogen bonding effects around the steroidal D-ring in the activity of these mols.  The SAR parameters established herein will assist the future design of anti-proliferative and anti-endocrine agents as potential therapeutics for both hormone dependent and independent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC4Cz4Pgw94bVg90H21EOLACvtfcHk0lglf_GIaB8KGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLs%253D&md5=0bc448776d6e96d5ee9f562de51eabb4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2005.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2005.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DAnti-cancer%2520activities%2520of%2520novel%2520D-ring%2520modified%25202-substituted%2520estrogen-3-O-sulfamates%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D94%26issue%3D1%25E2%2580%25933%26spage%3D239%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukroger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of C-17 cyano-substituted estratrienes as anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701319c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1295-1308&issue=5&author=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=K.+Gaukrogerauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=P.+A.+Fosterauthor=C.+Stengelauthor=S.+Regis-Lydiauthor=E.+Ferrandisauthor=A.+Di+Fioreauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Structure%E2%80%93activity+relationships+of+C-17+cyano-substituted+estratrienes+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm701319c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701319c%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DGaukroger%26aufirst%3DK.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520C-17%2520cyano-substituted%2520estratrienes%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D5%26spage%3D1295%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Jourdan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-<i>O</i>-sulfamates: synthesis, in vitro evaluation and computational modelling</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">4108</span><span class="NLM_x">–</span> <span class="NLM_lpage">4119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=4108-4119&issue=22&author=F.+Jourdanauthor=C.+Bubertauthor=M.+P.+Leeseauthor=A.+Smithauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Effects+of+C-17+heterocyclic+substituents+on+the+anticancer+activity+of+2-ethylestra-1%2C3%2C5%2810%29-triene-3-O-sulfamates%3A+synthesis%2C+in+vitro+evaluation+and+computational+modelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJourdan%26aufirst%3DF.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DEffects%2520of%2520C-17%2520heterocyclic%2520substituents%2520on%2520the%2520anticancer%2520activity%2520of%25202-ethylestra-1%252C3%252C5%252810%2529-triene-3-O-sulfamates%253A%2520synthesis%252C%2520in%2520vitro%2520evaluation%2520and%2520computational%2520modelling%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26issue%3D22%26spage%3D4108%26epage%3D4119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">3,17-Disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4431</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070405v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4431-4443&author=C.+Bubertauthor=M.+P.+Leeseauthor=M.+F.+Mahonauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=P.+G.+Kasprzykauthor=S.+P.+Newmanauthor=Y.+T.+Hoauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=3%2C17-Disubstituted+2-alkylestra-1%2C3%2C5%2810%29-trien-3-ol+derivatives%3A+synthesis%2C+in+vitro+and+in+vivo+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm070405v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070405v%26sid%3Dliteratum%253Aachs%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D3%252C17-Disubstituted%25202-alkylestra-1%252C3%252C5%252810%2529-trien-3-ol%2520derivatives%253A%2520synthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4431%26epage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Yan, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. C.</span><span> </span><span class="NLM_article-title">Dichloromethane activation. Direct methylenation of ketones and aldehydes with CH<sub>2</sub>Cl<sub>2</sub> promoted by Mg/TiCl<sub>4</sub>/THF</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">4961</span><span class="NLM_x">–</span> <span class="NLM_lpage">4963</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0478887" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4961-4963&issue=26&author=T.+H.+Yanauthor=C.+C.+Tsaiauthor=C.+T.+Chienauthor=C.+C.+Choauthor=P.+C.+Huang&title=Dichloromethane+activation.+Direct+methylenation+of+ketones+and+aldehydes+with+CH2Cl2+promoted+by+Mg%2FTiCl4%2FTHF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol0478887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0478887%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DT.%2BH.%26aulast%3DTsai%26aufirst%3DC.%2BC.%26aulast%3DChien%26aufirst%3DC.%2BT.%26aulast%3DCho%26aufirst%3DC.%2BC.%26aulast%3DHuang%26aufirst%3DP.%2BC.%26atitle%3DDichloromethane%2520activation.%2520Direct%2520methylenation%2520of%2520ketones%2520and%2520aldehydes%2520with%2520CH2Cl2%2520promoted%2520by%2520Mg%252FTiCl4%252FTHF%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26issue%3D26%26spage%3D4961%26epage%3D4963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, N.</span><span> </span><span class="NLM_article-title">Efficient general method for sulfamoylation of a hydroxyl group</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">36</span><span class="NLM_x">) </span> <span class="NLM_fpage">7047</span><span class="NLM_x">–</span> <span class="NLM_lpage">7051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=7047-7051&issue=36&author=M.+Okadaauthor=S.+Iwashitaauthor=N.+Koizumi&title=Efficient+general+method+for+sulfamoylation+of+a+hydroxyl+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DIwashita%26aufirst%3DS.%26aulast%3DKoizumi%26aufirst%3DN.%26atitle%3DEfficient%2520general%2520method%2520for%2520sulfamoylation%2520of%2520a%2520hydroxyl%2520group%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26issue%3D36%26spage%3D7047%26epage%3D7051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hartley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Main, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKiernan, G. J.</span><span> </span><span class="NLM_article-title">Titanium carbenoid reagents for converting carbonyl groups into alkenes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4825</span><span class="NLM_x">–</span> <span class="NLM_lpage">4864</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=4825-4864&issue=23&author=R.+C.+Hartleyauthor=J.+F.+Liauthor=C.+A.+Mainauthor=G.+J.+McKiernan&title=Titanium+carbenoid+reagents+for+converting+carbonyl+groups+into+alkenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHartley%26aufirst%3DR.%2BC.%26aulast%3DLi%26aufirst%3DJ.%2BF.%26aulast%3DMain%26aufirst%3DC.%2BA.%26aulast%3DMcKiernan%26aufirst%3DG.%2BJ.%26atitle%3DTitanium%2520carbenoid%2520reagents%2520for%2520converting%2520carbonyl%2520groups%2520into%2520alkenes%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26issue%3D23%26spage%3D4825%26epage%3D4864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Tsuchiya, T.</span><span> </span><span class="NLM_article-title">Chemistry and developments of fluorinated carbohydrates</span> <span class="citation_source-journal">Adv. Carbohydr. Chem. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1990&pages=91-277&author=T.+Tsuchiya&title=Chemistry+and+developments+of+fluorinated+carbohydrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuchiya%26aufirst%3DT.%26atitle%3DChemistry%2520and%2520developments%2520of%2520fluorinated%2520carbohydrates%26jtitle%3DAdv.%2520Carbohydr.%2520Chem.%2520Biochem.%26date%3D1990%26volume%3D48%26spage%3D91%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1368</span><span class="NLM_x">–</span> <span class="NLM_lpage">1376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=17426705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1368-1376&issue=9&author=S.+K.+Chanderauthor=P.+A.+Fosterauthor=M.+P.+Leeseauthor=S.+P.+Newmanauthor=B.+V.+L.+Potterauthor=A.+Purohitauthor=M.+J.+Reed&title=In+vivo+inhibition+of+angiogenesis+by+sulphamoylated+derivatives+of+2-methoxyoestradiol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol</span></div><div class="casAuthors">Chander, S. K.; Foster, P. A.; Leese, M. P.; Newman, S. P.; Potter, B. V. L.; Purohit, A.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1368-1376</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs that inhibit growth of tumors and their blood supply could have considerable therapeutic potential.  2-Methoxyestradiol-3,17-O,O-bis-sulfamate (2-MeOE2bisMATE) has been shown to inhibit the proliferation of MCF-7 (ER+) breast cancer cells and angiogenesis in vitro.  2-MeOE2bisMATE and its analog, 17-Cym-2-MeOE2MATE, were investigated for their ability to inhibit in vivo angiogenesis and tumor growth.  The mouse Matrigel plug assay for angiogenesis was used to investigate the effect of compds. on neovascularization and was quantified using a FITC-dextran injection technique.  Nude mice bearing tumors derived from MCF-7 cells were used to assess efficacy on tumor growth.  Tumor sections were stained for VEGFR-2 and Ki67 to assess tumor angiogenesis and cell proliferation resp.  Matrigel plugs supplemented with basic fibroblast growth factor resulted in increased neovascularization over 7 days.  Oral administration of 2-MeOE2bisMATE for 7 days at 10 or 50 mg kg-1 significantly reduced neovascularization to or below control levels resp.  17-Cym-2-MeOE2MATE at 20 mg kg-1 was equally effective.  2-MeOE2bisMATE, dosed daily for 21 days, caused a 52% redn. in tumor growth at 5 mg kg-1 and 38% regression at 20 mg kg-1.  17-Cym-2-MeOE2MATE (20 mg kg-1) reduced tumor growth by 92%.  Immunohistochem. revealed a redn. in angiogenesis and proliferation.  Matrigel plug and tumor imaging after FITC-dextran injection indicated that 2-MeOE2bisMATE caused a marked disruption of vasculature.  These sulfamoylated estrogen derivs. have been shown to be potent inhibitors of angiogenesis in vivo.  This, together with their ability to inhibit tumor growth, indicates the potential of this new class of drugs for further development for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqermbvXLYR8LVg90H21EOLACvtfcHk0livaJstQDCryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslyisro%253D&md5=a589de69ba3adc8e5ca93cff2cda1ede</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520angiogenesis%2520by%2520sulphamoylated%2520derivatives%2520of%25202-methoxyoestradiol%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26issue%3D9%26spage%3D1368%26epage%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Laurence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Questel, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, E.</span><span> </span><span class="NLM_article-title">The pK(BHX) database: toward a better understanding of hydrogen-bond basicity for medicinal chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4073</span><span class="NLM_x">–</span> <span class="NLM_lpage">4086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801331y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4073-4086&issue=14&author=C.+Laurenceauthor=K.+A.+Brameldauthor=J.+Gratonauthor=J.+Y.+Le+Questelauthor=E.+Renault&title=The+pK%28BHX%29+database%3A+toward+a+better+understanding+of+hydrogen-bond+basicity+for+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists</span></div><div class="casAuthors">Laurence, Christian; Brameld, Ken A.; Graton, Jerome; Le Questel, Jean-Yves; Renault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4073-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pKBHX database is presented, which corresponds to three main fields of data: hydrogen bond donor identification, thermodn. data and spectroscopic data.  The pKBHX scale of hydrogen donor basicity differs considerable from the pKBH+ scale of proton transfer basicity.  The hydrogen bond basicities of functional groups relevant to medicinal chem. and drug design is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9OhmMu2VILVg90H21EOLACvtfcHk0livaJstQDCryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D&md5=9ce4bea3e810752baba6ea5784b55ea0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm801331y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801331y%26sid%3Dliteratum%253Aachs%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DGraton%26aufirst%3DJ.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.%2BY.%26aulast%3DRenault%26aufirst%3DE.%26atitle%3DThe%2520pK%2528BHX%2529%2520database%253A%2520toward%2520a%2520better%2520understanding%2520of%2520hydrogen-bond%2520basicity%2520for%2520medicinal%2520chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D14%26spage%3D4073%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alley, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camalier, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span> </span><span class="NLM_article-title">In vivo cultivation of tumor cells in hollow fibres</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=131-141&author=M.+Hollingsheadauthor=M.+C.+Alleyauthor=R.+F.+Camalierauthor=B.+J.+Abbottauthor=J.+G.+Mayoauthor=L.+Malspeisauthor=M.+R.+Grever&title=In+vivo+cultivation+of+tumor+cells+in+hollow+fibres"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DAlley%26aufirst%3DM.%2BC.%26aulast%3DCamalier%26aufirst%3DR.%2BF.%26aulast%3DAbbott%26aufirst%3DB.%2BJ.%26aulast%3DMayo%26aufirst%3DJ.%2BG.%26aulast%3DMalspeis%26aufirst%3DL.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26atitle%3DIn%2520vivo%2520cultivation%2520of%2520tumor%2520cells%2520in%2520hollow%2520fibres%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D57%26spage%3D131%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_contrib-group">Passaniti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pili, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. R.</span><span> </span><span class="NLM_article-title">Methods in laboratory investigation—a simple, quantitative method fot assessing angiogenesis and antiangiogenic agents using reconstituted base-membrane, heparin, and fibroblast growth-factor</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1992&pages=519-528&issue=4&author=A.+Passanitiauthor=R.+M.+Taylorauthor=R.+Piliauthor=Y.+Guoauthor=P.+V.+Longauthor=J.+A.+Haneyauthor=R.+R.+Paulyauthor=D.+S.+Grantauthor=G.+R.+Martin&title=Methods+in+laboratory+investigation%E2%80%94a+simple%2C+quantitative+method+fot+assessing+angiogenesis+and+antiangiogenic+agents+using+reconstituted+base-membrane%2C+heparin%2C+and+fibroblast+growth-factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPassaniti%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DR.%2BM.%26aulast%3DPili%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DP.%2BV.%26aulast%3DHaney%26aufirst%3DJ.%2BA.%26aulast%3DPauly%26aufirst%3DR.%2BR.%26aulast%3DGrant%26aufirst%3DD.%2BS.%26aulast%3DMartin%26aufirst%3DG.%2BR.%26atitle%3DMethods%2520in%2520laboratory%2520investigation%25E2%2580%2594a%2520simple%252C%2520quantitative%2520method%2520fot%2520assessing%2520angiogenesis%2520and%2520antiangiogenic%2520agents%2520using%2520reconstituted%2520base-membrane%252C%2520heparin%252C%2520and%2520fibroblast%2520growth-factor%26jtitle%3DLab.%2520Invest.%26date%3D1992%26volume%3D67%26issue%3D4%26spage%3D519%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_contrib-group">Prewett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overholser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pytowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohlen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span> </span><span class="NLM_article-title">Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">5209</span><span class="NLM_x">–</span> <span class="NLM_lpage">5218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5209-5218&issue=20&author=M.+Prewettauthor=J.+Huberauthor=Y.+W.+Liauthor=A.+Santiagoauthor=W.+O%E2%80%99Connorauthor=K.+Kingauthor=J.+Overholserauthor=A.+Hooperauthor=B.+Pytowskiauthor=L.+Witteauthor=P.+Bohlenauthor=D.+J.+Hicklin&title=Antivascular+endothelial+growth+factor+receptor+%28fetal+liver+kinase+1%29+monoclonal+antibody+inhibits+tumor+angiogenesis+and+growth+of+several+mouse+and+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrewett%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%2BW.%26aulast%3DSantiago%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DW.%26aulast%3DKing%26aufirst%3DK.%26aulast%3DOverholser%26aufirst%3DJ.%26aulast%3DHooper%26aufirst%3DA.%26aulast%3DPytowski%26aufirst%3DB.%26aulast%3DWitte%26aufirst%3DL.%26aulast%3DBohlen%26aufirst%3DP.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26atitle%3DAntivascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528fetal%2520liver%2520kinase%25201%2529%2520monoclonal%2520antibody%2520inhibits%2520tumor%2520angiogenesis%2520and%2520growth%2520of%2520several%2520mouse%2520and%2520human%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D20%26spage%3D5209%26epage%3D5218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twentyman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embleton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J.</span><span> </span><span class="NLM_article-title">United Kingdom Co-Ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition)</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fbjc.1998.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1998&pages=1-10&issue=1&author=P.+Workmanauthor=P.+Twentymanauthor=F.+Balkwillauthor=A.+Balmainauthor=D.+Chaplinauthor=J.+Doubleauthor=J.+Embletonauthor=D.+Newellauthor=R.+Raymondauthor=J.+Stablesauthor=T.+Stephensauthor=J.+Wallace&title=United+Kingdom+Co-Ordinating+Committee+on+Cancer+Research+%28UKCCCR%29+guidelines+for+the+welfare+of+animals+in+experimental+neoplasia+%28second+edition%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1998.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1998.1%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DTwentyman%26aufirst%3DP.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DChaplin%26aufirst%3DD.%26aulast%3DDouble%26aufirst%3DJ.%26aulast%3DEmbleton%26aufirst%3DJ.%26aulast%3DNewell%26aufirst%3DD.%26aulast%3DRaymond%26aufirst%3DR.%26aulast%3DStables%26aufirst%3DJ.%26aulast%3DStephens%26aufirst%3DT.%26aulast%3DWallace%26aufirst%3DJ.%26atitle%3DUnited%2520Kingdom%2520Co-Ordinating%2520Committee%2520on%2520Cancer%2520Research%2520%2528UKCCCR%2529%2520guidelines%2520for%2520the%2520welfare%2520of%2520animals%2520in%2520experimental%2520neoplasia%2520%2528second%2520edition%2529%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1998%26volume%3D77%26issue%3D1%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Appel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, G.</span><span> </span><span class="NLM_article-title">Uber das hydrazidosulfamid (on hydrazidosulfamide)</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1339</span><span class="NLM_x">–</span> <span class="NLM_lpage">1341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1958&pages=1339-1341&author=R.+Appelauthor=G.+Berger&title=Uber+das+hydrazidosulfamid+%28on+hydrazidosulfamide%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DR.%26aulast%3DBerger%26aufirst%3DG.%26atitle%3DUber%2520das%2520hydrazidosulfamid%2520%2528on%2520hydrazidosulfamide%2529%26jtitle%3DChem.%2520Ber.%26date%3D1958%26volume%3D91%26spage%3D1339%26epage%3D1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightowler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1016%2F0960-0760%2895%2900244-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=8645620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1996&pages=79-88&issue=1%E2%80%932&author=L.+W.+L.+Wooauthor=M.+Lightowlerauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Heteroatom-substituted+analogues+of+the+active-site+directed+inhibitor+estra-1%2C3%2C5%2810%29-trien-17-one-3-sulphamate+inhibit+estrone+sulphatase+by+a+different+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Hetero atom-substituted analogs of the active-side directed inhibitor estra-1,3,5(10)-triene-17-one-3-sulfamate inhibit estrone sulfatase by a different mechanism</span></div><div class="casAuthors">Woo, L. W. Lawrence; Lightowler, Mark; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Estrogens have a pivotal role in the growth and development of hormone-dependent breast cancers.  In postmenopausal women, the hydrolysis of the conjugate estrone sulfate (E1S) to estrone (E1) by the enzyme estrone sulfatase is the major source of breast tumor estrogen.  Inhibitors of estrone sulfatase should therefore have considerable therapeutic potential for the treatment of hormone-dependent tumors of the breast, either as the sole agent or in conjunction with aromatase inhibitors.  Several inhibitors of estrone sulfatase have now been developed of which estra-1,3,5(10)-trien-17-one-3-sulfamate (EMATE) is the most potent and also inhibits the enzyme in a time- and concn.-dependent manner, showing that it acts as an irreversible inhibitor.  Analogs of EMATE in which the 3-O-atom is replaced by other heteroatoms (S and N) were prepd. and tested for inhibition against estrone sulfatase.  3-Methoxyphenylsulfamide, 4-chlorothiophenyl-S-(N,N-dimethyl)sulfamate, estra-1,3,5(10)-trien-17-one-3-sulfamide, estra-1,3,5(10)-trien-17-one-3-S-sulfamate, and estra-1,3,5(10)-trien-17-one-3-S-(N,N-dimethyl)sulfamate inhibited estrone sulfatase weakly, but none of these compds. appears to behave as a time-dependent inhibitor.  A model of the mechanism of enzyme inhibition by EMATE is proposed and the authors conclude that the sulfamate bridging oxygen atom of EMATE is essential for active site-directed inhibition of estrone sulfatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlWZCRBBmXtLVg90H21EOLACvtfcHk0lijpGQ3bDmvVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D&md5=ce13a9f57587179a9d5a3a104fd67740</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900244-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900244-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLightowler%26aufirst%3DM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHeteroatom-substituted%2520analogues%2520of%2520the%2520active-site%2520directed%2520inhibitor%2520estra-1%252C3%252C5%252810%2529-trien-17-one-3-sulphamate%2520inhibit%2520estrone%2520sulphatase%2520by%2520a%2520different%2520mechanism%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D57%26issue%3D1%25E2%2580%25932%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Grégory  Menchon</span>, <span class="hlFld-ContribAuthor ">Andrea E.  Prota</span>, <span class="hlFld-ContribAuthor ">Paul A.  Foster</span>, <span class="hlFld-ContribAuthor ">Pascoe  Mannion</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Mark P.  Thomas</span>, <span class="hlFld-ContribAuthor ">Philip G.  Kasprzyk</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Michel O.  Steinmetz</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, and <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>  . </span><span class="cited-content_cbyCitation_article-title">Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1031-1044. <a href="https://doi.org/10.1021/acs.jmedchem.7b01474" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01474%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DQuinazolinone-Based%252BAnticancer%252BAgents%25253A%252BSynthesis%25252C%252BAntiproliferative%252BSAR%25252C%252BAntitubulin%252BActivity%25252C%252Band%252BTubulin%252BCo-crystal%252BStructure%26aulast%3DDohle%26aufirst%3DWolfgang%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D04102017%26date%3D08012018%26date%3D08022018%26date%3D11122017%26volume%3D61%26issue%3D3%26spage%3D1031%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Spillane</span>  , <span class="hlFld-ContribAuthor ">Jean-Baptiste  Malaubier</span>  . </span><span class="cited-content_cbyCitation_article-title">Sulfamic Acid and Its N- and O-Substituted Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (4)
                                     , 2507-2586. <a href="https://doi.org/10.1021/cr400230c" title="DOI URL">https://doi.org/10.1021/cr400230c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr400230c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr400230c%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DSulfamic%252BAcid%252Band%252BIts%252BN-%252Band%252BO-Substituted%252BDerivatives%26aulast%3DSpillane%26aufirst%3DWilliam%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D29042013%26date%3D17122013%26date%3D26022014%26volume%3D114%26issue%3D4%26spage%3D2507%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anke  Löhndorf</span>, <span class="hlFld-ContribAuthor ">Leon  Hosang</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Francesca  Odoardi</span>, <span class="hlFld-ContribAuthor ">Sissy-Alina  Waschkowski</span>, <span class="hlFld-ContribAuthor ">Anette  Rosche</span>, <span class="hlFld-ContribAuthor ">Andreas  Bauche</span>, <span class="hlFld-ContribAuthor ">Riekje  Winzer</span>, <span class="hlFld-ContribAuthor ">Eva  Tolosa</span>, <span class="hlFld-ContribAuthor ">Sabine  Windhorst</span>, <span class="hlFld-ContribAuthor ">Stephen  Marry</span>, <span class="hlFld-ContribAuthor ">Alexander  Flügel</span>, <span class="hlFld-ContribAuthor ">Barry V.L.  Potter</span>, <span class="hlFld-ContribAuthor ">Björn-Philipp  Diercks</span>, <span class="hlFld-ContribAuthor ">Andreas H.  Guse</span>. </span><span class="cited-content_cbyCitation_article-title">2-Methoxyestradiol and its derivatives inhibit store-operated Ca2+ entry in T cells: Identification of a new and potent inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2021,</strong> <em>1868 </em>
                                    (6)
                                     , 118988. <a href="https://doi.org/10.1016/j.bbamcr.2021.118988" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2021.118988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2021.118988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2021.118988%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3D2-Methoxyestradiol%252Band%252Bits%252Bderivatives%252Binhibit%252Bstore-operated%252BCa2%25252B%252Bentry%252Bin%252BT%252Bcells%25253A%252BIdentification%252Bof%252Ba%252Bnew%252Band%252Bpotent%252Binhibitor%26aulast%3DL%25C3%25B6hndorf%26aufirst%3DAnke%26date%3D2021%26volume%3D1868%26issue%3D6%26spage%3D118988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Svetlana  N. Morozkina</span>, <span class="hlFld-ContribAuthor ">Alexander  G. Shavva</span>. </span><span class="cited-content_cbyCitation_article-title">Estrone Sulfatase Inhibitors as New Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.5772/intechopen.85850" title="DOI URL">https://doi.org/10.5772/intechopen.85850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.85850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.85850%26sid%3Dliteratum%253Aachs%26atitle%3DEstrone%252BSulfatase%252BInhibitors%252Bas%252BNew%252BAnticancer%252BAgents%26aulast%3DN.%2BMorozkina%26aufirst%3DSvetlana%26date%3D2020%26date%3D2020%26pub%3DIntechOpen%26atitle%3DChemistry%252Band%252BBiological%252BActivity%252Bof%252BSteroids%26aulast%3DAnt%25C3%25B3nio%2BRibeiro%2BSalvador%26aufirst%3DJorge%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mateusz  Daśko</span>, <span class="hlFld-ContribAuthor ">Sebastian  Demkowicz</span>, <span class="hlFld-ContribAuthor ">Karol  Biernacki</span>, <span class="hlFld-ContribAuthor ">Olga  Ciupak</span>, <span class="hlFld-ContribAuthor ">Witold  Kozak</span>, <span class="hlFld-ContribAuthor ">Maciej  Masłyk</span>, <span class="hlFld-ContribAuthor ">Janusz  Rachon</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in the development of steroid sulphatase inhibitors – examples of the novel and most promising compounds from the last decade. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1163-1184. <a href="https://doi.org/10.1080/14756366.2020.1758692" title="DOI URL">https://doi.org/10.1080/14756366.2020.1758692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1758692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1758692%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Bthe%252Bdevelopment%252Bof%252Bsteroid%252Bsulphatase%252Binhibitors%252B%2525E2%252580%252593%252Bexamples%252Bof%252Bthe%252Bnovel%252Band%252Bmost%252Bpromising%252Bcompounds%252Bfrom%252Bthe%252Blast%252Bdecade%26aulast%3DDa%25C5%259Bko%26aufirst%3DMateusz%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1163%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Izabella  Sinka</span>, <span class="hlFld-ContribAuthor ">Anita  Kiss</span>, <span class="hlFld-ContribAuthor ">Erzsébet  Mernyák</span>, <span class="hlFld-ContribAuthor ">János  Wölfling</span>, <span class="hlFld-ContribAuthor ">Gyula  Schneider</span>, <span class="hlFld-ContribAuthor ">Imre  Ocsovszki</span>, <span class="hlFld-ContribAuthor ">Ching-Ying  Kuo</span>, <span class="hlFld-ContribAuthor ">Hui-Chun  Wang</span>, <span class="hlFld-ContribAuthor ">István  Zupkó</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2018,</strong> <em>123 </em>, 362-370. <a href="https://doi.org/10.1016/j.ejps.2018.07.029" title="DOI URL">https://doi.org/10.1016/j.ejps.2018.07.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2018.07.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2018.07.029%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DAntiproliferative%252Band%252Bantimetastatic%252Bproperties%252Bof%252B3-benzyloxy-16-hydroxymethylene-estradiol%252Banalogs%252Bagainst%252Bbreast%252Bcancer%252Bcell%252Blines%26aulast%3DSinka%26aufirst%3DIzabella%26date%3D2018%26volume%3D123%26spage%3D362%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bowen  Li</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhou</span>, <span class="hlFld-ContribAuthor ">Shucheng  Wang</span>, <span class="hlFld-ContribAuthor ">Xingyi  Sun</span>, <span class="hlFld-ContribAuthor ">Zemei  Ge</span>, <span class="hlFld-ContribAuthor ">Runtao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of organic sulfonic acid derivatives containing dithiocarbamate side chains. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (27-28)
                                     , 3885-3889. <a href="https://doi.org/10.1016/j.tet.2016.05.011" title="DOI URL">https://doi.org/10.1016/j.tet.2016.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DEfficient%252Bsynthesis%252Bof%252Borganic%252Bsulfonic%252Bacid%252Bderivatives%252Bcontaining%252Bdithiocarbamate%252Bside%252Bchains%26aulast%3DLi%26aufirst%3DBowen%26date%3D2016%26volume%3D72%26issue%3D27-28%26spage%3D3885%26epage%3D3889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Ebrahim-Alkhalil  Ahmed</span>, <span class="hlFld-ContribAuthor ">Bin  Xiao</span>, <span class="hlFld-ContribAuthor ">Qian-Qian  Lu</span>, <span class="hlFld-ContribAuthor ">Yun-Long  Wang</span>, <span class="hlFld-ContribAuthor ">Chu-Guo  Yu</span>, <span class="hlFld-ContribAuthor ">Yao  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Pd-Catalyzed Regioselective Activation of
              gem
              -Difluorinated Cyclopropanes: A Highly Efficient Approach to 2-Fluorinated Allylic Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (28)
                                     , 8349-8353. <a href="https://doi.org/10.1002/ange.201502308" title="DOI URL">https://doi.org/10.1002/ange.201502308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201502308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201502308%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPd-Catalyzed%252BRegioselective%252BActivation%252Bof%252Bgem%252B-Difluorinated%252BCyclopropanes%25253A%252BA%252BHighly%252BEfficient%252BApproach%252Bto%252B2-Fluorinated%252BAllylic%252BScaffolds%26aulast%3DXu%26aufirst%3DJun%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D28%26spage%3D8349%26epage%3D8353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Ebrahim-Alkhalil  Ahmed</span>, <span class="hlFld-ContribAuthor ">Bin  Xiao</span>, <span class="hlFld-ContribAuthor ">Qian-Qian  Lu</span>, <span class="hlFld-ContribAuthor ">Yun-Long  Wang</span>, <span class="hlFld-ContribAuthor ">Chu-Guo  Yu</span>, <span class="hlFld-ContribAuthor ">Yao  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Pd-Catalyzed Regioselective Activation of
              gem
              -Difluorinated Cyclopropanes: A Highly Efficient Approach to 2-Fluorinated Allylic Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (28)
                                     , 8231-8235. <a href="https://doi.org/10.1002/anie.201502308" title="DOI URL">https://doi.org/10.1002/anie.201502308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201502308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201502308%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPd-Catalyzed%252BRegioselective%252BActivation%252Bof%252Bgem%252B-Difluorinated%252BCyclopropanes%25253A%252BA%252BHighly%252BEfficient%252BApproach%252Bto%252B2-Fluorinated%252BAllylic%252BScaffolds%26aulast%3DXu%26aufirst%3DJun%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D28%26spage%3D8231%26epage%3D8235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sven  Sommerwerk</span>, <span class="hlFld-ContribAuthor ">Lucie  Heller</span>, <span class="hlFld-ContribAuthor ">René  Csuk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxic Activity of Pentacyclic Triterpenoid Sulfamates. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (1)
                                     , 46-54. <a href="https://doi.org/10.1002/ardp.201400297" title="DOI URL">https://doi.org/10.1002/ardp.201400297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201400297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201400297%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BCytotoxic%252BActivity%252Bof%252BPentacyclic%252BTriterpenoid%252BSulfamates%26aulast%3DSommerwerk%26aufirst%3DSven%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D1%26spage%3D46%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Chapman</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Optimisation of Tetrahydroisoquinoline-Based Chimeric Microtubule Disruptors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>132 </em>, n/a-n/a. <a href="https://doi.org/10.1002/cmdc.201402025" title="DOI URL">https://doi.org/10.1002/cmdc.201402025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402025%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DOptimisation%252Bof%252BTetrahydroisoquinoline-Based%252BChimeric%252BMicrotubule%252BDisruptors%26aulast%3DDohle%26aufirst%3DWolfgang%26date%3D2014%26date%3D2014%26volume%3D132%26spage%3Dn%252Fa%26epage%3Dn%252Fa" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Meriel R.  Major</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Mark P.  Thomas</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Mary F.  Mahon</span>, <span class="hlFld-ContribAuthor ">Simon P.  Newman</span>, <span class="hlFld-ContribAuthor ">Atul  Purohit</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Anti-tubulin and Antiproliferative SAR of Steroidomimetic Dihydroisoquinolinones. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (4)
                                     , 798-812. <a href="https://doi.org/10.1002/cmdc.201400017" title="DOI URL">https://doi.org/10.1002/cmdc.201400017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201400017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201400017%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%25252C%252BAnti-tubulin%252Band%252BAntiproliferative%252BSAR%252Bof%252BSteroidomimetic%252BDihydroisoquinolinones%26aulast%3DLeese%26aufirst%3DMathew%2BP.%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3D798%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Meriel R.  Major</span>, <span class="hlFld-ContribAuthor ">Ruoli  Bai</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Philip G.  Kasprzyk</span>, <span class="hlFld-ContribAuthor ">Ann  Fiore</span>, <span class="hlFld-ContribAuthor ">Simon P.  Newman</span>, <span class="hlFld-ContribAuthor ">Atul  Purohit</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1-Substituted Tetrahydroisoquinolines. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (2)
                                     , 350-370. <a href="https://doi.org/10.1002/cmdc.201300412" title="DOI URL">https://doi.org/10.1002/cmdc.201300412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300412%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%25252C%252BAntitubulin%25252C%252Band%252BAntiproliferative%252BSAR%252Bof%252BC3%25252FC1-Substituted%252BTetrahydroisoquinolines%26aulast%3DDohle%26aufirst%3DWolfgang%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3D350%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Meriel R.  Major</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Ann  Fiore</span>, <span class="hlFld-ContribAuthor ">Philip G.  Kasprzyk</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydroisoquinolinone-Based Steroidomimetic and Chimeric Microtubule Disruptors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (1)
                                     , 85-108. <a href="https://doi.org/10.1002/cmdc.201300261" title="DOI URL">https://doi.org/10.1002/cmdc.201300261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300261%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTetrahydroisoquinolinone-Based%252BSteroidomimetic%252Band%252BChimeric%252BMicrotubule%252BDisruptors%26aulast%3DLeese%26aufirst%3DMathew%2BP.%26date%3D2014%26date%3D2013%26volume%3D9%26issue%3D1%26spage%3D85%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucas C.  Kopel</span>, <span class="hlFld-ContribAuthor ">Mahmoud S.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Fathi T.  Halaweish</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel estrone analogs by incorporation of thiophenols via conjugate addition to an enone side chain. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2013,</strong> <em>78 </em>
                                    (11)
                                     , 1119-1125. <a href="https://doi.org/10.1016/j.steroids.2013.07.005" title="DOI URL">https://doi.org/10.1016/j.steroids.2013.07.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2013.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2013.07.005%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DSynthesis%252Bof%252Bnovel%252Bestrone%252Banalogs%252Bby%252Bincorporation%252Bof%252Bthiophenols%252Bvia%252Bconjugate%252Baddition%252Bto%252Ban%252Benone%252Bside%252Bchain%26aulast%3DKopel%26aufirst%3DLucas%2BC.%26date%3D2013%26volume%3D78%26issue%3D11%26spage%3D1119%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atul  Gupta</span>, <span class="hlFld-ContribAuthor ">B.  Sathish Kumar</span>, <span class="hlFld-ContribAuthor ">Arvind S.  Negi</span>. </span><span class="cited-content_cbyCitation_article-title">Current status on development of steroids as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2013,</strong> <em>137 </em>, 242-270. <a href="https://doi.org/10.1016/j.jsbmb.2013.05.011" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2013.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2013.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2013.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DCurrent%252Bstatus%252Bon%252Bdevelopment%252Bof%252Bsteroids%252Bas%252Banticancer%252Bagents%26aulast%3DGupta%26aufirst%3DAtul%26date%3D2013%26volume%3D137%26spage%3D242%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeane M.  Govan</span>, <span class="hlFld-ContribAuthor ">Andrew L.  McIver</span>, <span class="hlFld-ContribAuthor ">Chad  Riggsbee</span>, <span class="hlFld-ContribAuthor ">Alexander  Deiters</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrogen Peroxide Induced Activation of Gene Expression in Mammalian Cells using Boronate Estrone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2012,</strong> <em>124 </em>
                                    (36)
                                     , 9200-9204. <a href="https://doi.org/10.1002/ange.201203222" title="DOI URL">https://doi.org/10.1002/ange.201203222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201203222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201203222%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DHydrogen%252BPeroxide%252BInduced%252BActivation%252Bof%252BGene%252BExpression%252Bin%252BMammalian%252BCells%252Busing%252BBoronate%252BEstrone%252BDerivatives%26aulast%3DGovan%26aufirst%3DJeane%2BM.%26date%3D2012%26date%3D2012%26volume%3D124%26issue%3D36%26spage%3D9200%26epage%3D9204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeane M.  Govan</span>, <span class="hlFld-ContribAuthor ">Andrew L.  McIver</span>, <span class="hlFld-ContribAuthor ">Chad  Riggsbee</span>, <span class="hlFld-ContribAuthor ">Alexander  Deiters</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrogen Peroxide Induced Activation of Gene Expression in Mammalian Cells using Boronate Estrone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2012,</strong> <em>51 </em>
                                    (36)
                                     , 9066-9070. <a href="https://doi.org/10.1002/anie.201203222" title="DOI URL">https://doi.org/10.1002/anie.201203222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201203222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201203222%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DHydrogen%252BPeroxide%252BInduced%252BActivation%252Bof%252BGene%252BExpression%252Bin%252BMammalian%252BCells%252Busing%252BBoronate%252BEstrone%252BDerivatives%26aulast%3DGovan%26aufirst%3DJeane%2BM.%26date%3D2012%26date%3D2012%26volume%3D51%26issue%3D36%26spage%3D9066%26epage%3D9070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of 2-methoxyestradiol <b>1</b>, 2-ethylestradiol <b>2</b>, 2-methoxyestradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamate <b>3</b>, 2-ethylestradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamate <b>4</b>, 2-methoxyestradiol-3-<i>O</i>-sulfamate <b>5</b>, 2-ethylestradiol-3-<i>O</i>-sulfamate <b>6</b>, 2-methoxyestrone-3-<i>O</i>-sulfamate <b>7</b>, 2-ethylestrone-3-<i>O</i>-sulfamate <b>8</b>, 2-methoxy-3-hydroxy-17β-cyanomethyl-1,3,5(10)-estratriene <b>9</b>, 2-ethyl-3-hydroxy-17β-cyanomethylestra-1,3,5(10)-triene <b>10</b>, 2-methoxy-3-<i>O</i>-sulfamoyl-17β-cyanomethylestra-1,3,5(10)-triene <b>11</b>, 2-ethyl-3-<i>O</i>-sulfamoyl-17β-cyanomethylestra-1,3,5(10)-triene <b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed modifications at C-17 of the 2-substituted estratriene nucleus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 17-Hydroxy- and Alkoxymethyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Mg, TiCl<sub>4</sub>, DCM, THF, 0 °C; (ii) 9-BBN, THF, 0 °C, then 37% H<sub>2</sub>O<sub>2</sub>, 10% NaOH, 0 °C; (iii) H<sub>2</sub>, Pd/C, THF, MeOH, room temp; (iv) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (v) NaH, MeI, THF, reflux; (vi) TBDPSCl, imidazole, DMF, room temp; (vii) TBAF, THF, room temp.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of C-17 Ethyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (EtO)<sub>2</sub>POCH<sub>2</sub>CO<sub>2</sub>Et, NaH, THF, reflux; (ii) H<sub>2</sub>, Pd/C, THF/MeOH, room temp; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (iv) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, room temp; (v) LiAlH<sub>4</sub>, THF, 0 °C; (vi) MeI, NaH, THF, room temp; (vii) TBDPSCl, imidazole, DMF, room temp; (viii) TBAF, THF, 0 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0014.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Various C-17 Olefin Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (EtO)<sub>2</sub>POCH<sub>2</sub>CO<sub>2</sub>Et, NaH, THF, reflux; (ii) TBAF, THF, 0 °C; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (iv) DIBAL-H, THF, −78 to 0 °C; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, 2,6-di-<i>tert</i>-butyl-4-methylpyridine, toluene, DCM, room temp.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of C-17 Tethered Alkoxy and Hydroxy Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) LiAlH<sub>4</sub>, THF, 0 °C; (ii) CH<sub>3</sub>I, NaH, THF, room temp; (iii) Na, <i>t</i>-BuOH, reflux; (iv) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (v) DIBAL-H, THF, −78 to 0 °C.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 17β-Acyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) EtPPh<sub>3</sub>I, NaH, DMSO, 100 °C; (ii) BH<sub>3</sub>–THF, THF, 0 °C, then NaOH 30%, H<sub>2</sub>O<sub>2</sub>, 37%; (iii) Dess–Martin periodinane, DCM; (iv) H<sub>2</sub>, Pd/C, THF, MeOH; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of C-17 2-Hydroxypropyl and 2-Oxopropyl Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIBAL-H, THF, 0 °C to room temp; (ii) MeMgBr, THF, 0 °C; (iii) Dess–Martin periodinane, DCM, 0 °C to room temp; (iv) H<sub>2</sub>, Pd/C, THF, MeOH, room temp; (v) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Improved Approach to 17-(2-Oxopropyl)estratriene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (EtO)<sub>2</sub>POCH<sub>2</sub>CO<sub>2</sub>Et, NaH, THF, reflux; (ii) H<sub>2</sub>, Pd/C, THF, MeOH, room temp; (iii) Tebbe reagent, pyridine, THF, toluene, −78 to 0 °C; (iv) 2 M HCl, room temp; (v) TBAF, THF, room temp; (vi) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp; (vii) NaBH<sub>4</sub>, <i>i</i>-PrOH, THF, room temp; (viii) H<sub>2</sub>NOH·HCl, NaOAc, MeOH/H<sub>2</sub>O, room temp.</p></p></figure><figure data-id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of 17-(Fluoroethyl)estratriene Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DAST, THF, 0 °C; (ii) H<sub>2</sub>, Pd/C, THF, MeOH, room temp; (iii) H<sub>2</sub>NSO<sub>2</sub>Cl, DMA, room temp.</p></p></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/medium/jm-2011-00483x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compounds <b>49a</b> and <b>55</b> on bFGF induced angiogenesis in Matrigel plugs in mice. Compounds <b>49a</b> and <b>55</b> were administered orally at the doses indicated for 4 days starting 24 h after Matrigel injection. (a) Quantification of angiogenesis within the Matrigel plugs was achieved after FITC-dextran injection. Compounds <b>49a</b> and <b>55</b> significantly inhibited FGF-induced angiogenesis at both doses (<i>p</i> < 0.05, unpaired <i>t</i> test). (b) Effect of <b>49a</b> and <b>55</b> on Matrigel plug neovascularization. Normal (upper) and fluorescent (lower) images of excised Matrigel plugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-13/jm200483x/production/images/large/jm-2011-00483x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200483x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiatt, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshaw, E.</span><span> </span><span class="NLM_article-title">Tumor angiogenesis—therapeutic implications</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">1182</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1056%2FNEJM197111182852108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=4938153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1971&pages=1182-1186&issue=21&author=J.+Folkmanauthor=M.+Bachauthor=J.+W.+Roweauthor=F.+Davidoffauthor=P.+Lambertauthor=C.+Hirschauthor=A.+Goldbergauthor=H.+H.+Hiattauthor=J.+Glassauthor=E.+Henshaw&title=Tumor+angiogenesis%E2%80%94therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor angiogenesis: therapeutic implications</span></div><div class="casAuthors">Folkman J</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1182-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA0C6odtE1LPxQvRxYU81tfW6udTcc2eY_qbCWtx1dmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D&md5=efdddcba0c04be542edd51fef2ef27b9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM197111182852108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197111182852108%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DM.%26aulast%3DRowe%26aufirst%3DJ.%2BW.%26aulast%3DDavidoff%26aufirst%3DF.%26aulast%3DLambert%26aufirst%3DP.%26aulast%3DHirsch%26aufirst%3DC.%26aulast%3DGoldberg%26aufirst%3DA.%26aulast%3DHiatt%26aufirst%3DH.%2BH.%26aulast%3DGlass%26aufirst%3DJ.%26aulast%3DHenshaw%26aufirst%3DE.%26atitle%3DTumor%2520angiogenesis%25E2%2580%2594therapeutic%2520implications%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26issue%3D21%26spage%3D1182%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fnrd1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=15136787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=391-400&issue=5&author=N.+Ferraraauthor=K.+J.+Hillanauthor=H.+P.+Gerberauthor=W.+Novotny&title=Discovery+and+development+of+bevacizumab%2C+an+anti-VEGF+antibody+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span></div><div class="casAuthors">Ferrara, Napoleone; Hillan, Kenneth J.; Gerber, Hans-Peter; Novotny, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The existence of factors that stimulate blood vessel growth, thereby recruiting a neovascular supply to nourish a growing tumor, was postulated many decades ago, although the identification and isolation of these factors proved elusive.  Now, vascular endothelial growth factor (VEGF), which was identified in the 1980s, is recognized as an essential regulator of normal and abnormal blood vessel growth.  In 1993, it was shown that a monoclonal antibody that targeted VEGF results in a dramatic suppression of tumor growth in vivo, which led to the development of bevacizumab (Avastin; Genentech), a humanized variant of this anti-VEGF antibody, as an anticancer agent.  The recent approval of bevacizumab by the US FDA as a first-line therapy for metastatic colorectal cancer validates the ideas that VEGF is a key mediator of tumor angiogenesis and that blocking angiogenesis is an effective strategy to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaLbfhdBKOLVg90H21EOLACvtfcHk0lit5FOb7CK2Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D&md5=4b1f647db4dfe2a24449cdf59b874e7c</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1381%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DGerber%26aufirst%3DH.%2BP.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DDiscovery%2520and%2520development%2520of%2520bevacizumab%252C%2520an%2520anti-VEGF%2520antibody%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26issue%3D5%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_contrib-group">Panares, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. A.</span><span> </span><span class="NLM_article-title">Bevacizumab in the management of solid tumors</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1586%2F14737140.7.4.433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=17428164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Wqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=433-445&issue=4&author=R.+L.+Panaresauthor=A.+A.+Garcia&title=Bevacizumab+in+the+management+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab in the management of solid tumors</span></div><div class="casAuthors">Panares, Roy L.; Garcia, Agustin A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">433-445</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is defined as the formation of new blood vessels from a pre-existing vascular bed.  By supplying nutrients and oxygen and removing waste products in malignant tumors, it is an essential process that regulates cancer growth and dissemination.  This process is regulated by both pro- and antiangiogenic compds.  Vascular endothelial growth factor is one of the most important and best-studied proangiogenic factors.  Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has been shown to inhibit angiogenesis and is proving to be of clin. benefit in a variety of tumor types.  The strongest evidence comes from studies in advanced colorectal and non-small-cell lung cancer, with growing evidence in breast and epithelial ovarian tumors.  The duration and timing of bevacizumab's use is currently the focus of several ongoing clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3gqfS8ed2N7Vg90H21EOLACvtfcHk0lit5FOb7CK2Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Wqs74%253D&md5=27084acb248645b4ff4c7b4fd4b70aab</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1586%2F14737140.7.4.433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.7.4.433%26sid%3Dliteratum%253Aachs%26aulast%3DPanares%26aufirst%3DR.%2BL.%26aulast%3DGarcia%26aufirst%3DA.%2BA.%26atitle%3DBevacizumab%2520in%2520the%2520management%2520of%2520solid%2520tumors%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D433%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wilhelm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simantov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S.</span><span> </span><span class="NLM_article-title">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=835-844&issue=10&author=S.+Wilhelmauthor=C.+Carterauthor=M.+Lynchauthor=T.+Lowingerauthor=J.+Dumasauthor=R.+A.+Smithauthor=B.+Schwartzauthor=R.+Simantovauthor=S.+Kelley&title=Discovery+and+development+of+sorafenib%3A+a+multikinase+inhibitor+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DLowinger%26aufirst%3DT.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520development%2520of%2520sorafenib%253A%2520a%2520multikinase%2520inhibitor%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26issue%3D10%26spage%3D835%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Faivre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sargent, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E.</span><span> </span><span class="NLM_article-title">Molecular basis for sunitinib efficacy and future clinical development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=734-745&issue=9&author=S.+Faivreauthor=G.+Demetriauthor=W.+Sargentauthor=E.+Raymond&title=Molecular+basis+for+sunitinib+efficacy+and+future+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaivre%26aufirst%3DS.%26aulast%3DDemetri%26aufirst%3DG.%26aulast%3DSargent%26aufirst%3DW.%26aulast%3DRaymond%26aufirst%3DE.%26atitle%3DMolecular%2520basis%2520for%2520sunitinib%2520efficacy%2520and%2520future%2520clinical%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D9%26spage%3D734%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kohne, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, H. J.</span><span> </span><span class="NLM_article-title">Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=478-488&issue=5&author=C.+H.+Kohneauthor=H.+J.+Lenz&title=Chemotherapy+with+targeted+agents+for+the+treatment+of+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKohne%26aufirst%3DC.%2BH.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26atitle%3DChemotherapy%2520with%2520targeted%2520agents%2520for%2520the%2520treatment%2520of%2520metastatic%2520colorectal%2520cancer%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26issue%3D5%26spage%3D478%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Taming vessels to treat cancer</span> <span class="citation_source-journal">Sci. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fscientificamerican0108-56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=18225696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FntVCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2008&pages=56-63&issue=1&author=R.+K.+Jain&title=Taming+vessels+to+treat+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Taming vessels to treat cancer</span></div><div class="casAuthors">Jain Rakesh K</div><div class="citationInfo"><span class="NLM_cas:title">Scientific American</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>
        ISSN:<span class="NLM_cas:issn">0036-8733</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8CG-CamYuQUEgZCMqtRBifW6udTcc2eZQw8lvUb4b6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FntVCnsQ%253D%253D&md5=42f355839dbe995f63f8ca415712d417</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fscientificamerican0108-56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fscientificamerican0108-56%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DTaming%2520vessels%2520to%2520treat%2520cancer%26jtitle%3DSci.%2520Am.%26date%3D2008%26volume%3D298%26issue%3D1%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Casanovas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanahan, D.</span><span> </span><span class="NLM_article-title">Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=299-309&issue=4&author=O.+Casanovasauthor=D.+J.+Hicklinauthor=G.+Bergersauthor=D.+Hanahan&title=Drug+resistance+by+evasion+of+antiangiogenic+targeting+of+VEGF+signaling+in+late-stage+pancreatic+islet+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCasanovas%26aufirst%3DO.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DBergers%26aufirst%3DG.%26aulast%3DHanahan%26aufirst%3DD.%26atitle%3DDrug%2520resistance%2520by%2520evasion%2520of%2520antiangiogenic%2520targeting%2520of%2520VEGF%2520signaling%2520in%2520late-stage%2520pancreatic%2520islet%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26issue%3D4%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_contrib-group">Ebos, J. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz-Munoz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjarnason, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerbel, R. S.</span><span> </span><span class="NLM_article-title">Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=232-239&issue=3&author=J.+M.+L.+Ebosauthor=C.+R.+Leeauthor=W.+Cruz-Munozauthor=G.+A.+Bjarnasonauthor=J.+G.+Christensenauthor=R.+S.+Kerbel&title=Accelerated+metastasis+after+short-term+treatment+with+a+potent+inhibitor+of+tumor+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEbos%26aufirst%3DJ.%2BM.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BR.%26aulast%3DCruz-Munoz%26aufirst%3DW.%26aulast%3DBjarnason%26aufirst%3DG.%2BA.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DKerbel%26aufirst%3DR.%2BS.%26atitle%3DAccelerated%2520metastasis%2520after%2520short-term%2520treatment%2520with%2520a%2520potent%2520inhibitor%2520of%2520tumor%2520angiogenesis%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D15%26issue%3D3%26spage%3D232%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_contrib-group">Paez-Ribes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinals, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanovas, O.</span><span> </span><span class="NLM_article-title">Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=220-231&issue=3&author=M.+Paez-Ribesauthor=E.+Allenauthor=J.+Hudockauthor=T.+Takedaauthor=H.+Okuyamaauthor=F.+Vinalsauthor=M.+Inoueauthor=G.+Bergersauthor=D.+Hanahanauthor=O.+Casanovas&title=Antiangiogenic+therapy+elicits+malignant+progression+of+tumors+to+increased+local+invasion+and+distant+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaez-Ribes%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DE.%26aulast%3DHudock%26aufirst%3DJ.%26aulast%3DTakeda%26aufirst%3DT.%26aulast%3DOkuyama%26aufirst%3DH.%26aulast%3DVinals%26aufirst%3DF.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DBergers%26aufirst%3DG.%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DCasanovas%26aufirst%3DO.%26atitle%3DAntiangiogenic%2520therapy%2520elicits%2520malignant%2520progression%2520of%2520tumors%2520to%2520increased%2520local%2520invasion%2520and%2520distant%2520metastasis%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D15%26issue%3D3%26spage%3D220%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_contrib-group">Vredenburgh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desjardins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcello, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathornsumetee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gururangan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span> </span><span class="NLM_article-title">Bevacizumab plus irinotecan in recurrent glioblastoma multiforme</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">30</span><span class="NLM_x">) </span> <span class="NLM_fpage">4722</span><span class="NLM_x">–</span> <span class="NLM_lpage">4729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1200%2FJCO.2007.12.2440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=17947719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCgsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=4722-4729&issue=30&author=J.+J.+Vredenburghauthor=A.+Desjardinsauthor=J.+E.+Herndonauthor=J.+Marcelloauthor=D.+A.+Reardonauthor=J.+A.+Quinnauthor=J.+N.+Richauthor=S.+Sathornsumeteeauthor=S.+Gururanganauthor=J.+Sampsonauthor=M.+Wagnerauthor=L.+Baileyauthor=D.+D.+Bignerauthor=A.+H.+Friedmanauthor=H.+S.+Friedman&title=Bevacizumab+plus+irinotecan+in+recurrent+glioblastoma+multiforme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab plus irinotecan in recurrent glioblastoma multiforme</span></div><div class="casAuthors">Vredenburgh, James J.; Desjardins, Annick; Herndon, James E., II; Marcello, Jennifer; Reardon, David A.; Quinn, Jennifer A.; Rich, Jeremy N.; Sathornsumetee, Sith; Gururangan, Sridharan; Sampson, John; Wagner, Melissa; Bailey, Leighann; Bigner, Darell D.; Friedman, Allan H.; Friedman, Henry S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4722-4729</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The prognosis for patients with recurrent glioblastoma multiforme is poor, with a median survival of 3 to 6 mo.  We performed a phase II trial of bevacizumab, a monoclonal antibody to vascular endothelial growth factor, in combination with irinotecan.  This phase II trial included two cohorts of patients.  The initial cohort, comprising 23 patients, received bevacizumab at 10 mg/kg plus irinotecan every 2 wk.  The dose of irinotecan was based on the patient's anticonvulsant: Patients taking enzyme-inducing antiepileptic drugs (EIAEDs) received 340 mg/m2, and patients not taking EIAEDs received 125 mg/m2.  After this regimen was deemed safe and effective, the irinotecan schedule was changed to an accepted brain tumor regimen of four doses in 6 wk, in anticipation of a phase III randomized trial of irinotecan vs. irinotecan and bevacizumab.  The second cohort, comprising 12 patients, received bevacizumab 15 mg/kg every 21 days and irinotecan on days 1, 8, 22, and 29.  Each cycle was 6 wk long and concluded with patient evaluations, including magnetic resonance imaging.  The 6-mo progression-free survival among all 35 patients was 46% (95% CI, 32% to 66%).  The 6-mo overall survival was 77% (95% CI, 64% to 92%).  Twenty of the 35 patients (57%; 95% CI, 39% to 74%) had at least a partial response.  One patient developed a CNS hemorrhage, which occurred in his 10th cycle.  Four patients developed thromboembolic complications (deep venous thrombosis and/or pulmonary emboli).  Bevacizumab and irinotecan is an effective treatment for recurrent glioblastoma multiforme and has moderate toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2VM5NokRnhrVg90H21EOLACvtfcHk0lhUgWnqeIh9Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCgsLjF&md5=5081884f8df26aaf0e6b7e70d2654a9e</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.12.2440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.12.2440%26sid%3Dliteratum%253Aachs%26aulast%3DVredenburgh%26aufirst%3DJ.%2BJ.%26aulast%3DDesjardins%26aufirst%3DA.%26aulast%3DHerndon%26aufirst%3DJ.%2BE.%26aulast%3DMarcello%26aufirst%3DJ.%26aulast%3DReardon%26aufirst%3DD.%2BA.%26aulast%3DQuinn%26aufirst%3DJ.%2BA.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26aulast%3DSathornsumetee%26aufirst%3DS.%26aulast%3DGururangan%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DL.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DA.%2BH.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26atitle%3DBevacizumab%2520plus%2520irinotecan%2520in%2520recurrent%2520glioblastoma%2520multiforme%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26issue%3D30%26spage%3D4722%26epage%3D4729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_contrib-group">Burger, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sill, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greer, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorosky, J. I.</span><span> </span><span class="NLM_article-title">Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a gynecologic oncology group study</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">33</span><span class="NLM_x">) </span> <span class="NLM_fpage">5165</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1200%2FJCO.2007.11.5345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=18024863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKnsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=5165-5171&issue=33&author=R.+A.+Burgerauthor=M.+W.+Sillauthor=B.+J.+Monkauthor=B.+E.+Greerauthor=J.+I.+Sorosky&title=Phase+II+trial+of+bevacizumab+in+persistent+or+recurrent+epithelial+ovarian+cancer+or+primary+peritoneal+cancer%3A+a+gynecologic+oncology+group+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a gynecologic oncology group study</span></div><div class="casAuthors">Burger, Robert A.; Sill, Michael W.; Monk, Bradley J.; Greer, Benjamin E.; Sorosky, Joel I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">5165-5171</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Vascular endothelial growth factor (VEGF) seems to be a promoter of tumor progression for epithelial ovarian cancer (EOC) and primary peritoneal cancer (PPC).  We conducted a phase II trial to assess the efficacy and tolerability of single-agent bevacizumab, an anti-VEGF monoclonal antibody.  Patients and Methods: Eligible patients had persistent or recurrent EOC/PPC after one to two prior cytotoxic regimens, measurable disease, and Gynecol. Oncol. Group performance status of at least 2.  Treatment consisted of bevacizumab 15 mg/kg i.v. every 21 days until disease progression or prohibitive toxicity.  Primary end points were progression-free survival (PFS) at 6 mo and clin. response.  Results: The study consisted of 62 eligible and assessable patients, median age 57 years, 41 (66.1%) having received two prior regimens and 26 (41.9%) considered platinum resistant.  Grade 3 adverse events at least possibly related to bevacizumab were hematol. (1), GI (3), hypertension (6), thromboembolism (1), allergy (2), hepatic (1), pain (3), coagulation (1), constitutional (1), and dyspnea (1).  Grade 4 adverse events included pulmonary embolus (1), vomiting and constipation (1), and proteinuria (1).  Thirteen patients (21.0%) experienced clin. responses (two complete, 11 partial; median response duration, 10 mo), and 25 (40.3%) survived progression free for at least 6 mo.  Median PFS and overall survival were 4.7 and 17 mo, resp.  There was no significant assocn. of prior platinum sensitivity, age, no. of prior chemotherapeutic regimens, or performance status with the hazard of progression or death.  Conclusion: Bevacizumab seems to be well tolerated and active in the second- and third-line treatment of patients with EOC/PPC and merits phase III investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoalKT4Ex-9J7Vg90H21EOLACvtfcHk0lhUgWnqeIh9Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKnsb%252FE&md5=eb2411fcae76037c7e214cf45c4a15ce</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.11.5345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.11.5345%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DR.%2BA.%26aulast%3DSill%26aufirst%3DM.%2BW.%26aulast%3DMonk%26aufirst%3DB.%2BJ.%26aulast%3DGreer%26aufirst%3DB.%2BE.%26aulast%3DSorosky%26aufirst%3DJ.%2BI.%26atitle%3DPhase%2520II%2520trial%2520of%2520bevacizumab%2520in%2520persistent%2520or%2520recurrent%2520epithelial%2520ovarian%2520cancer%2520or%2520primary%2520peritoneal%2520cancer%253A%2520a%2520gynecologic%2520oncology%2520group%2520study%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26issue%3D33%26spage%3D5165%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span><span class="NLM_issue">49</span><span class="NLM_x">) </span> <span class="NLM_fpage">7683</span><span class="NLM_x">–</span> <span class="NLM_lpage">7696</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=7683-7696&issue=49&author=M.+P.+Leeseauthor=B.+Leblondauthor=A.+Smithauthor=S.+P.+Newmanauthor=A.+Di+Fioreauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Substituted+estradiol+bis-sulfamates%2C+multitargeted+antitumor+agents%3A+synthesis%2C+in+vitro+SAR%2C+protein+crystallography%2C+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Substituted%2520estradiol%2520bis-sulfamates%252C%2520multitargeted%2520antitumor%2520agents%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520protein%2520crystallography%252C%2520and%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26issue%3D49%26spage%3D7683%26epage%3D7696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">A-Ring-substituted estrogen-3-<i>O</i>-sulfamates: potent multitargeted anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5243</span><span class="NLM_x">–</span> <span class="NLM_lpage">5256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5243-5256&issue=16&author=M.+P.+Leeseauthor=H.+A.+M.+Hejazauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=A-Ring-substituted+estrogen-3-O-sulfamates%3A+potent+multitargeted+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm050066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050066a%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DA-Ring-substituted%2520estrogen-3-O-sulfamates%253A%2520potent%2520multitargeted%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D16%26spage%3D5243%26epage%3D5256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, R. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fsj.bjc.6601591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=14970876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=932-937&issue=4&author=C.+R.+Iresonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=S.+Pereraauthor=S.+P.+Newmanauthor=D.+Parishauthor=M.+P.+Leeseauthor=A.+C.+Smithauthor=B.+V.+L.+Potterauthor=R.+J.+Reed&title=Pharmacokinetics+and+efficacy+of+2-methoxyoestradiol+and+2-methoxyoestradiol-bis-sulphamate+in+vivo+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span></div><div class="casAuthors">Ireson, C. R.; Chander, S. K.; Purohit, A.; Perera, S.; Newman, S. P.; Parish, D.; Leese, M. P.; Smith, A. C.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">932-937</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Methoxyoestradiol (2-MeOE2) is an endogenous estrogen metabolite that inhibits the proliferation of cancer cells in vitro, and it is also antiangiogenic.  In vivo 2-MeOE2, when administered at relatively high doses, inhibits the growth of tumors derived from breast cancer cells, sarcomas and melanomas.  Sulphamoylated derivs. of 2-MeOE2 are more potent inhibitors of in vitro breast cancer cell growth than 2-MeOE2.  In the present study, the authors have compared the pharmacokinetic profiles and metab. of 2-MeOE2 and its sulfamoylated deriv., 2-methoxyestradiol-bis-sulfamate (2-MeOE2bisMATE), in adult female rats.  Their ability to inhibit tumor growth was compared in nude mice bearing xenografts derived from MDA-MB-435 (estrogen receptor neg.) melanoma cancer cells.  After a single oral 10 mg kg-1 dose of 2-MeOE2bisMATE, significant concns. of this compd. were still detectable at 24 h.  In contrast, no 2-MeOE2 or metabolites were detected in plasma at any time after a 10 mg kg-1 oral dose.  Thus, the bioavailability of 2-MeOE2 is very low, whereas for 2-MeOE2bisMATE it was 85%.  No significant metabolites of 2-MeOE2bisMATE were detected in plasma after oral or i.v. dosing, showing that this drug is resistant to metab.  In the tumor efficacy model, oral administration of 2-MeOE2bisMATE, at 20 mg kg-1 day-1 daily for 28 days, almost completely inhibited tumor growth.  Inhibition of tumor growth was maintained for a further 28 days after the cessation of dosing.  At this dose level, 2-MeOE2 did not inhibit tumor growth.  The resistance to metab. shown by 2-MeOE2bisMATE and its ability to inhibit tumor growth in vivo suggest that this compd. should have considerable potential for development as a novel anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogMoiaDGhPlLVg90H21EOLACvtfcHk0ljazhXBmmSMmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D&md5=e92f1f7f94f9d2fdb3afad25cc41903d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601591%26sid%3Dliteratum%253Aachs%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DR.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520efficacy%2520of%25202-methoxyoestradiol%2520and%25202-methoxyoestradiol-bis-sulphamate%2520in%2520vivo%2520in%2520rodents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26issue%3D4%26spage%3D932%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=909-914&issue=4&author=Y.+T.+Hoauthor=A.+Purohitauthor=N.+Vickerauthor=S.+P.+Newmanauthor=J.+J.+Robinsonauthor=M.+P.+Leeseauthor=D.+Ganeshapillaiauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+carbonic+anhydrase+II+by+steroidal+and+non-steroidal+sulphamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVicker%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DJ.%2BJ.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520carbonic%2520anhydrase%2520II%2520by%2520steroidal%2520and%2520non-steroidal%2520sulphamates%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D305%26issue%3D4%26spage%3D909%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutill, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">The role of 17 beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=324-330&issue=1&author=S.+P.+Newmanauthor=C.+R.+Iresonauthor=H.+J.+Tutillauthor=J.+M.+Dayauthor=M.+F.+C.+Parsonsauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=The+role+of+17+beta-hydroxysteroid+dehydrogenases+in+modulating+the+activity+of+2-methoxyestradiol+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DTutill%26aufirst%3DH.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DParsons%26aufirst%3DM.%2BF.%2BC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%252017%2520beta-hydroxysteroid%2520dehydrogenases%2520in%2520modulating%2520the%2520activity%2520of%25202-methoxyestradiol%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D1%26spage%3D324%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddersen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B.</span><span> </span><span class="NLM_article-title">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">3–4</span><span class="NLM_x">) </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1016%2F0960-0760%2895%2900214-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=8541236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=395-403&issue=3%E2%80%934&author=W.+Elgerauthor=S.+Schwarzauthor=A.+M.+Heddenauthor=G.+Reddersenauthor=B.+Schneider&title=Sulfamates+of+various+estrogens+are+prodrugs+with+increased+systemic+and+reduced+hepatic+estrogenicity+at+oral+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span></div><div class="casAuthors">Elger, Walter; Schwarz, Sigfrid; Hedden, Annemarie; Reddersen, Gudrun; Schneider, Birgitt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">395-403</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oral therapy with natural or synthetic estrogens, like ethinylestradiol, suffers from low, suboptimally defined bioavailability and excess hepatic estrogen actions.  N,N-alkylated and non-alkylated sulfamates of ethinylestradiol, estradiol and estrone overcome these deficiencies.  Ovariectomized Wistar rats (-7/group) were orally treated for 7 days, and killed on day 8, plasma was gained on days 0, 4, and 8.  Systemic estrogenicity was quantified by assessment of uterine wt., vaginal cornification, and measurement of gonadotropins by homologous RIA.  Estrogenicity in the liver was analyzed.  Angiotensinogen was estd. by RIA of angiotensin-I after incubation of EDTA-plasma with porcine renin.  Total and high-d. cholesterol were measured by enzymic methods.  Preliminary biotransformation studies were performed after oral administration of 10 μg, 5 μ Ci [2,4,6,7-3H]estradiol sulfonate.  Ethinylestradiol led to distinct elevation of angiotensin-I and dramatic depression of cholesterol fractions, reflecting hepatic estrogen effects, already at doses with marginal systemic effects.  Estradiol and estrone had systemic and hepatic estrogenic activity at much higher doses only.  Estrogen sulfamates had systemic estrogen activity 10-90-fold above that of their parent estrogen.  Non-alkylated sulfamates of given estrogens were more active than N-alkylated ones.  Elevation of systemic estrogen activity was always combined with a dramatic redn. of hepatic estrogenicity.  Estradiol sulfamate had a 90-fold elevated systemic estrogen activity vs. estradiol, but lacked hepatic activity including the 30-fold dose inducing vaginal response.  Three hours after administration no unchanged estradiol sulfamate was detectable in plasma.  Rather peaks, probably representing estradiol and estrone, were found.  Estrogen sulfamates are considered prodrugs of their parent estrogen, which do not interact with any liver function during the first-pass.  They represent a new strategy of oral hormone administration.  Their main potential seems to be the systemic generation of natural estrogen when used in oral contraceptives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq93WhQsNTWFbVg90H21EOLACvtfcHk0ljazhXBmmSMmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D&md5=60ff9ba569eb4001a4a023073e8737e0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900214-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900214-6%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DHedden%26aufirst%3DA.%2BM.%26aulast%3DReddersen%26aufirst%3DG.%26aulast%3DSchneider%26aufirst%3DB.%26atitle%3DSulfamates%2520of%2520various%2520estrogens%2520are%2520prodrugs%2520with%2520increased%2520systemic%2520and%2520reduced%2520hepatic%2520estrogenicity%2520at%2520oral%2520application%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D55%26issue%3D3%25E2%2580%25934%26spage%3D395%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: molecular biology, regulation and inhibition</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1210%2Fer.2004-0003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=15561802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=171-202&issue=2&author=M.+J.+Reedauthor=A.+Purohitauthor=S.+P.+Newmanauthor=B.+V.+L.+Potter&title=Steroid+sulfatase%3A+molecular+biology%2C+regulation+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulfatase: Molecular biology, regulation, and inhibition</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Woo, L. W. L.; Newman, S. P.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-202</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Steroid sulfatase (STS) is responsible for the hydrolysis of aryl and alkyl steroid sulfates and therefore has a pivotal role in regulating the formation of biol. active steroids.  STS is widely distributed throughout the body, and its action is implicated in physiol. processes and pathol. conditions.  The crystal structure of STS has been resolved, but relatively little is known about what regulates its expression or activity.  Research into the control and inhibition of this enzyme has been stimulated by its important role in supporting the growth of hormone-dependent tumors of the breast and prostate.  STS is responsible for the hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate to estrone and dehydroepiandrosterone, resp., both of which can be converted to steroids with estrogenic properties (i.e., estradiol and androstenediol) that can stimulate tumor growth.  STS expression is increased in breast tumors and has prognostic significance.  The role of STS in supporting tumor growth prompted the development of potent STS inhibitors.  Several steroidal and nonsteroidal STS inhibitors are now available, with the irreversible type of inhibitor having a phenol sulfamate ester as its active pharmacophore.  One such inhibitor, 667 COUMATE, has now entered a phase I trial in postmenopausal women with breast cancer.  The skin is also an important site of STS activity, and deficiency of this enzyme is assocd. with X-linked ichthyosis.  STS may also be involved in regulating part of the immune response and some aspects of cognitive function.  The development of potent STS inhibitors will allow investigation of the role of this enzyme in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvDkv9jdOyZ7Vg90H21EOLACvtfcHk0ljazhXBmmSMmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D&md5=5ea6cff3a5f23b3f31d08506c724df06</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0003%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulfatase%253A%2520molecular%2520biology%252C%2520regulation%2520and%2520inhibition%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26issue%3D2%26spage%3D171%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jourdan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-<i>O</i>,<i>O</i>-bis-sulfamate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2942</span><span class="NLM_x">–</span> <span class="NLM_lpage">2951</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9018806" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2942-2951&issue=7&author=F.+Jourdanauthor=M.+P.+Leeseauthor=W.+Dohleauthor=E.+Hamelauthor=E.+Ferrandisauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Synthesis%2C+antitubulin%2C+and+antiproliferative+SAR+of+analogues+of+2-methoxyestradiol-3%2C17-O%2CO-bis-sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm9018806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9018806%26sid%3Dliteratum%253Aachs%26aulast%3DJourdan%26aufirst%3DF.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%252C%2520antitubulin%252C%2520and%2520antiproliferative%2520SAR%2520of%2520analogues%2520of%25202-methoxyestradiol-3%252C17-O%252CO-bis-sulfamate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D7%26spage%3D2942%26epage%3D2951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raobaikady, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">The therapeutic potential of a series of orally bioavailable antiangiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1682</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fsj.bjc.6604100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=18026194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSrsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=1673-1682&issue=12&author=S.+P.+Newmanauthor=P.+A.+Fosterauthor=Y.+T.+Hoauthor=J.+M.+Dayauthor=B.+Raobaikadyauthor=P.+G.+Kasprzykauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=The+therapeutic+potential+of+a+series+of+orally+bioavailable+antiangiogenic+microtubule+disruptors+as+therapy+for+hormone-independent+prostate+and+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers</span></div><div class="casAuthors">Newman, S. P.; Foster, P. A.; Ho, Y. T.; Day, J. M.; Raobaikady, B.; Kasprzyk, P. G.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1673-1682</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Therapies for hormone-independent prostate and breast cancer are limited, with the effectiveness of the taxanes compromised by toxicity, lack of oral bioavailability and drug resistance.  This study aims to identify and characterize new microtubule disruptors, which may have improved efficacy relative to the taxanes in hormone-independent cancer.  2-Methoxy-3-O-sulfamoyl-17β-cyanomethyl-estra-1,3,5(10)-triene (STX641), 2-methoxy-3-hydroxy-17β-cyanomethyl-estra-1,3,5(10)-triene (STX640) and 2-methoxyoestradiol-3,17-O,O-bis-sulfamate (STX140) were all potent inhibitors of cell proliferation in a panel of prostate and breast cancer cell lines.  STX641 and STX640 significantly inhibited tumor growth in the MDA-MB-231 xenograft model.  STX641 inhibited both in vitro and in vivo angiogenesis.  Despite good in vivo activity, STX641 was not as potent in vivo as STX140.  Therefore, STX140 was evaluated in the prostate hormone-independent PC-3 xenograft model.  STX140 had superior efficacy to docetaxel, 2-MeOE2 and bevacizumab.  In contrast to vinorelbine, no significant toxicity was obsd.  Furthermore, STX140 could be given daily over a 60-day period leading to tumor regression and complete responses, which were maintained after the cessation of dosing.  This study demonstrates that STX641 and STX140 have considerable potential for the treatment of hormone-independent breast and prostate cancer.  In contrast to the taxanes, STX140 can be dosed orally, with no toxicity being obsd. even after prolonged daily dosing. published online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj4UzNL9Xur7Vg90H21EOLACvtfcHk0liPqkNqECmYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSrsLzI&md5=68915a360f3fab3a75120ba88422a5b9</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604100%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DRaobaikady%26aufirst%3DB.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520a%2520series%2520of%2520orally%2520bioavailable%2520antiangiogenic%2520microtubule%2520disruptors%2520as%2520therapy%2520for%2520hormone-independent%2520prostate%2520and%2520breast%2520cancers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D97%26issue%3D12%26spage%3D1673%26epage%3D1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judde, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassalle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevost, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1158%2F1078-0432.CCR-07-1717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=18223236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=597-606&issue=2&author=S.+P.+Newmanauthor=P.+A.+Fosterauthor=C.+Stengelauthor=J.+M.+Dayauthor=Y.+T.+Hoauthor=J.+G.+Juddeauthor=M.+Lassalleauthor=G.+Prevostauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=STX140+is+efficacious+in+vitro+and+in+vivo+in+taxane-resistant+breast+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">STX140 Is Efficacious In vitro and In vivo in Taxane-Resistant Breast Carcinoma Cells</span></div><div class="casAuthors">Newman, Simon P.; Foster, Paul A.; Stengel, Chloe; Day, Joanna M.; Ho, Yaik T.; Judde, Jean-Gabriel; Lassalle, Myriam; Prevost, Gregoire; Leese, Mathew P.; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The aim of these studies was to characterize the action of STX140 in a P-glycoprotein-overexpressing tumor cell line both in vitro and in vivo.  In addn., its efficacy was detd. against xenografts derived from patients who failed docetaxel therapy.  Exptl. Design: The effects of STX140, Taxol, and 2-methoxyestradiol (2-MeOE2) on cell proliferation, cell cycle, and apoptosis were assessed in vitro in drug-resistant cells (MCF-7DOX) and the parental cell line (MCF-7WT).  Mice bearing an MCF-7DOX tumor on one flank and an MCF-7WT tumor on the other flank were used to assess the in vivo efficacy.  Furthermore, the responses to STX140 of three xenografts, derived from drug-resistant patients, were assessed.  RESULTS: In this study, STX140 caused cell cycle arrest, cyclin B1 induction, and subsequent apoptosis of both MCF-7DOX and MCF-7WT cells.  Taxol and 2-MeOE2 were only active in the MCF-7WT parental cell line.  Although both STX140 and Taxol inhibited the growth of xenografts derived from MCF-7WT cells, only STX140 inhibited the growth of tumors derived from MCF-7DOX cells. 2-MeOE2 was ineffective at the dose tested against both tumor types.  Two out of the three newly derived docetaxel-resistant xenografts, including a metastatic triple-neg. tumor, responded to STX140 but not to docetaxel treatment.  CONCLUSIONS: STX140 shows excellent efficacy in both MCF-7WT and MCF-7DOX breast cancer xenograft models, in contrast to Taxol and 2-MeOE2.  The clin. potential of STX140 was further highlighted by the efficacy seen in xenografts recently derived from patients who had failed on taxane therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3lf55ZqF0FLVg90H21EOLACvtfcHk0liPqkNqECmYEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKhtrk%253D&md5=8bfc633408bab42c4ccf5eab3d0e68c5</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1717%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DJudde%26aufirst%3DJ.%2BG.%26aulast%3DLassalle%26aufirst%3DM.%26aulast%3DPrevost%26aufirst%3DG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DSTX140%2520is%2520efficacious%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520taxane-resistant%2520breast%2520carcinoma%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26issue%3D2%26spage%3D597%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">Differential effects of estrone and estrone-3-<i>O</i>-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5441</span><span class="NLM_x">–</span> <span class="NLM_lpage">5450</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5441-5450&issue=19&author=L.+MacCarthy-Morroghauthor=P.+A.+Townsendauthor=A.+Purohitauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=Differential+effects+of+estrone+and+estrone-3-O-sulfamate+derivatives+on+mitotic+arrest%2C+apoptosis%2C+and+microtubule+assembly+in+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DTownsend%26aufirst%3DP.%2BA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3DDifferential%2520effects%2520of%2520estrone%2520and%2520estrone-3-O-sulfamate%2520derivatives%2520on%2520mitotic%2520arrest%252C%2520apoptosis%252C%2520and%2520microtubule%2520assembly%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26issue%3D19%26spage%3D5441%26epage%3D5450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummelinck, A. E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The development of A-ring modified analogues of oestrone-3-<i>O</i>-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">5–6</span><span class="NLM_x">) </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1016%2FS0960-0760%2897%2900196-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=9618028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFSqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1998&pages=269-275&issue=5%E2%80%936&author=A.+Purohitauthor=K.+A.+Vernonauthor=A.+E.+W.+Hummelinckauthor=L.+W.+L.+Wooauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+development+of+A-ring+modified+analogues+of+oestrone-3-O-sulphamate+as+potent+steroid+sulphatase+inhibitors+with+reduced+oestrogenicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The development of A-ring modified analogs of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors with reduced estrogenicity</span></div><div class="casAuthors">Purohit, A.; Vernon, K. A.; Hummelinck, A. E. Wagenaar; Woo, L. W. L.; Hejaz, H. A. M.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Steroid sulfatases regulate the formation of estrogenic steroids which can support the growth of endocrine-dependent breast tumors.  The development of potent steroid sulfatase inhibitors could therefore have considerable therapeutic potential.  Several such inhibitors have now been developed of which the most potent to date is estrone-3-O-sulfamate (EMATE).  Unexpectedly, this inhibitor proved to be a potent estrogen.  In an attempt to reduce the estrogenicity, while retaining the potent sulfatase inhibitory properties assocd. with this type of mol., a no. of A-ring modified derivs. were designed and synthesized.  A-ring modified compds. included the 2-methoxy, 2/4-nitro, 2/4-Pr and 2/4-allyl EMATE analogs.  The ability of these derivs. to inhibit estrone sulfatase activity was examd. using placental microsomes.  The allyl-substituted EMATE derivs. were more potent inhibitors than the Pr analogs but were all considerably less potent than EMATE.  In contrast, the 2-methoxy and 2/4-nitro analogs were potent sulfatase inhibitors with 4-nitro EMATE being 5 times more active than EMATE.  The 4-nitro, 2-methoxy, 4-Pr and 4-allyl derivs. were also tested in vivo for their estrogenicity and ability to inhibit sulfatase activity.  While both 4-nitro and 2-methoxy EMATE were potent inhibitors in vivo, 2-methoxy EMATE had no stimulatory effect on uterine growth in ovariectomized rats.  The identification of a potent steroid sulfatase inhibitor lacking any estrogenicity, such as 2-methoxy EMATE, should be of considerable value in evaluating the potential of steroid sulfatase inhibition for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXafBnPzDzL7Vg90H21EOLACvtfcHk0li1VTbMKeF2Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFSqsLs%253D&md5=1607054465d5934ad19e93f7e92acd14</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2900196-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252900196-9%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVernon%26aufirst%3DK.%2BA.%26aulast%3DHummelinck%26aufirst%3DA.%2BE.%2BW.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%2520A-ring%2520modified%2520analogues%2520of%2520oestrone-3-O-sulphamate%2520as%2520potent%2520steroid%2520sulphatase%2520inhibitors%2520with%2520reduced%2520oestrogenicity%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D64%26issue%3D5%25E2%2580%25936%26spage%3D269%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effect of 2-methoxyoestrone-3-<i>O</i>-sulphamate on the growth of breast cancer cells and induced mammary tumours</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">584</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=10699934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=584-589&issue=4&author=A.+Purohitauthor=H.+A.+M.+Hejazauthor=L.+Waldenauthor=L.+MacCarthy-Morroghauthor=G.+Packhamauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effect+of+2-methoxyoestrone-3-O-sulphamate+on+the+growth+of+breast+cancer+cells+and+induced+mammary+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours</span></div><div class="casAuthors">Purohit A; Hejaz H A; Walden L; MacCarthy-Morrogh L; Packham G; Potter B V; Reed M J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">584-9</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">2-Methoxyoestrogens are emerging as a new class of drug that can inhibit tumour growth and angiogenesis.  As sulphamoylation of oestrogens enhances their potency and bioavailability we have synthesized 2-methoxyoestrone-3-O-sulphamate (2-MeOEMATE) and compared its ability to inhibit the proliferation of breast cancer cells with that of 2-methoxyoestrone (2-MeOE1). 2-MeOEMATE (1 microM) inhibited the growth of oestrogen receptor positive MCF-7 breast cancer cells by 52% whereas 2-MeOE1 had little effect at this concentration. 2-MeOEMATE also inhibited the growth of oestrogen receptor negative MDA-MB-231 breast cancer cells.  Exposure of cells to 2-MeOEMATE caused them to round up and become detached suggesting that this compound may induce cells to undergo apoptosis.  Cell cycle analysis revealed that 2-MeOEMATE caused cells to arrest in the G(2)/M phase with the increase in G(2)/M arrested cells being detectable by 12 hr.  Exposure of MCF-7 cells to 2 L-MeOEMATE for 24 hr followed by culture in drug-free medium for 24 hr did not reverse the arrest of cells in the G(2)/M phase.  TUNEL analysis confirmed that 2-MeOEMATE induced apoptosis in a significant proportion of treated MCF-7 cells.  In an in vivo study, employing nitrosomethylurea-induced mammary tumours in intact rats, 2-MeOE1 (20mg/kg/d, p.o. for 11 days) had little effect on tumour growth.  In contrast, the same dose of 2-MeOEMATE resulted in the almost complete regression of 2/3 tumours over an 11-day period.  We conclude that 2-MeOEMATE should have considerable therapeutic potential for the treatment of breast tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqkhlCxw4mrynGiHuhFGv8fW6udTcc2eYbCnvlwrdx_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D&md5=75a9c5a896a1a00886a9c17cf2cbe241</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000215%252985%253A4%253C584%253A%253AAID-IJC22%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DWalden%26aufirst%3DL.%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effect%2520of%25202-methoxyoestrone-3-O-sulphamate%2520on%2520the%2520growth%2520of%2520breast%2520cancer%2520cells%2520and%2520induced%2520mammary%2520tumours%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26issue%3D4%26spage%3D584%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3135</span><span class="NLM_x">–</span> <span class="NLM_lpage">3138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3135-3138&issue=12&author=M.+P.+Leeseauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Alkylsulfanyl+estrogen+derivatives%3A+synthesis+of+a+novel+class+of+multi-targeted+anti-tumour+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Alkylsulfanyl%2520estrogen%2520derivatives%253A%2520synthesis%2520of%2520a%2520novel%2520class%2520of%2520multi-targeted%2520anti-tumour%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D12%26spage%3D3135%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-<i>O</i>-sulfamates</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1016%2Fj.jsbmb.2005.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=15862971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=239-251&issue=1%E2%80%933&author=M.+P.+Leeseauthor=B.+Leblondauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Anti-cancer+activities+of+novel+D-ring+modified+2-substituted+estrogen-3-O-sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates</span></div><div class="casAuthors">Leese, Mathew P.; Leblond, Bertrand; Newman, Simon P.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">239-251</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulfamoylated derivs. of the endogenous estrogen metabolite 2-methoxyestradiol [2-MeOE2 (I)], such as 2-methoxy-3-O-sulfamoylestrone [2-MeOEMATE (II)], display greatly enhanced activity against the proliferation of human cancer cells and inhibit steroid sulfatase (STS), another current oncol. target.  We explore here the effects of steroidal D-ring modification on the activity of such 2-substituted estrogen-3-O-sulfamates in respect of inhibition of tumor cell proliferation and steroid sulfatase.  The novel 17-deoxy analogs of 2-MeOEMATE and the related 2-Et and 2-methylsulfanyl compds. showed greatly reduced inhibition of MCF-7 proliferation.  Introduction of a 17α-benzyl substituent to such 2-substituted estrogen sulfamates also proved deleterious to anti-proliferative activity but could, in one case, enhance STS inhibition with respect to the parent substituted estrone sulfamate.  In contrast, selected 17-oxime derivs. of 2-MeOEMATE displayed an enhanced anti-proliferative activity.  These results illustrate that enhanced in vitro anti-cancer activity can be achieved in the 2-substituted estrogen sulfamate series and highlight, in particular, the importance of potential hydrogen bonding effects around the steroidal D-ring in the activity of these mols.  The SAR parameters established herein will assist the future design of anti-proliferative and anti-endocrine agents as potential therapeutics for both hormone dependent and independent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC4Cz4Pgw94bVg90H21EOLACvtfcHk0li1VTbMKeF2Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLs%253D&md5=0bc448776d6e96d5ee9f562de51eabb4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2005.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2005.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DAnti-cancer%2520activities%2520of%2520novel%2520D-ring%2520modified%25202-substituted%2520estrogen-3-O-sulfamates%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D94%26issue%3D1%25E2%2580%25933%26spage%3D239%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukroger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of C-17 cyano-substituted estratrienes as anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701319c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1295-1308&issue=5&author=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=K.+Gaukrogerauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=P.+A.+Fosterauthor=C.+Stengelauthor=S.+Regis-Lydiauthor=E.+Ferrandisauthor=A.+Di+Fioreauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Structure%E2%80%93activity+relationships+of+C-17+cyano-substituted+estratrienes+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm701319c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701319c%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DGaukroger%26aufirst%3DK.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520C-17%2520cyano-substituted%2520estratrienes%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D5%26spage%3D1295%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Jourdan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-<i>O</i>-sulfamates: synthesis, in vitro evaluation and computational modelling</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">4108</span><span class="NLM_x">–</span> <span class="NLM_lpage">4119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=4108-4119&issue=22&author=F.+Jourdanauthor=C.+Bubertauthor=M.+P.+Leeseauthor=A.+Smithauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Effects+of+C-17+heterocyclic+substituents+on+the+anticancer+activity+of+2-ethylestra-1%2C3%2C5%2810%29-triene-3-O-sulfamates%3A+synthesis%2C+in+vitro+evaluation+and+computational+modelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJourdan%26aufirst%3DF.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DEffects%2520of%2520C-17%2520heterocyclic%2520substituents%2520on%2520the%2520anticancer%2520activity%2520of%25202-ethylestra-1%252C3%252C5%252810%2529-triene-3-O-sulfamates%253A%2520synthesis%252C%2520in%2520vitro%2520evaluation%2520and%2520computational%2520modelling%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26issue%3D22%26spage%3D4108%26epage%3D4119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">3,17-Disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4431</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070405v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4431-4443&author=C.+Bubertauthor=M.+P.+Leeseauthor=M.+F.+Mahonauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=P.+G.+Kasprzykauthor=S.+P.+Newmanauthor=Y.+T.+Hoauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=3%2C17-Disubstituted+2-alkylestra-1%2C3%2C5%2810%29-trien-3-ol+derivatives%3A+synthesis%2C+in+vitro+and+in+vivo+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm070405v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070405v%26sid%3Dliteratum%253Aachs%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D3%252C17-Disubstituted%25202-alkylestra-1%252C3%252C5%252810%2529-trien-3-ol%2520derivatives%253A%2520synthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4431%26epage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Yan, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. C.</span><span> </span><span class="NLM_article-title">Dichloromethane activation. Direct methylenation of ketones and aldehydes with CH<sub>2</sub>Cl<sub>2</sub> promoted by Mg/TiCl<sub>4</sub>/THF</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">4961</span><span class="NLM_x">–</span> <span class="NLM_lpage">4963</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0478887" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4961-4963&issue=26&author=T.+H.+Yanauthor=C.+C.+Tsaiauthor=C.+T.+Chienauthor=C.+C.+Choauthor=P.+C.+Huang&title=Dichloromethane+activation.+Direct+methylenation+of+ketones+and+aldehydes+with+CH2Cl2+promoted+by+Mg%2FTiCl4%2FTHF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol0478887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0478887%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DT.%2BH.%26aulast%3DTsai%26aufirst%3DC.%2BC.%26aulast%3DChien%26aufirst%3DC.%2BT.%26aulast%3DCho%26aufirst%3DC.%2BC.%26aulast%3DHuang%26aufirst%3DP.%2BC.%26atitle%3DDichloromethane%2520activation.%2520Direct%2520methylenation%2520of%2520ketones%2520and%2520aldehydes%2520with%2520CH2Cl2%2520promoted%2520by%2520Mg%252FTiCl4%252FTHF%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26issue%3D26%26spage%3D4961%26epage%3D4963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, N.</span><span> </span><span class="NLM_article-title">Efficient general method for sulfamoylation of a hydroxyl group</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">36</span><span class="NLM_x">) </span> <span class="NLM_fpage">7047</span><span class="NLM_x">–</span> <span class="NLM_lpage">7051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=7047-7051&issue=36&author=M.+Okadaauthor=S.+Iwashitaauthor=N.+Koizumi&title=Efficient+general+method+for+sulfamoylation+of+a+hydroxyl+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DIwashita%26aufirst%3DS.%26aulast%3DKoizumi%26aufirst%3DN.%26atitle%3DEfficient%2520general%2520method%2520for%2520sulfamoylation%2520of%2520a%2520hydroxyl%2520group%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26issue%3D36%26spage%3D7047%26epage%3D7051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hartley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Main, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKiernan, G. J.</span><span> </span><span class="NLM_article-title">Titanium carbenoid reagents for converting carbonyl groups into alkenes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4825</span><span class="NLM_x">–</span> <span class="NLM_lpage">4864</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=4825-4864&issue=23&author=R.+C.+Hartleyauthor=J.+F.+Liauthor=C.+A.+Mainauthor=G.+J.+McKiernan&title=Titanium+carbenoid+reagents+for+converting+carbonyl+groups+into+alkenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHartley%26aufirst%3DR.%2BC.%26aulast%3DLi%26aufirst%3DJ.%2BF.%26aulast%3DMain%26aufirst%3DC.%2BA.%26aulast%3DMcKiernan%26aufirst%3DG.%2BJ.%26atitle%3DTitanium%2520carbenoid%2520reagents%2520for%2520converting%2520carbonyl%2520groups%2520into%2520alkenes%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26issue%3D23%26spage%3D4825%26epage%3D4864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Tsuchiya, T.</span><span> </span><span class="NLM_article-title">Chemistry and developments of fluorinated carbohydrates</span> <span class="citation_source-journal">Adv. Carbohydr. Chem. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1990&pages=91-277&author=T.+Tsuchiya&title=Chemistry+and+developments+of+fluorinated+carbohydrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuchiya%26aufirst%3DT.%26atitle%3DChemistry%2520and%2520developments%2520of%2520fluorinated%2520carbohydrates%26jtitle%3DAdv.%2520Carbohydr.%2520Chem.%2520Biochem.%26date%3D1990%26volume%3D48%26spage%3D91%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1368</span><span class="NLM_x">–</span> <span class="NLM_lpage">1376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=17426705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1368-1376&issue=9&author=S.+K.+Chanderauthor=P.+A.+Fosterauthor=M.+P.+Leeseauthor=S.+P.+Newmanauthor=B.+V.+L.+Potterauthor=A.+Purohitauthor=M.+J.+Reed&title=In+vivo+inhibition+of+angiogenesis+by+sulphamoylated+derivatives+of+2-methoxyoestradiol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol</span></div><div class="casAuthors">Chander, S. K.; Foster, P. A.; Leese, M. P.; Newman, S. P.; Potter, B. V. L.; Purohit, A.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1368-1376</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drugs that inhibit growth of tumors and their blood supply could have considerable therapeutic potential.  2-Methoxyestradiol-3,17-O,O-bis-sulfamate (2-MeOE2bisMATE) has been shown to inhibit the proliferation of MCF-7 (ER+) breast cancer cells and angiogenesis in vitro.  2-MeOE2bisMATE and its analog, 17-Cym-2-MeOE2MATE, were investigated for their ability to inhibit in vivo angiogenesis and tumor growth.  The mouse Matrigel plug assay for angiogenesis was used to investigate the effect of compds. on neovascularization and was quantified using a FITC-dextran injection technique.  Nude mice bearing tumors derived from MCF-7 cells were used to assess efficacy on tumor growth.  Tumor sections were stained for VEGFR-2 and Ki67 to assess tumor angiogenesis and cell proliferation resp.  Matrigel plugs supplemented with basic fibroblast growth factor resulted in increased neovascularization over 7 days.  Oral administration of 2-MeOE2bisMATE for 7 days at 10 or 50 mg kg-1 significantly reduced neovascularization to or below control levels resp.  17-Cym-2-MeOE2MATE at 20 mg kg-1 was equally effective.  2-MeOE2bisMATE, dosed daily for 21 days, caused a 52% redn. in tumor growth at 5 mg kg-1 and 38% regression at 20 mg kg-1.  17-Cym-2-MeOE2MATE (20 mg kg-1) reduced tumor growth by 92%.  Immunohistochem. revealed a redn. in angiogenesis and proliferation.  Matrigel plug and tumor imaging after FITC-dextran injection indicated that 2-MeOE2bisMATE caused a marked disruption of vasculature.  These sulfamoylated estrogen derivs. have been shown to be potent inhibitors of angiogenesis in vivo.  This, together with their ability to inhibit tumor growth, indicates the potential of this new class of drugs for further development for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqermbvXLYR8LVg90H21EOLACvtfcHk0lg4ylvUfCkuvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslyisro%253D&md5=a589de69ba3adc8e5ca93cff2cda1ede</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520angiogenesis%2520by%2520sulphamoylated%2520derivatives%2520of%25202-methoxyoestradiol%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26issue%3D9%26spage%3D1368%26epage%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Laurence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Questel, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, E.</span><span> </span><span class="NLM_article-title">The pK(BHX) database: toward a better understanding of hydrogen-bond basicity for medicinal chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4073</span><span class="NLM_x">–</span> <span class="NLM_lpage">4086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801331y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4073-4086&issue=14&author=C.+Laurenceauthor=K.+A.+Brameldauthor=J.+Gratonauthor=J.+Y.+Le+Questelauthor=E.+Renault&title=The+pK%28BHX%29+database%3A+toward+a+better+understanding+of+hydrogen-bond+basicity+for+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The pKBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists</span></div><div class="casAuthors">Laurence, Christian; Brameld, Ken A.; Graton, Jerome; Le Questel, Jean-Yves; Renault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4073-4086</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pKBHX database is presented, which corresponds to three main fields of data: hydrogen bond donor identification, thermodn. data and spectroscopic data.  The pKBHX scale of hydrogen donor basicity differs considerable from the pKBH+ scale of proton transfer basicity.  The hydrogen bond basicities of functional groups relevant to medicinal chem. and drug design is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9OhmMu2VILVg90H21EOLACvtfcHk0lg4ylvUfCkuvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKns7w%253D&md5=9ce4bea3e810752baba6ea5784b55ea0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm801331y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801331y%26sid%3Dliteratum%253Aachs%26aulast%3DLaurence%26aufirst%3DC.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DGraton%26aufirst%3DJ.%26aulast%3DLe%2BQuestel%26aufirst%3DJ.%2BY.%26aulast%3DRenault%26aufirst%3DE.%26atitle%3DThe%2520pK%2528BHX%2529%2520database%253A%2520toward%2520a%2520better%2520understanding%2520of%2520hydrogen-bond%2520basicity%2520for%2520medicinal%2520chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D14%26spage%3D4073%26epage%3D4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hollingshead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alley, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camalier, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malspeis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span> </span><span class="NLM_article-title">In vivo cultivation of tumor cells in hollow fibres</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1995&pages=131-141&author=M.+Hollingsheadauthor=M.+C.+Alleyauthor=R.+F.+Camalierauthor=B.+J.+Abbottauthor=J.+G.+Mayoauthor=L.+Malspeisauthor=M.+R.+Grever&title=In+vivo+cultivation+of+tumor+cells+in+hollow+fibres"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DAlley%26aufirst%3DM.%2BC.%26aulast%3DCamalier%26aufirst%3DR.%2BF.%26aulast%3DAbbott%26aufirst%3DB.%2BJ.%26aulast%3DMayo%26aufirst%3DJ.%2BG.%26aulast%3DMalspeis%26aufirst%3DL.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26atitle%3DIn%2520vivo%2520cultivation%2520of%2520tumor%2520cells%2520in%2520hollow%2520fibres%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D57%26spage%3D131%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_contrib-group">Passaniti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pili, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. R.</span><span> </span><span class="NLM_article-title">Methods in laboratory investigation—a simple, quantitative method fot assessing angiogenesis and antiangiogenic agents using reconstituted base-membrane, heparin, and fibroblast growth-factor</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1992&pages=519-528&issue=4&author=A.+Passanitiauthor=R.+M.+Taylorauthor=R.+Piliauthor=Y.+Guoauthor=P.+V.+Longauthor=J.+A.+Haneyauthor=R.+R.+Paulyauthor=D.+S.+Grantauthor=G.+R.+Martin&title=Methods+in+laboratory+investigation%E2%80%94a+simple%2C+quantitative+method+fot+assessing+angiogenesis+and+antiangiogenic+agents+using+reconstituted+base-membrane%2C+heparin%2C+and+fibroblast+growth-factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPassaniti%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DR.%2BM.%26aulast%3DPili%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DP.%2BV.%26aulast%3DHaney%26aufirst%3DJ.%2BA.%26aulast%3DPauly%26aufirst%3DR.%2BR.%26aulast%3DGrant%26aufirst%3DD.%2BS.%26aulast%3DMartin%26aufirst%3DG.%2BR.%26atitle%3DMethods%2520in%2520laboratory%2520investigation%25E2%2580%2594a%2520simple%252C%2520quantitative%2520method%2520fot%2520assessing%2520angiogenesis%2520and%2520antiangiogenic%2520agents%2520using%2520reconstituted%2520base-membrane%252C%2520heparin%252C%2520and%2520fibroblast%2520growth-factor%26jtitle%3DLab.%2520Invest.%26date%3D1992%26volume%3D67%26issue%3D4%26spage%3D519%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_contrib-group">Prewett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overholser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pytowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohlen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span> </span><span class="NLM_article-title">Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">5209</span><span class="NLM_x">–</span> <span class="NLM_lpage">5218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5209-5218&issue=20&author=M.+Prewettauthor=J.+Huberauthor=Y.+W.+Liauthor=A.+Santiagoauthor=W.+O%E2%80%99Connorauthor=K.+Kingauthor=J.+Overholserauthor=A.+Hooperauthor=B.+Pytowskiauthor=L.+Witteauthor=P.+Bohlenauthor=D.+J.+Hicklin&title=Antivascular+endothelial+growth+factor+receptor+%28fetal+liver+kinase+1%29+monoclonal+antibody+inhibits+tumor+angiogenesis+and+growth+of+several+mouse+and+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrewett%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%2BW.%26aulast%3DSantiago%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DW.%26aulast%3DKing%26aufirst%3DK.%26aulast%3DOverholser%26aufirst%3DJ.%26aulast%3DHooper%26aufirst%3DA.%26aulast%3DPytowski%26aufirst%3DB.%26aulast%3DWitte%26aufirst%3DL.%26aulast%3DBohlen%26aufirst%3DP.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26atitle%3DAntivascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528fetal%2520liver%2520kinase%25201%2529%2520monoclonal%2520antibody%2520inhibits%2520tumor%2520angiogenesis%2520and%2520growth%2520of%2520several%2520mouse%2520and%2520human%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26issue%3D20%26spage%3D5209%26epage%3D5218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twentyman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embleton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J.</span><span> </span><span class="NLM_article-title">United Kingdom Co-Ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition)</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1038%2Fbjc.1998.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1998&pages=1-10&issue=1&author=P.+Workmanauthor=P.+Twentymanauthor=F.+Balkwillauthor=A.+Balmainauthor=D.+Chaplinauthor=J.+Doubleauthor=J.+Embletonauthor=D.+Newellauthor=R.+Raymondauthor=J.+Stablesauthor=T.+Stephensauthor=J.+Wallace&title=United+Kingdom+Co-Ordinating+Committee+on+Cancer+Research+%28UKCCCR%29+guidelines+for+the+welfare+of+animals+in+experimental+neoplasia+%28second+edition%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1998.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1998.1%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DTwentyman%26aufirst%3DP.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DChaplin%26aufirst%3DD.%26aulast%3DDouble%26aufirst%3DJ.%26aulast%3DEmbleton%26aufirst%3DJ.%26aulast%3DNewell%26aufirst%3DD.%26aulast%3DRaymond%26aufirst%3DR.%26aulast%3DStables%26aufirst%3DJ.%26aulast%3DStephens%26aufirst%3DT.%26aulast%3DWallace%26aufirst%3DJ.%26atitle%3DUnited%2520Kingdom%2520Co-Ordinating%2520Committee%2520on%2520Cancer%2520Research%2520%2528UKCCCR%2529%2520guidelines%2520for%2520the%2520welfare%2520of%2520animals%2520in%2520experimental%2520neoplasia%2520%2528second%2520edition%2529%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1998%26volume%3D77%26issue%3D1%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Appel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, G.</span><span> </span><span class="NLM_article-title">Uber das hydrazidosulfamid (on hydrazidosulfamide)</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1958</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1339</span><span class="NLM_x">–</span> <span class="NLM_lpage">1341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1958&pages=1339-1341&author=R.+Appelauthor=G.+Berger&title=Uber+das+hydrazidosulfamid+%28on+hydrazidosulfamide%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DR.%26aulast%3DBerger%26aufirst%3DG.%26atitle%3DUber%2520das%2520hydrazidosulfamid%2520%2528on%2520hydrazidosulfamide%2529%26jtitle%3DChem.%2520Ber.%26date%3D1958%26volume%3D91%26spage%3D1339%26epage%3D1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightowler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm200483x&amp;key=10.1016%2F0960-0760%2895%2900244-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm200483x&amp;key=8645620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200483x&amp;key=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1996&pages=79-88&issue=1%E2%80%932&author=L.+W.+L.+Wooauthor=M.+Lightowlerauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Heteroatom-substituted+analogues+of+the+active-site+directed+inhibitor+estra-1%2C3%2C5%2810%29-trien-17-one-3-sulphamate+inhibit+estrone+sulphatase+by+a+different+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Hetero atom-substituted analogs of the active-side directed inhibitor estra-1,3,5(10)-triene-17-one-3-sulfamate inhibit estrone sulfatase by a different mechanism</span></div><div class="casAuthors">Woo, L. W. Lawrence; Lightowler, Mark; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Estrogens have a pivotal role in the growth and development of hormone-dependent breast cancers.  In postmenopausal women, the hydrolysis of the conjugate estrone sulfate (E1S) to estrone (E1) by the enzyme estrone sulfatase is the major source of breast tumor estrogen.  Inhibitors of estrone sulfatase should therefore have considerable therapeutic potential for the treatment of hormone-dependent tumors of the breast, either as the sole agent or in conjunction with aromatase inhibitors.  Several inhibitors of estrone sulfatase have now been developed of which estra-1,3,5(10)-trien-17-one-3-sulfamate (EMATE) is the most potent and also inhibits the enzyme in a time- and concn.-dependent manner, showing that it acts as an irreversible inhibitor.  Analogs of EMATE in which the 3-O-atom is replaced by other heteroatoms (S and N) were prepd. and tested for inhibition against estrone sulfatase.  3-Methoxyphenylsulfamide, 4-chlorothiophenyl-S-(N,N-dimethyl)sulfamate, estra-1,3,5(10)-trien-17-one-3-sulfamide, estra-1,3,5(10)-trien-17-one-3-S-sulfamate, and estra-1,3,5(10)-trien-17-one-3-S-(N,N-dimethyl)sulfamate inhibited estrone sulfatase weakly, but none of these compds. appears to behave as a time-dependent inhibitor.  A model of the mechanism of enzyme inhibition by EMATE is proposed and the authors conclude that the sulfamate bridging oxygen atom of EMATE is essential for active site-directed inhibition of estrone sulfatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlWZCRBBmXtLVg90H21EOLACvtfcHk0liiZI5P-Uz3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D&md5=ce13a9f57587179a9d5a3a104fd67740</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900244-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900244-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLightowler%26aufirst%3DM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHeteroatom-substituted%2520analogues%2520of%2520the%2520active-site%2520directed%2520inhibitor%2520estra-1%252C3%252C5%252810%2529-trien-17-one-3-sulphamate%2520inhibit%2520estrone%2520sulphatase%2520by%2520a%2520different%2520mechanism%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D57%26issue%3D1%25E2%2580%25932%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i82"><a href="/doi/suppl/10.1021/jm200483x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_45048"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis results and <sup>13</sup>C NMR data. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200483x/suppl_file/jm200483x_si_001.pdf">jm200483x_si_001.pdf (86.1 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200483x&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-13%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm200483x" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200483x" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799811bdc043c76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
